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Abstract 
Background 
Unintended pregnancy and sexually transmitted infections among young people are 
priority public health issues in the UK. Social marketing is the preferred Government 
approach to intervention despite limited evidence on efficacy. There is need to understand 
its applicability and effectiveness in addressing the specified sexual health issues. 
 
Methods 
Three studies were carried out, of which the first was a systematic review of 12 studies 
assessing the effectiveness of social marketing in reducing unintended teenage 
pregnancies. The second and third were consumer research applications examining factors 
associated with Long Acting Reversible Contraceptive (LARC) use and Chlamydia 
screening respectively. The second study involved analysing five ONS Contraception 
survey datasets while the third involved analysing Havering PCT Chlamydia screening 
records and qualitative data from 28 participants. Data were analysed using Stata.10 and 
Framework statistical packages and maps drawn using MapInfo.10.5 
 
Results 
The systematic review showed that nine studies achieved significant effects on at least one 
of the specified outcomes (reduced pregnancy rates and related behaviour changes). The 
second study showed that the NICE guidelines published in 2005 successfully addressed 
the disparity in LARC uptake previously experienced by women aged below 20.  The third 
study identified females and non-white participants as more likely to take Chlamydia tests. 
Motivating factors for testing included convenient access to kits and fear of infertility, 
while barriers included ignorance and fear of results. 
 
Conclusion 
Social marketing appears to be effective in reducing unintended teenage pregnancies but 
evidence is limited to particular outcomes and context. Consumer research provides vital 
intelligence about target populations necessary for designing effective interventions and 
addressing inequalities. However to assess its influence on outcomes, studies that feature 
all social marketing components are required. Overall there is need for more studies that 
specifically utilize social marketing principles to enable more robust evaluations. 
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Chapter 1: Introduction 
Young people’s sexual health is of immense significance to public health. This is because 
the adverse consequences of unsafe sexual behaviour such as unintended pregnancy and 
sexually transmitted infections  (STI) affect not only individual young people and their 
families but the wider society as well (Nicoll et al., 1999; Department of Health, 2004; 
Tripp & Viner, 2005; Healthcare Commission, 2007;Department of Health, 2009c). 
Evidence shows that unintended teenage pregnancy is associated with poor health, social, 
educational and economic outcomes for the affected mother and child (Seamark & Pereira 
Gray, 1997; Swann et al., 2003; Berrington et al., 2005; Imamura et al., 2007). Chlamydia 
trachomatis which is the most common sexually transmitted infection among young people 
in the UK if untreated can lead to infertility and increased susceptibility to Human 
Immunodeficiency Virus (HIV) (Cohen et al., 2000; Farley et al., 2003; McClure et al., 
2006). The financial implications of sexual ill health to the national economy are 
significant. The UK which has the highest teenage pregnancy and abortion rates in Western 
Europe spends approximately £500 million annually on unintended pregnancy related 
interventions such as abortion, miscarriage and live birth services (Bayer Health Care & 
Bayer Schering Pharma, 2008) and another £100 million annually on management of 
Chlamydia related complications such as infertility, ectopic pregnancy and pelvic 
inflammatory disease (The National Chlamydia Screening Programme, 2009). 
 
Policy Context 
In England, sexual health is considered a key public health issue (Healthcare Commission, 
2007; Guilleband, 2007; Department of Children, Schools and Families, 2010; Family 
Planning Association, 2010). The current sexual health strategy is based on a policy 
document published by the Department of Health in 2001 entitled, “Better Prevention 
Better Services, Better Sexual Health: The National Strategy for Sexual Health and HIV” 
(Department of Health, 2001a). The strategy’s main aims are: 
 
 To reduce the transmission of HIV & STIs 
 To reduce unintended pregnancy rates 
 To reduce the prevalence of undiagnosed HIV & STIs 
 To improve the health and social care of people living with HIV 
 To reduce the stigma associated with HIV & STIs. 
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The Government’s vision has been to modernise sexual health services, make them more 
accessible, comprehensive and based on patient need (Department of Health, 2001a; The 
Medical Foundation for AIDS & Sexual Health (MedFASH), 2008). Prior to the 
publication of the strategy, evaluations carried out had indicated that sexual health services 
in England were fragmented, poorly advertised, inaccessible in some parts of the country 
and too narrowly focused (Department of Health, 2001a). The strategy has mainly four 
dimensions to its approach: 
 
 Strengthening the prevention of ill sexual health by providing appropriate 
information to people of all ages and targeting specific groups known to be at 
high risk of ill sexual health such as young people. 
 Improving the quality of services by making them comprehensive. These 
include contraception and abortion services, diagnosis and treatment of STI, 
offering psychological support at GP practices, Community Family Planning 
and Genitourinary Medicine (GUM) clinics and specific services for vulnerable 
groups such as young people. 
 Better commissioning of sexual health services by Primary Care Trusts (PCTs) 
that are responsive to local needs, multi-agency, multidisciplinary and involves 
users, with clear targets and outcomes. 
 Supporting change through improved information and data collection, improved 
evidence base and staff development and training. 
 
In order to monitor and support the implementation of the strategy an independent advisory 
group (IAG) on Sexual Health and HIV was formed in 2003. This followed concerns that 
the strategy was having no impact on improving population sexual health (The Medical 
Foundation for AIDS & Sexual Health (MedFASH), 2008). In the same year (2003), the 
Government introduced the National Chlamydia Screening Programme targeting young 
people below age 25 whom evidence had shown were most affected. The programme 
continues to be implemented by Primary Care Trusts and in a variety of health and non-
healthcare settings such as youth services, prisons, colleges and military bases (The 
National Chlamydia Screening Programme, 2009). In 2005, the National Institute for 
Clinical Excellence (NICE) commissioned by the Department of Health published 
guidelines on promoting use of Long Acting Reversible Contraceptives (LARC) among 
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women of reproductive age. This was to address the high rate of unintended pregnancies 
which evidence had shown were mostly due to reliance on methods with high failure rate 
such as pills and condoms (Schunmann & Glasier, 2006; Rowlands, 2007). 
 
The need to address health behaviour as a key determinant of population health was first 
highlighted in the Acheson report in 1998 (Department of Health, 1998). Previously the 
public health policy in England was mainly focused on meeting morbidity and mortality 
reduction targets through an improved health care service (Department of Health, 2004; 
Wanless, 2004; Department of Health, 1992), hence the infamous reference to the National 
Health Service (NHS) as a “National Sickness Service” (Wanless, 2004). Although there 
had been efforts towards encouraging people to lead healthy lifestyles in the past, the 
approach was often “top down” and passive, mainly consisting of mass media campaigns 
coordinated by the Health Education Authority (HEA) (Department of Health, 2004; 
Wanless, 2004). The closure of the HEA in 2000 and transfer of health education function 
to Department of Health appears not to have helped as observed by the Wanless report: 
 
“At a time when full engagement requires the public and the health workforce to 
have more support, it has been noted that the educational role, previously played by 
the Health Education Authority, is not a clearly assigned responsibility. There is no 
single easily accessible source of advice for interested or confused individuals” 
(Wanless, 2004, p.185).  
 
Wanless (2004) further noted that the approach to health behaviour change was having a 
minimal impact due to what he termed as “information failure”. This was attributed to the 
failure to craft messages carefully according to target audiences and desired outcomes. The 
report recommended the undertaking of market research within target populations and 
using results to design interventions that would fully engage the population. The choice of 
social marketing
1
 as the preferred model to achieve this was first articulated and published 
in the 2004 Public Health White Paper (Department of Health, 2004). The publication 
highlighted the potential of social marketing in building public awareness and facilitating 
health behaviour change. This was followed by the commissioning of an independent 
                                                 
1
 Social marketing in health is defined as the systematic application of marketing concepts and techniques to 
achieve specific behavioural goals in order to improve health and reduce health inequalities (National Social 
Marketing Centre, 2007). 
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review to explore the potential of social marketing in augmenting national and local health 
improvement initiatives. As a result of this review, the National Social Marketing Centre 
(NSMC) was established in 2006 as a strategic partnership between the Department of 
Health and the National Consumer Council. To date the NSMC has implemented several 
pilot projects in sexual health e.g. the Chlamydia Outreach Advice Screening and 
Treatment (COAST) programme in Yorkshire and Humber and the Design and Sexual 
Health Programme in North East England which have reported promising outcomes 
(National Social Marketing Centre, 2011).  
 
Research Projects 
Whereas there is substantial evidence on the effectiveness and application of social 
marketing principles in health behaviour change initiatives in the developing countries 
(Centres for Disease Control and Prevention, 2005; National Social Marketing Centre, 
2009; Centres for Disease Control and Prevention, 2011), in the UK and other developed 
countries the evidence base is limited owing to the relatively recent adoption of the 
approach. The three studies reported in this thesis therefore address this identified gap by 
firstly assessing the effectiveness of a social marketing approach in reducing unintended 
teenage pregnancies. Secondly, by exploring the application of the consumer 
research/orientation component of social marketing in the understanding of factors 
associated with the use of Long Acting Reversible Contraceptives, the uptake of 
Chlamydia screening services and Chlamydia prevalence among young people. The 
following were the specific aims of the three studies: 
 
 To determine the effectiveness of a social marketing approach in the reduction of 
unintended teenage pregnancies in developed countries. 
 To examine factors associated with use of Long Acting Reversible Contraceptives 
among young women aged 16-24 in the UK. 
 To determine factors associated with Chlamydia screening and prevalence among 
young people of ages 16-24 living in the London Borough of Havering. 
 
The first study (Unintended teenage pregnancy) was a systematic review of research 
conducted in the UK and USA. The study was carried out during my first internship at the 
National Social Marketing Centre, London in 2008. The institution was by then newly 
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established and was engaged in building an evidence base on the effectiveness of social 
marketing in various health behaviour change interventions including sexual health. 
Professor Jeff French who was the director at the centre provided the necessary supervision 
throughout the internship period while liaising with my academic supervisors at the 
graduate school (Professors Daniel Reidpath and Pascale Allotey). The second study (Long 
Acting Reversible Contraceptives) involved analysing five data sets of the Office for 
National Statistics (ONS) Opinion Surveys on contraception use carried out between 2002 
and 2007. The study was conducted entirely at the graduate school with supervision from 
Dr Geraldine Barrett and Professor Daniel Reidpath. The third study (Chlamydia 
screening) was carried out during my second internship with the National Health Service 
(NHS) at Havering, London (2009-2010) and involved analysing records of young people 
who had been screened for Chlamydia between September 2008 and August 2009. I also 
collected qualitative data from 28 young people on their perceptions of barriers and 
motivating factors in relation to Chlamydia screening. The Chlamydia screening 
programme at NHS Havering where the study was undertaken was then newly established 
and struggling to meet the set national target of screening at least 17% of the 16 – 24 year 
olds population. The coordinating team was therefore interested in developing a strategy 
that would enhance screening uptake by identifying and addressing key factors among the 
target population. The study was therefore designed in response to this need. Supervision 
was provided by my academic supervisors in collaboration with the NHS Havering’s 
associate director for health improvement Dr. Louise Dibsdall. 
 
Overview of Chapters 
The thesis consists of seven chapters. In Chapter 2, I review the available evidence on the 
application of social marketing principles in young people’s sexual health interventions in 
general and specifically to the three areas of study (Unintended teenage pregnancy, Long 
Acting Reversible Contraception and Chlamydia screening). In Chapter 3, I describe the 
first study on the effectiveness of a social marketing approach in the reduction of 
unintended teenage pregnancies and in Chapter 4, the second study on factors associated 
with use of LARC methods among young women aged 16-24 in the UK. In Chapter 5, I 
describe the third study on factors associated with Chlamydia prevalence and screening 
uptake among young people living in the London borough of Havering. Each of the three 
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chapters (3, 4 & 5) features an introduction section describing the rationale for the study, 
policy context and a discussion on evidence from other related studies, a methods section 
with a list of the study’s aim and objectives, and a description of methods and ethics 
approval process. Also included is a results section with findings from analyses, a 
discussion section with a review of main findings, their implications for public health 
policy/practice and social marketing and study strengths/limitations. The last sections 
include conclusions, recommendations and suggestions for further research. In Chapter 6, I 
discuss the main findings from the three studies and their implications for public health 
policy and practice in the UK. In Chapter 7, I highlight the main findings from the three 
studies and draw conclusions on the effectiveness and applicability of social marketing in 
reducing unintended teenage pregnancies, increasing LARC uptake and Chlamydia 
screening among young people and make suggestions on further research. 
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Chapter 2: Literature Review 
In this chapter, I explain what social marketing is and provide a brief history of its origin 
and adoption in public health.  I also review available evidence on the application of social 
marketing principles in young people’s sexual health interventions in general and 
specifically to the three areas of study (unintended teenage pregnancy, long acting 
reversible contraception and Chlamydia screening). 
 
2.1. What is Social Marketing? 
Social Marketing was first explicitly defined in 1971 by Kotler & Zaltman (1971, p.5) as:  
 
“The application of principles and tools of marketing to achieve socially desirable 
goals, with benefits for society as a whole rather than for profit or other 
organizational goals and includes the design, implementation and control of 
programs calculated to influence the acceptability of social ideas and involves 
considerations of product planning, pricing, communications and market research.” 
 
Although since then other social marketing definitions have emerged (Kotler et al. 2002; 
Maibach, 2002; Andreasen, 2002), they appear similar with all emphasising the use of 
marketing principles for social good. The most widely used definition in the UK public 
health sector is by the National Social Marketing Centre which states: 
 
“Social marketing is the systematic application of marketing concepts and 
techniques, to achieve specific behavioural goals to improve health and reduce 
health inequalities” (French & Blair Stevens, 2007, p.33).  
 
The original idea of social marketing is accredited to Wiebe who in 1952 in an article 
entitled, “Merchandising Commodities and Citizenship on Television,” he demonstrated 
how mass media campaigns can motivate people to take action, and challenged the 
marketing community by asking, “Why can’t you sell brotherhood and rational thinking 
like you sell soap?” (Weibe, 1952). This became the precursor to serious thinking about 
marketing methods being successfully used to influence behaviour in the commercial 
sector being transferred to the non-profit area (Gordon et al., 2006). The unique aspect of 
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social marketing is indeed thought to be the application of marketing tools that have been 
proven to work in commercial marketing to the resolution of social and health problems 
(Lazer & Kelley, 1973).The adoption of social marketing principles to social causes 
initially met resistance from traditional marketers. Luck (1974) for example objected to the 
concept of replacing marketing of tangible products with ideas/values and thought this 
threatened the economic exchange concept. Others feared it would lead to social control 
and propaganda (Laczniak et al., 1979). However, the opposition appears to have helped 
the proponents of social marketing to refine their ideas and address cited ethical concerns 
(McFadyen et al., 1999). 
 
2.2 Features of social marketing 
Social marketing it is argued is not a theory but rather a discipline that draws from other 
bodies of knowledge such as sociology, anthropology and communication to understand 
how to influence people’s behaviour (Kotler & Zaltman, 1971). Social marketing has 
mainly four features that distinguish it from other health improvement approaches: 
 
 Behavioural change is voluntary i.e. not by coercion or enforcement. 
 It operates on the principle of exchange i.e. there has to be a clear benefit for the 
customer (target group or individual) if change is to occur. 
 Uses marketing techniques such as consumer oriented market research, 
segmentation and targeting and marketing mix. 
 The ultimate goal is to improve individual and societal welfare not make profit for 
the organization carrying out the intervention as is the case with commercial 
marketing. 
       (Houston & Gassenheimer, 1987; MacFadyen et al. 2002)  
Andreasen (2002) further clarifies what a social marketing approach to health 
improvement and behaviour change entails by describing what he terms as the essential 
benchmarks of a genuine social marketing approach. He names the six main components 
as: consumer research/orientation, specific behaviour change goal, segmentation and 
targeting, marketing mix, exchange and competition. More recently, the National Social 
Marketing Centre, England reviewed the six bench mark criteria and included two more 
components namely, “Insight Driven” and “Theory Based and Informed.” The two 
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components emphasize the need for deep understanding (insight) of what moves and 
motivates consumers and for interventions to be guided by behavioural theory respectively. 
The eight components in total make up the National Bench Mark Criteria for England 
which guides policy and strategy development as well as implementation and delivery of 
social marketing interventions (National Social Marketing Centre, 2007). The six 
components of social marketing as originally defined by Andreasen (2002) are summarised 
in Table 2.1 and thereafter discussed. 
 
Table 2.1: Andreasen’s benchmark criteria for social marketing interventions 
 
Benchmark Explanation 
Behaviour change Intervention seeks to change behaviour and has 
specific measurable behavioural objectives. 
 
Consumer research Intervention is based on an understanding of consumer 
experiences, values and needs. Formative research is 
conducted to identify these. Intervention elements are 
pre-tested with the target group. 
 
Segmentation and targeting Different segmentation variables are considered when 
selecting the intervention target group. Intervention 
strategy is tailored for the selected segment/s. 
 
Marketing mix Intervention considers the best strategic application of 
the “marketing mix”. This consists of the four Ps of 
“product”, “price”, “place” and “promotion”. Other Ps 
might include “policy change” or “people” (e.g. 
training is provided to intervention delivery agents). 
Interventions which only use the promotion P are 
social advertising, not social marketing. 
 
Exchange Intervention considers what will motivate people to 
engage voluntarily with the intervention and offers 
them something beneficial in return. The offered 
benefit may be intangible (e.g. personal satisfaction) 
or tangible (e.g. rewards for participating in the 
programme and making behavioural changes). 
 
Competition Competing forces to the behaviour change are 
analysed. Intervention considers the appeal of 
competing behaviours (including current behaviour) 
and uses strategies that seek to remove or minimise 
this competition. 
Source:  (Andreasen, 2002)  
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Behaviour Change 
Behaviour change by clients leading to the adoption of suggested health behaviour is the 
ultimate goal in social marketing. This could be use of a particular health product such as 
contraception or a particular service such as taking a Chlamydia or HIV test. However 
other desired process related outcomes may include raised awareness of health service or 
increase in knowledge on how to access appropriate healthcare. In social marketing it is 
recommended that the desired behaviour change is clearly defined and be supported by 
Specific, Measurable, Realistic and Time bound (SMART) objectives to guide the 
implementation and evaluation process (National Social Marketing Centre, 2007; French et 
al., 2010).  
 Consumer Research/Orientation 
In commercial marketing, a commitment to understanding consumers of a product or 
service is emphasised. This is based on the fact that the consumers’ needs and wants 
determine whether a product or service will be bought or not. In social marketing, the same 
principle applies, as there is a need to understand the people whose behaviour an 
intervention intends to change (Andreasen, 1995). Formative research with the target 
population is therefore important in understanding what motivates or deters people from 
adopting recommended behaviours such as using a condom for protection against sexually 
transmitted infections (STI), or taking a Chlamydia test. Consumer research also provides 
vital information on population subgroups and their social cultural environment  which is 
important in making decisions on what segments of the population to target and how (Grier 
& Bryant, 2005). Consumer research also includes other stakeholders who are not 
necessarily beneficiaries such as community leaders, health workers and other 
professionals who may have significant impact on programme implementation (National 
Social Marketing Centre, 2007). Consumer research therefore can be described as the main 
foundation for social marketing interventions. 
 
Audience Segmentation & Targeting  
This component is derived from consumer research and uses its results to differentiate 
populations into subgroups or segments of people who share needs, wants, lifestyles, 
behaviour and values that make them more likely to respond to public health interventions. 
These include gender, age, ethnicity and socio-economic status but also include distinct 
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current behaviour such as high and low risk sexual behaviour or use or non-use of 
contraception. The identification of target segments is crucial in the design of the 
marketing mix component (Grier & Bryant, 2005; French et al., 2010). 
 
Competition 
Whereas in commercial marketing competition refers to products and companies that try to 
satisfy similar needs and wants as the product being promoted, in social marketing, 
competition refers to behavioural options that compete with public health 
recommendations such as the glamorisation of risky sexual behaviour, alcohol and drug 
misuse among youth by some television channels, music and magazines (Grier & Bryant, 
2005). A social marketer would therefore in designing an intervention consider how to 
counter the existing competition and develop a sustainable competitive advantage 
(Hastings, 2007).  
 
Exchange 
Contrary to commercial exchanges where a consumer receives a product for cash, in public 
health situations rarely is there an immediate, explicit payback to target audiences in return 
for their adoption of specified health behaviour. This in the past has been considered a 
significant barrier to health behaviour change and uptake of some services such as 
screening which have no immediate rewards. Social marketing therefore emphasises the 
need to consider using incentives either tangible or intangible and outlining that clearly to 
the consumer/client who must feel that he or she is receiving valued benefits in return of 
effort (National Social Marketing Centre, 2007; Grier & Bryant, 2005). 
Marketing mix 
In commercial marketing, the main goal is about getting the right “product” at the right 
“price,” in the right “place,” presented in such way as to satisfy the consumer 
(“promotion”). These are in brief termed as the four Ps of marketing and make up what is 
also called the marketing mix which has been adopted by social marketing as a key 
component of its approach (Stead & Hastings, 1997; Kotler, 1999). 
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Product 
In social marketing a product may be tangible (for example, contraceptives, Chlamydia test 
kit or medication) or intangible (for example, health education or counselling service) 
(National Social Marketing Centre, 2007). 
 
Price 
Unlike commercial marketing where price refers to the monetary cost of buying a product, 
in social marketing this represents what consumers must give up if they are to adopt a 
certain health behaviour often emotional and psychological e.g. looking different in one’s 
peer group e.g. taking a Chlamydia test which is often stigmatised or practical efforts such 
as seeking for a screening kit at a sexual health clinic or attending a health talk (National 
Social Marketing Centre, 2007). 
 
Place 
Place refers to channels by which a particular product is made available to consumers in 
commercial marketing. In social marketing this refers to places in which consumers can 
obtain certain products such as contraceptives or services such as screening or counselling. 
Place includes settings such as working places, homes, schools, colleges, and health 
institutions (National Social Marketing Centre, 2007). 
 
Promotion 
As in commercial marketing this refers to the means and messages by which the benefits of 
a particular product or behaviour change are communicated. Most common means include 
advertisement (radio, televisions, billboards), leaflets, posters, dedicated websites and 
community outreach activities. However, social marketers have since recognised  the 
limitations of applying the four Ps to public health, and therefore also recommend that 
building “partnerships” with other stakeholders,  influencing “policy” and “politics” for the 




Branding is considered a vital aspect of a marketing mix strategy. A brand is defined as a 
name, term, sign, logo, symbol or design or a combination of them intended to identify the 
goods or services of one seller or a group of sellers and to differentiate them from those of 
  21 
other competing sellers (Hastings, 2007; French et al., 2010). The importance of branding 
has been proven in commercial marketing and is now increasingly used in social marketing 
interventions. The creation of a powerful brand that would engage with the target audience 
and influence its position in the market in relation to similar or opposing products or 
services involves understanding the needs and wants of customers achieved through 
conducting a robust consumer research (French et al., 2010). A successful brand reinforces 
the functional and emotional benefits of a product or service or behaviour hence 
encouraging consumption, behaviour change and loyalty (Hastings, 2007). Examples of 
social marketing interventions where branding has been successfully employed include 
The Florida Anti-smoking Truth campaign (The Social Marketing Institute, 2011), The 
VERB Summer Score Card – a physical activity promotion programme (Wong et al., 
2004) and The Heart Truth (Long et al. 2008). 
 
2.3 Social marketing and Public health 
The adoption of social marketing by public health is thought to have been formalized when 
Weibe (1952) evaluated four different social change campaigns in the United States of 
America (USA) and concluded that the more similarity they had with commercial 
marketing, the more successful they were. Public health experts developed and refined this 
thinking by examining international development efforts where social marketing was being 
used mainly in family planning and disease control and made a similar observation 
(Manoff, 1985; Gordon et al., 2006). Although initially social marketing was mainly 
practiced in developing countries, the approach has spread rapidly to most developed 
countries in the past two decades (Centres for Disease Control and Prevention, 2005). In 
the USA social marketing is increasingly being advocated as the core public health strategy 
for influencing voluntary behaviours such as smoking, drinking, drug use and diet (Centres 
for Disease Control and Prevention, 2005). In the UK the potential for social marketing 
was recognized in the 2004 Public Health White Paper (Department of Health, 2004) 
which highlighted the power of social marketing and marketing tools being used to build 
public awareness and behaviour change. This was followed by the creation of the National 
Social Marketing Centre in 2005 with a mission to help realize the full potential of 
effective social marketing in contributing to national and local efforts to improve health 
and reduce health inequality (Gordon et al., 2006). The National Social Marketing Centre 
in collaboration with the Department of Health released the first strategic framework for 
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maximizing the potential of social marketing and health related behaviour in 2008 
(Department of Health, 2008a). In 2009 a specific social marketing and sexual health 
strategy document was published which has since guided the implementation of 
government sexual health programmes (Department of Health, 2009d). More recently the 
UK Department of Health published a new social marketing strategy for public health 
(Department of Health, 2011). In this policy paper, the government reiterates its 
commitment to using social marketing in improving public health and highlights 
achievements of social marketing interventions so far such as the Change4Life programme 
addressing obesity (Department of Health, 2010a), Smokefree England campaign 
(Department of Health, 2008b) and ActFAST – a stroke awareness campaign (Department 
of Health, 2009a). There is a notable change in this strategy with a shift away from 
addressing single issues and instead taking a life course approach of delivering support on 
all topics that are relevant to a person at a given stage. Among young people this implies 
that the strategy will focus on influencing behaviours such as risky sexual lifestyles 
alongside other related issues such as binge drinking, experimenting with drugs and 
smoking (Department of Health, 2011). 
 
2.4 Critique of social marketing  
Literature on the critique of social marketing is limited in quantity and scope. A few 
scholars (Buchanan et al. 1994) have questioned the validity of the two main components 
of social marketing namely consumer research/orientation and marketing mix especially 
the aspects of integrated approach and profitability. They have also challenged social 
marketing by questioning if it was offering anything new or just repackaging familiar ideas 
overlaid with marketing jargon and also whether social marketing is more effective than 
current health promotion practices (Buchanan et al. 1994; The National Social Marketing 
Centre, 2006).  
Consumer research/orientation 
Critics of social marketing have acknowledged that the social marketing emphasis on 
consumer orientation has brought a refreshing antidote to the provider approach otherwise 
known as the “top down” approach to health interventions (Buchanan et al. 1994). But they 
have also pointed out that this insight has existed in health promotion since as early as 
1945, when Derryberry recognized that people had to be involved from the outset of any 
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program for it to be successful (Derryberry, 1945). They further argue that recent health 
promotion documents such as, Planned Approach to Community Health ( National Centre 
for Chronic Disease Prevention and Health promotion, 1991), Community Participation in 
Local Health and Sustainable Development: Approaches and Techniques (The World 
Health Organisation, 2002), Community Participation in Public Health: World Health 
Report (The World Health Organisation, 2004) emphasize the importance of people 
involvement which they consider to be synonymous with consumer research. They also 
point out that the first step in public health campaigns is widely accepted as a needs 
assessment which is directly comparable to consumer research/orientation as refereed to in 
social marketing (Buchanan et al., 1994). However, Hastings & Haywood (1991) in their 
response argue that in social marketing consumer orientation goes beyond needs 
assessment and people involvement. It is more about gaining competitive advantage in a 
market place characterized by contradicting messages. 
 
Integrated approach 
The integrated approach in social marketing otherwise termed as marketing mix or the four 
Ps: Promotion, Product, Price and Place has also been under scrutiny by health promotion 
specialists. According to Hill (2001) & Buchanan et al. (1994) these ideas are not new to 
public health and they represent a comprehensive approach which is the bedrock of public 
health founded on the familiar triad: agent, host and environment. They further point out 
that the need for multisectoral approach was emphasized as early as 1978 during the 
Declaration of Alma-Ata (The World Health Organisation, 1978). The four Ps it is argued 
are not easily manipulated in the health field. For example, “stop smoking” (product) is 
difficult (price) and involves a degree of suffering by the targeted individual from 
withdrawal symptoms and loss of social capital (Buchanan et al., 1994). Barach (1984) and 
Bloom & Novelli (1981) further assert that it is less difficult to sell soap than brotherhood. 
In recognition of the difficulty in applying the four Ps/marketing mix, social marketers 
advocate for a thorough consumer orientation through research and use of data systems. It 
is recommended that this is followed by a broad and robust analysis of behavioural patterns 
and trends to determine the problem and desired behaviour. The understanding of the key 
influences of behaviour and what moves and motivates consumers is also emphasized 
(National Social Marketing Centre, 2007).  
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Voluntary Behaviour Change 
The social marketing principle about the understanding of what moves or motivates people 
towards a particular behaviour (consumer research/orientation) and utilizing that 
knowledge in designing effective  interventions that result in voluntary behaviour change 
has been challenged. Thaler & Sustein (2008) in their book entitled: “Nudge: Improving 
Decisions about Health, Wealth and Happiness,” describe a concept termed as “nudging” 
based on the idea of behavioural economics. They argue that most health behaviour 
challenges observed among populations result from personal choice, environment, culture 
and economic factors and that people don’t always act in a logical manner or make 
decisions that are advantageous to them. They further explain that most people do not 
dispassionately analyse their behavioural decisions and that decisions are mostly based on 
automatic mental systems otherwise termed as mindless choosing. In which case therefore 
health organisations or governments have to act as choice architects crafting successful 
nudges to overcome mindless choosing and make alternative good choices (Thaler & 
Sustein, 2008; French, 2011). Examples of nudges include actions such as increasing the 
prominence of healthy food in canteens, requiring people to opt out of rather than into 
organ donor schemes or providing small incentives for people to act more healthily without 
being coercive (Bonell et al., 2011).  
Bonell et al. (2011) argue that the Nudge theory doesn’t offer anything new as existing 
public health isn't coercive (and where it is, like the smoking ban, this is usually to prevent 
harm to third parties) and goes beyond mere communicating of health messages to 
influencing how choices are presented (for example using techniques like social 
marketing). They further point out that many of the examples in Thaler and Sunstein's 
book don't fit with their own definition. Bonell et al. (2011) highlight one of the examples 
of a nudge programme in the USA which pays a dollar a day to teenage mothers, 
contingent on their having no further pregnancies. They consider this approach as coercive 
and a major pressure on young women in poverty thus contradicting the authors’ definition 
of nudges as not exerting such pressures (Bonell et al., 2011). French (2011) gives a more 
balanced view. He argues that rather than adopting a position that positive rewards and 
mindless choosing are the default intervention mode, robust and proactive citizen 
engagement (starting with consumer/target population research and orientation) should 
always provide the evidence base for deciding on the intervention approach to all 
initiatives.  
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Marketing failure 
There has been scepticism as well on whether the basic principle guiding commercial 
marketing – “supply and demand” can flourish in a health promotion context. Foxall 
(1989) suggests that social marketing renders the concept of a “marketing place” redundant 
and that it has no place for consumers choice or for the functions of the market mechanism 
(supply and demand). Buchanan et al. (1994) further clarify this by explaining that in true 
functional markets, entrepreneurs produce products to satisfy unmet needs. But in social 
markets, producers are not responding to consumer demand (market failure) and that in 
fact social marketers largely try to persuade people to give up things such as cigarettes and 
alcohol that the commercial market has delivered too successfully.  Marketing being 
essentially the process of buying and selling (exchanging values) in a competitive market 
where the seller has to be highly motivated and aggressive to succeed, the question has 
been whether the incentives for a health promoter can be  equivalent or even comparable to 
those of a commercial sales executive with high performance related bonus payments. 
Hastings & Haywood (1991) suggest that the incentive for a health promoter is not profit 
or bonus payments but rather better quality of life and improved public health for the 
targeted population. Furthermore, they argue that in both commercial and social markets 
success results mainly from a thorough understanding of consumers followed by a well 
thought strategy to influence their behaviour. Social marketers generally argue that we 
should criticize commercial marketing when it does harm such as the tobacco industry but 
also learn from it when the opportunity exists to do good (Stead et al. 2007). 
 
The ethics debate 
Although the social marketing’s key aim is to contribute towards social good, the issue of 
ethics in social marketing practice has been debated for decades. In particular social 
marketing has been criticised as having a sinister motive of social control and being part of 
governments’ agendas of population behaviour re-modification (French et al., 2010). 
However, social marketers have argued that the need to collaborate with governments is 
fundamental and that governments have democratic mandates to modify and control 
behaviour through legislation to ensure smooth running of society. This may be necessary 
in public health especially where voluntary approaches have failed like in the case of 
smoking in public places. Social marketers further argue that in most cases voluntary 
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approaches work especially where a robust consumer/client research is carried out before 
design and implementation of programmes (Hastings, 2007; French et al., 2010).  
 
Partnerships in health interventions between social marketers and some institutions have 
also been questioned. Whereas partnering with big business institutions often brings in the 
much needed finances that may enhance the quantity and probably the quality of 
programmes, the risk of being part of unethical practices has been of major concern 
(Hastings, 2007; Eagle, 2009). To this end social marketers argue that this is not a unique 
risk to social marketing per se and recommends that a thorough partnership analysis should 
always be carried out and an agreed ethical code signed before collaborative interventions 
are undertaken to avoid getting trapped into unethical practices (French et al., 2010).  
 
Unintended consequences of social marketing interventions have also raised ethical 
questions. A widely cited example is the Road Crew social marketing intervention in 
Wisconsin, USA (National Social Marketing Centre, 2011) whose aim was to reduce 
alcohol related road traffic accidents by providing dedicated taxis to and from drinking 
places as an alternative to self driven cars. Whereas the programme succeeded in reducing 
accident rates significantly, it also had an unintended effect of increased alcohol use 
beyond recommended levels among the targeted population. French et al. (2010) 
emphasise the need for ethical considerations at planning stages that also include impact 
evaluations in all interventions and that this aspect should be as intrinsic and fundamental 
to social marketing as the other six specified components. 
 
2.5 Effectiveness of social marketing 
Due to the abundance of social marketing projects in the developing countries that have 
been implemented for decades, most of the evidence on the applicability and effectiveness 
of social marketing is based on studies carried out in these countries (Chapman & Astatke, 
2003; Meekers & Rahaim, 2005; Kesterton & Cabral de Mello, 2010). In developed 
countries, the pioneering applications of social marketing were first seen in the 1980s 
mainly addressing cardiovascular disease morbidity and mortality (Ward, 1984). Later 
social marketing was adopted by other agencies working on public health issues such as 
the Center for Substance Abuse Prevention and the Office of Cancer Communications at 
the National Cancer Institute in the USA, the Victorian Health Promotion Foundation in 
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Australia, the Health Sponsorship Council in New Zealand and the National Social 
Marketing Centre in the UK. The few studies that have been carried out in the developed 
countries have indicated that social marketing may be an effective approach in health 
behaviour change interventions (National Social Marketing Centre, 2006a; National Social 
Marketing Centre, 2006b; Stead et al., 2007). Evidence on the application and 
effectiveness of social marketing in sexual health interventions is even more scarce with a 
few studies mainly emanating from the USA. A systematic search identified ten relevant 
studies (Appendix 2.1) which are summarised in Table 2 and discussed below under two 
broad themes i.e. contraception and unintended pregnancy and sexually transmitted 
infection screening.  
 
Contraception & unintended pregnancy  
Four studies (Bertrand et al., 1987; Tanfer et al., 2000; Tanner et al., 2009; Messer et al. 
2011) evaluated social marketing interventions on contraception use and unintended 
pregnancy. Tanfer et al. (2000) carried out an analysis of data from three US National 
Women Surveys (1991, 1993 and 1995) in order to identify reasons why the uptake of 
LARC methods (implants and injectables) among women aged 20-39 was low. The 
findings from the consumer research were to inform the design and implementation of 
interventions and targeted social marketing to promote LARC use. They found three main 
reasons namely: lack of knowledge about the specified contraceptives, fear of side effects 
and satisfaction with the current non-LARC methods. They also observed that older 
women (over 30 ), those with college education or higher and single women with one or 
more children were less likely to cite side effects as reason for not using LARC methods as 
compared to younger women (less than 30), those with no college education and the  
married and childless. Most women had a negative attitude towards use of the two LARC 
methods highlighting the cost, side effects and partner disapproval as main reasons in all 
waves of interviews. The study successfully identified important factors associated with 
LARC use. However, the attrition rate was high especially among black and single women 
known to be at a higher risk of unintended pregnancy hence making it difficult to draw 
conclusions on the applicability of the findings to the general women population. Although 
the study identified factors associated with low LARC uptake, due to the limitations of the 
study design, it was not possible to identify the decision making processes (and the role of 
partners and health professionals) among those using LARC methods  and also if non-use 
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of LARC methods and reasons given was based on experience or anecdotes. The study did 
not include teenage women who evidence shows are most affected by unintended 
pregnancy and therefore an important target group. The study was also limited to only two 
kinds of LARC methods i.e. IUD & IUS were not included.  
 
Tanner et al. (2009) evaluated an abstinence education programme branded “Worth the 
Wait.”  The programme was based on social marketing principles and was implemented in 
five counties in Texas, USA involving 2007 year 7 to 12 (Ages 11 to 16) students. The 
main intervention outcomes were reduction in intentions to engage in sexual activity and 
commitment to abstinence. The main measures were the likelihood of remaining abstinent, 
sexual activity or abstinence intentions, attitude towards abstinence and attitude towards 
teen sex. The intervention included a sexual health school curriculum, extra curriculum 
activities, and parent and community involvement, advertisements, professional and staff 
development (marketing mix) and was based on findings from  baseline surveys carried out 
with the target group and other stakeholders (consumer research). Evaluations were carried 
out at varied periods of the intervention over a five year period. Results showed that years 
of participation were associated positively with knowledge, beliefs, attitudes and 
intentions. No relationship was found between intentions to engage in sexual activity and 
parental monitoring, talking to adults and media recall (measuring impact of 
advertisement). Although the study found that years of participation were a significant 
factor, it was not able to establish if this was as result of the social marketing intervention 
or the traditional school curriculum. Improved outcomes could also have been due to 
maturation effect among participants and not necessarily due to the intervention. The 
participation rate was low (48%) meaning more than half of the parents withheld consent. 
Measuring intentions is also controversial as it is not what people always do. Considering 
that the school policy was restrictive and only allowed abstinence education, the responses 
could have been biased towards what was socially acceptable in the participants’ settings. 
Although the study concluded that the social marketing programme was effective in 
reducing teen pregnancy, teen pregnancy rates before and after the intervention were not 
reported. No baseline survey findings for all outcomes were reported as well. 
 
Messer et al. (2011) carried out a study to demonstrate the application of social marketing 
techniques in the development of an intervention aimed at correcting youth misperception 
about teenage pregnancy. The intervention was part of the project branded “Taking 
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Responsible Actions in Life” (TRAIL). Four schools in North Carolina USA were 
involved. The programme targeted grade 7 to 9 students (Ages 11 to 13). A thousand 
students were involved in the study. The schools were chosen because they were 
experiencing high teenage pregnancy incidences. The majority of the participants were 
from low socio-economic backgrounds. The study used self-administered questionnaires to 
collect information on the following themes: parent child communication, attitudes 
towards teen sex and marriage, sexual intentions, abstinence commitment and prior sexual 
activity. The findings from the baseline study (consumer research) were used to design and 
implement a social marketing campaign which included: adolescent pregnancy prevention 
education, youth development programming, parental involvement and a norms marketing 
campaign which utilised various media such as video shows, billboards, radio and 
newsletters (marketing mix). The study however did not report the post implementation 
results to demonstrate the effectiveness of the intervention and relied on informal feedback 
from participants in concluding that the intervention supported appropriate behaviour and 
corrected the normative misperceptions.  The generalisability of study findings is also 
limited to low socioeconomic populations with high risk of teenage pregnancies. 
 
Bertrand et al. (1987) carried out a consumer research to ascertain family planning needs 
before the establishment of a family planning service. The study involved 1,000 women 
aged between 15-35 years and resident in New Orleans, USA. The majority were of black 
ethnic background. The study was designed to provide data on the 4 Ps of marketing mix 
(Product: the extent of need for the service, Place: alternative current sources, satisfaction 
levels of current service, preferred service delivery methods, Price: amount believed 
reasonable for the service, Promotion: recognition of the service provider’s name and 
preferred channels of communication). The study successfully demonstrated how 
consumer research can be carried out and results used to design services that are accessible 
by a targeted population. However the study might have excluded some low income 
earners with no phones in their houses by using telephone interviews to collect data. 
Another limitation was the ethnicity of the target population which was mainly black, 
which implies that the study findings may not be generalised to other populations with a 
different ethnic mix. Also, the study did not include a multivariate analysis to determine 
the association between various socio-demographic characteristics and responses which 
would have been vital in a targeted marketing mix strategy.   
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Sexually Transmitted Infection Screening 
Six studies ( Futterman et al., 2001; Montoya et al., 2005; Plant et al., 2008; Guy et al., 
2009; Martinez-Donate et al., 2010; National Social Marketing Centre, 2011) evaluated 
social marketing interventions aimed at increasing screening uptake for sexually 
transmitted infections. Montoya et al. (2005) and Plant et al. (2008) evaluated interventions 
designed to increase screening for Syphilis among men who have sex with men (MSM) in 
San Francisco and Los Angeles, USA respectively. The two studies had similar 
approaches. They carried out consumer research that included focus group discussions and 
interviews with target groups as well as an examination of findings from other similar 
interventions which informed the marketing mix strategies. The marketing mix included 
adverts in gay publications, posters on streets and areas frequented by the target group, 
television and billboards. A convenience sample of 244 men (Montoya et al., 2005) after a 
year of implementation and 297 men (Plant et al., 2008) after 2 years of implementation 
were recruited and interviewed to evaluate the impact of the interventions. Results showed 
that 80% after one year of implementation in San Francisco (Montoya et al., 2005) and 
71% after 2 years of implementation in Los Angeles (Plant et al., 2008) were aware of the 
campaign and that awareness was significantly associated with having taken a test in the 
last 6 months in both studies. However the two studies’ use of convenience samples and 
face to face interviews which are often prone to social desirability bias might have 
impacted on the validity of results. The two studies also did not report whether overall the 
uptake of tests increased after the interventions among the targeted populations or not. As 
the interventions focused on special subgroups (MSM), their findings may only be 
generalisable to similar groups. 
 
Guy et al. (2009) evaluated a social marketing campaign in Victoria, Australia aimed at 
increasing uptake of HIV and STI tests among MSM. The study did not report if any 
consumer research was done. The campaign branded “Check it Out” involved mainly 
advertisements on radio, dedicated website, posters in strategic places. Analysis of test 
records during and after the campaign showed no increase. The overall number of tests 
actually dropped from 1803 to 1634. However it was not clear whether tests by MSM 
might have increased or not as sexual orientation was not recorded. Behavioural surveys 
based on self report showed no increase in test uptake either. Martinez-Donate et al. (2010) 
evaluated a social marketing campaign to increase condom use and HIV testing among 
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heterosexual Latino men including those who have sex with men in San Diego California 
USA. The campaign was branded “Hombres Sanos” meaning healthy men. The study 
included consumer research that involved target group members and other stakeholders in 
designing the intervention. The campaign included posters, radio advertisements, 
community outreach activities and promotional activities at local clubs. Although exposure 
rate was high (80%) and knowledge levels showed improvement, test uptake did not 
increase during and after the campaigns. Among men who have sex with men and women 
(MSMW) the rates actually dropped. The response rate at the end of the campaign was low 
at only 49% and no information on those refusing to participate was collected. 
 
Futterman et al. (2001) evaluated a social marketing campaign implemented in five cities 
in the USA (Baltimore, Miami, Los Angeles, Philadelphia, Washington DC) aimed at 
increasing HIV testing among adolescents. The campaign targeted non-white adolescents 
who evidence had shown were disproportionately affected by HIV infection. The campaign 
was branded “HIV. Live With It. Get Tested.” The study included consumer research that 
involved focus group discussions, interviews with target group youths, communication 
specialists, health workers and a pilot study. The findings were utilised in designing the 
intervention. The campaign included advertising on radio, youth magazines and other 
popular newspapers, television adverts, local outreach activities, establishment of free 
counselling and testing centres, a free hotline for youth to request tests or information 
(marketing mix). Evaluation results showed that calls for information and test requests 
peaked during the campaign period but fell back to pre-campaign figures after the 
campaign period. Results also showed increased awareness about HIV both during and 
after the campaign. The intervention was implemented for only 3 months and did not 
achieve the long term behaviour change goal.  
 
The National Social Marketing Centre in its Showcase site (National Social Marketing 
Centre, 2011) where interventions that have successfully used a social marketing approach 
in addressing various public health issues are posted, have a report on  a Chlamydia 
screening programme implemented by the NHS North Lincolnshire and North East 
Lincolnshire Care Trust Plus, England. The intervention branded COAST (Chlamydia 
Outreach Advice Screening & Treatment) aimed at raising awareness about Chlamydia 
infection and encouraging young people to get tested. The intervention targeted young 
people aged 15-24. The intervention included consumer research which featured focus 
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group discussions, interviews with young people, health workers, youth centre 
representatives and other organisations dealing with young people. A secondary data 
analysis of previous screening records was also carried out to understand the screening 
uptake patterns. The intervention utilised findings from the consumer research  to design a 
Chlamydia screening marketing mix which included setting up of free screening sites 
across the region, provision for ordering test kits on line or by text, posters, urinal stickers, 
leaflets, beer mats and radio adverts. As part of the exchange component, incentives such 
as free pants and entry into competitions to win items such as popular computer game 
gadgets were provided post test. Evaluation results showed that screening uptake increased 
in the two regions over the three year period (2007-2010). However, whereas the North 
East Lincolnshire’s performance was above the national targets over the three year period, 
North Lincolnshire never met the set targets despite implementing a similar programme. 
This disparity is not explained by the report. A notable limitation is the lack of a 
multivariate analysis of participant characteristics and their association with screening 
uptake before and after the implementation of interventions which if carried out could have 
enhanced the understanding of uptake patterns. 
 
2.6 Conclusion 
Social Marketing as an approach to health behaviour change is currently widely practiced 
internationally. However most of the available evidence on its effectiveness and 
applicability is largely based on studies carried out in developing countries where the bulk 
of social marketing projects have been implemented for decades (Chapman & Astatke 
2003; Meekers & Rahaim, 2005; Kesterton & Cabral de Mello, 2010). The applicability of 
this evidence to the developed countries’ context has been limited due to the difference in 
how social marketing is defined and implemented. Whereas social marketing in developing 
countries focuses more on delivery of material products such as contraceptives (Kesterton 
& Cabral de Mello, 2010) mosquito bed nets (Agha et al., 2007) and condoms (Meekers & 
Rahaim, 2005), in developed countries its more about influencing behaviour change among 
target populations such as physical exercise, healthy eating, and screening uptake (National 
Social Marketing Centre, 2011). Evidence in developed countries on the effectiveness and 
application of social marketing in sexual health interventions in particular is minimal and 
fragmented. I found only 10 relevant studies after an extensive search. Findings from the 
review of these studies show mixed results. Whereas most of the studies adhered to the 
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social marketing principles as specified, they were not able demonstrate clearly whether 
social marketing interventions worked or not mainly due to study design limitations. These 
included high attrition rates (Tanfer et al., 2000; Tanner et al., 2009; Guy et al., 2009), 
short implementation duration (Futterman et al., 2001), limited generalisibility to only 
specified subgroups (Tanfer et al., 2000; Futterman et al., 2001; Montoya et al., 2005; 
Plant et al., 2008; Tanner et al., 2009; Guy et al., 2009; Martinez-Donate et al., 2010; 
Messer et al., 2011), possible confounding factors ( Montoya et al., 2005; Plant et al., 
2008; Tanner et al., 2009; Guy et al., 2009; Martinez-Donate et al., 2010; Messer et al., 
2011), inadequate data collection methods  (Montoya et al., 2005; Plant et al., 2008) and 
data analysis deficiencies (Bertrand et al., 1987; National Social Marketing Centre, 2011).  
 
Overall the evaluation designs adopted by the reviewed studies i.e. repeated cross sectional 
(Tanfer et al., 2000) and quasi-experimental without control (Futterman et al., 2001; 
Montoya et al., 2005; Plant et al., 2008; Tanner et al., 2009; Guy et al., 2009; Martinez-
Donate et al., 2010; National Social Marketing Centre, 2011; Messer et al., 2011) meant 
that the differences observed in pre-test and post-test could not be causally related to 
specified social marketing interventions. There is therefore a need for more primary studies 
using randomised control trial design to firmly ascertain the effectiveness of a social 
marketing approach in sexual health interventions. 
 
  34 
Table 2.2: Reviewed Social Marketing Studies 
 
Authors Study Title Study/Intervention 
Description 
Study Aim Social 
Marketing  
Components 




Why are U.S. 
Women not using 
long acting 
contraceptives? 
A secondary data 
analysis of the 
National Survey of 
Women (1993 & 1995) 
To identify reasons 
why women have 
spurned LARC 
methods in order to 
inform the design 
and implementation 
of interventions and 
targeted social 













norms and the 





A description of how 
data on local sexual 
norms  were collected, 
analysed  and how the 






















in New Orleans 
Telephone survey 
involving women aged 
15-35 to inform the 
design of family 
planning service 
To demonstrate the 
role of social 




























and its effects on 
adolescents’ sexual 
attitudes and behaviour 
To determine the 
effectiveness of a 
social marketing 
strategy in abstinence 
education and 


























Methods and First 
Year Results From 
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 Chapter 3: The effectiveness of social marketing in 
reduction of teenage pregnancies: a review of studies in 
developed countries 
 
In this chapter, I present the first study on the effectiveness of a social marketing approach 
in the reduction of unintended teenage pregnancies. In the introduction section I provide a 
rationale for the study and discuss evidence from evaluations of teenage pregnancy 
interventions. I also include a table showing the six components of social marketing and 
their application to unintended teenage pregnancy context. In the second section I describe 
the study methods and ethics approval process. In the results section, I include a flow chart 
showing the process of article selection and a summary description of the 12 selected 
articles.  I further provide two tables showing a detailed description of the 12 studies and 
how I carried out quality assessment. In the discussion section I include a review of 
findings and their implications for public health policy/practice and social marketing and 
review limitations and strengths. Lastly, I draw conclusions and make recommendations 
and suggestions on further research. An article from this study has been published in a peer 
reviewed journal, Social Marketing Quarterly, a copy of which appears in appendix 3.3. 
 
3.1 Introduction 
Unintended teenage pregnancy is a significant health and social issue that affects both 
developing and developed countries. Worldwide, 16 million women aged 15-19 years give 
birth each year (The World Health Organization, 2011). Whereas not all these births result 
from unintended pregnancy, evidence shows that births to unmarried teenage mothers are 
more likely to be, often as a consequence of coercive sexual relationships with older males 
(The World Health Organization, 2011). The developing countries bear a larger burden of 
teenage pregnancies. However, the relatively lower teenage pregnancy rates in developed 
countries are mainly attributed to availability of effective contraception and abortion 
services rather than difference in adolescent behaviour (Treffers, 2003; Bearinger et al., 
2007).  
 
 It is estimated that at least 1.25 million teenagers become pregnant each year in countries 
belonging to the Organisation for Economic Co-operation and Development (OECD) 
(Guilleband, 2007). Of those pregnancies, approximately half a million seek an abortion 
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and the remainder become teenage mothers. The latest statistics from the World Bank (The 
World Bank, 2011) show United States of America (USA) still has the highest teenage 
birth rate among OECD countries (33/1000) while the United Kingdom (UK) leads in 
Western Europe (22/1000) with a rate more than five times that of Netherlands (4/1000), 
more than three times that of France (6/1000) and Germany (7/1000) (Guilleband, 2007) 
(Figure 3.1). Although in most developed countries the average teenage pregnancy rate has 
been declining, rates within countries are highly varied with some regions and population 
groups exceeding those of developing countries (Harden et al., 1999; Swann et al., 2003; 
Malarcher et al., 2010). Furthermore, the decline has been slower than anticipated and 
therefore the issue remains a priority (UNICEF, 2001). 
 
The concern with unintended teenage pregnancies arises because of the associated short 
and long term health, social and economic consequences. Teenage pregnancy is associated 
with medical complications such as pre-eclampsia, cephalo-pelvic disproportion, 
prolonged labour and post-natal depression (Seamark & Pereira Gray, 1997; Social 
Exclusion Unit, 1999).  Babies born to teenage mothers are more at risk of sudden infant 
death syndrome, low birth weight, poor growth, hospital admissions for intestinal 
problems, and accidental and non- accidental injuries (Social Exclusion Unit, 1999). The 
social, educational, and economic outcomes for the children born to teenage mothers, and 
for the mothers themselves, tend to be worse, with the danger of a poverty-trap/poverty-
cycle developing (Harden et al., 1999; Swann et al., 2003). 
 
Risk factors associated with teenage pregnancy are complex and vary between countries. 
However, some commonalities have been identified, such as insufficient sex education 
(Cromer & McCarthy, 1999; Department of Health, 2001b; The Royal Institute of Public 
Health, 2008), peer pressure and pressure from older partners (Fullerton et al., 1997; 
Cromer & McCarthy, 1999; Kirby, 2007), delay in accessing contraceptive services, a poor 
relationship between teenagers and available sexual health services ( Cromer & McCarthy, 
1999; Healthcare Commission, 2007; The Royal Institute of Public Health, 2008), 
contraceptive failure and social deprivation (Fullerton et al., 1997; Wellings & Kane, 1999; 
Swann et al., 2003; Imamura et al., 2007; The Royal Institute of Public Health, 2008). 
Studies with teenagers have also typically found associations between alcohol, binge 
drinking, and sex (with multiple partners) (Seamark & Pereira Gray, 1997; DiCenso et al., 
2002; Department for Education & Skills, 2006). 
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Interventions to reduce teenage pregnancies that have been evaluated include school based 
sex education programmes, community based education programmes, changes to 
contraceptive services, personal development programmes, and vocational and family 
outreach programmes (DiCenso et al., 2002; Swann et al., 2003). The results have been 
mixed, and there is no clear, single best approach. However, Kirby in his review of reviews 
highlights key characteristics of successful teenage pregnancy interventions (Kirby, 1999). 
The characteristics include: a behaviour change focus, appropriateness and sensitivity to 
participants, sufficient duration, variety in teaching methodology, attention to risk factors, 
and the provision of training in communication and assertiveness skills. Most of these 
characteristics share core elements with social marketing approaches that have been 
effectively  applied to other health-behaviour change interventions such as increasing 
uptake of family planning services by adolescents (Cromer & McCarthy, 1999), healthy 
eating, increasing physical exercise, and tackling the misuse of substances like alcohol, 
tobacco, and illicit drugs (Gordon et al., 2006; National Social Marketing Centre, 2006a; 
National Social Marketing Centre, 2006b; Stead et al., 2007). This raises the interesting 
prospect of social marketing as an appropriate approach to reducing unintended teenage 
pregnancies. 
 
Although individual teenage pregnancy related interventions, using social marketing 
approaches are often evaluated there has been no systematic review to date to explore the 
effectiveness of the approach. This is a crucial gap because it is important to understand 
the efficacy of the approach in and of itself as well as its effectiveness in comparison with 
other interventions. The aim of this study was to explore the gap identified above: the 
efficacy of a social marketing approach in the reduction of unintended teenage pregnancies 
in selected OECD countries. Previous studies have demonstrated that relying solely on the 
label “social marketing” is problematic as it excludes many interventions which may not 
be labelled as such but nonetheless incorporate social marketing principles (McDermott et 
al., 2005). Therefore, in this review I extended the search using Andreasen’s bench mark 
criteria for social marketing to select studies. The Andreasen’s benchmark criteria define 
six basic characteristics that must feature in a social marketing intervention. These are: 
specific behaviour change goal, consumer research, segmentation and targeting, 
marketing mix, exchange and competition. Using this approach also made it possible to 
exclude ‘poor’ examples of social marketing and some media campaigns which are often 
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erroneously referred to as social marketing interventions (Stead & Hastings, 1997; Gordon 
et al., 2006).  Table 3.1 further provides details on the six components which I applied to 
unintended teenage pregnancy intervention context. 
 
Figure 3.1: Adolescent Fertility Rate (Births per 1,000 Women Aged 15-19) 
for Selected Developed Countries, 2009.  
 
Number of Births per 1,000 Women Aged 15-19, 2009






























Data Source: World Bank (2011): http://data.worldbank.org/indicator/SP.ADO.TFRT 
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Table 3.1: Andreasen’s benchmark criteria for social marketing interventions 















Intervention seeks to change behaviour 
and has specific measurable 
behavioural objectives. 
 
The specified aim or objective(s) are 
measurable and are relevant to 
unintended teenage pregnancy reduction. 
Consumer 
Research 
Formative research is conducted to 
identify target consumer characteristics 
and needs. Intervention elements are 
pre-tested with the target group. 
 
Before programme implementation at 
least one of the following was carried 
out; quantitative survey, qualitative 
interviews, focus group discussions, pre 





Different segmentation variables are 
considered when selecting the 
intervention target group. Intervention 
strategy is tailored for the selected 
segment/s. 
 
The intervention considered ‘age’ and at 
least one of the following in its 
participant selection and implementation 
strategy; ethnicity, socio-economic status 
and educational level. 
Marketing 
Mix 
Intervention considers the best strategic 
application of the “marketing mix”. 
This consists of the four Ps of 
“product”, “price”, “place” and 
“promotion”. Other Ps might include 
“policy change” or “people” (e.g. 
training of intervention delivery 
agents). 
 
The intervention used the ‘Promotion’ P 
and any other P as specified below: 
Product- Contraceptive provision or 
information on access, competency in 
avoiding unintended teenage pregnancy 
Price- Considered the cost, time effort 
and inconvenience involved in accessing 
contraceptives and other intervention 
activities and had solutions to minimise 
these.  
Place – Ensured that contraceptives and 
other intervention activities were easily 
accessible by teenagers. 
Promotion- Integrated use of advertising, 
public relations, promotions, media 
advocacy and entertainment vehicles to 
promote use of contraceptives and other 
skills of avoiding unintended pregnancy. 
Partnerships – Involved parents and 
other relevant organisations within the 
community. 
Policy – Had a strategy in place to 
influence government or local policies 
on contraceptive use and other methods 
of unintended teenage pregnancy 
reduction.  
Personnel/People – Ensured staff 
involved in the programme were well 
trained and experienced in adolescent 
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sexual health and in dealing with teenage 
pregnancy issues. 
 
Exchange Intervention considers what will 
motivate people to engage voluntarily 
with the intervention and offers them 
something beneficial in return. The 
offered benefit may be intangible (e.g. 
personal satisfaction) or tangible (e.g. 
rewards for participating in the 
programme and making behavioural 
changes) 
 
Intervention had tangible (e.g. monetary 
rewards, gift vouchers, and 
entertainment opportunities) or 
intangible incentives (e.g. improved 
sexual health knowledge and skills, 
improved communication between 
parents and teenagers on sexual health 
matters).   
Competition Competing forces to the behaviour 
change are analysed. Intervention 
considers the appeal of competing 
behaviours (including current 
behaviour) and uses strategies that seek 
to remove or minimise this 
competition. 
 
Intervention addressed at least one of the 
following: 
Peer/social influence, cultural/religious 
beliefs, substance misuse, idleness, low 
self esteem and poor academic 
performance. 
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 3.2 Methods 
Search strategy  
I searched for studies on unintended teenage pregnancy reported between January1990 and 
October 2008 in the following data bases: MEDLINE, PUBMED, SCIENCE DIRECT, 
COCHRANE Library, EMBASE, SCOPUS, CRD data base (Centre for Reviews and 
Dissemination, UK), CDC data base (Centre for Disease Prevention & Control, USA), 
TRIP data base and Teenage Pregnancy Unit (TPU) Research data base (UK). 
Bibliographies of selected studies were also manually searched and relevant articles 
identified. Experts in teenage pregnancy and social marketing were contacted regarding the 
existence of other published or unpublished studies not captured in the electronic search. 
Search terms included a combination of the following keywords: Teen, Adolescent, 
Pregnancy, Sexual health, Reproductive health, Abortion, Pregnancy termination, 
Contraceptive, Birth control, Condom, Social Marketing, Health marketing, Prevention, 
Intervention, Abstinence, School health.  
Article selection 
Articles on unintended teenage pregnancy intervention were considered for inclusion if 
they were written in English and reported effectiveness studies (controlled trials or before 
and after studies), involving 11-19 year olds carried out in the USA, Western Europe, 
Canada, New Zealand or Australia. Additionally, the studies needed to have reported on at 
least one of the following outcomes; change in number of unintended pregnancies, delay in 
sexual initiation/abstinence among participants, contraceptive use, knowledge of 
contraception and reproductive health, and self efficacy to refuse unwanted sexual 
intercourse. Abstracts from the initial search were independently screened by two 
reviewers (I and a DrPH colleague) and a further search of full articles carried out from 
those short listed. The short listed articles were assessed as to whether they met the social 
marketing benchmark criteria or not (See Table 3.1). We further discussed and agreed on 
the final full articles to be included. Disagreements were rare but whenever they occurred 
they were resolved by discussion and by consulting a social marketing specialist. 
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Quality assessment 
The methodological quality of selected studies was assessed and rated as strong/high, 
moderate or weak using a tool adopted from the Effective Public Health Practice Project 
(http://www.ephpp.ca/PDF/QATool.pdf.) (See also appendices 3.1 & 3.2). In rating the 
studies, principal consideration was given to the study design, appropriateness of 
randomisation, participant selection and allocation, the control of confounders, blinding of 
participants and assessors, validity and reliability of data collection methods, withdrawals 
and drop outs, intervention integrity, appropriateness of analysis, and whether it was an 
‘intention to treat’ analysis. Two researchers (I and a DrPH colleague) were involved in the 
quality assessment. Discrepancies were rare but whenever they occurred, they were 
resolved by joint review and consensus. 
 
Data extraction and synthesis 
We (I and a DrPH colleague) independently extracted data on the setting, sample size, 
participant characteristics, the theoretical framework guiding the intervention, intervention 
components, social marketing characteristics, length of follow up, proportion followed to 
study completion and  study outcomes. This approach is in line with the tool developed by 
(DiCenso et al., 2002). Again, discrepancies were rare but whenever they occurred, they 
were resolved by joint review and consensus. Outcomes from the selected studies were 
summarised and presented in tables. The effects of various interventions were assessed by 
comparing outcomes in the intervention group and those in the control group. The odds 
ratio/relative risk, confidence intervals, and P values were reported where available. A 
meta-analysis could not be performed due to the heterogeneity of the selected studies. 
 
Ethical approval 
This review dealt entirely with data from secondary sources and was therefore exempt 
from a regular human research ethics review process. Exemption was secured via the 
Brunel Graduate School ethics process. 
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3.3 Results 
The process from the searching of the databases through to the final selection of studies for 
the systematic review is shown in Figure 3.2. 
 
Figure 3.2: Flowchart of included studies 
 
 
Records recovered by 
search (n=7345) 
Studies excluded because not 
done in specified countries or 
did not include teenagers or did 
not evaluate teenage pregnancy 
intervention (n=7261) 





Full text studies retrieved 
and subjected to 
Andreasen’s Social 
Marketing criteria (n=32) 
Studies included in the 
systematic review (n=12) 
Studies excluded because: 
-Full text unavailable (n=23) 
-Did not report specific 
outcomes (n=28) 
-Redundant publication (n=1) 
 
 
Studies excluded for not 
meeting the social marketing 
benchmark criteria (n=20) 
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The search for relevant studies initially retrieved 7,345 records which included citations, 
abstracts and protocols. Eighty-four of the initially retrieved records were judged to be 
potentially relevant and selected for further scrutiny. A further 52 were excluded on the 
basis of not being unintended teenage pregnancy interventions, not measuring the 
outcomes of interest or inaccessible full text. Thirty two studies were retained and further 
evaluated using Andreasen’s criteria for social marketing interventions (Andreasen, 2002). 
Twelve studies met the criteria and were included in the final systematic review.  
 
General description of studies 
Table 3.2 shows a summary description of the 12 studies that met the inclusion criteria. 
Nine were randomised control trials (RCTs) (Eisen et al, 1990; Aarons et al., 2000; 
McBride & Gienapp, 2000; Coyle et al., 2001;Wight et al., 2002; Philliber et al., 2002; 
Stephenson et al., 2003; Coyle et al., 2006; Lederman et al., 2008) and three were “before 
and after studies” (observational studies which measure specific participants’ 
characteristics before and after intervention and compare the results) (Hughes et al., 1995; 
Tiezzi et al., 1997; Paine-Andrews et al., 1999).  Studies that met the inclusion criteria 
were mainly from the USA (ten), with two from the UK (Wight et al., 2002; Stephenson et 
al., 2003). A total of 31,921 adolescents between age 11 and 19 were enrolled in the 12 
studies. Seven studies were school based (Tiezzi et al., 1997; Aarons et al., 2000; Coyle et 
al., 2001; Wight et al., 2002; Stephenson et al., 2003; Coyle et al., 2006; Lederman et al., 
2008). Three were both community and school based (Eisen et al.1990; Paine-Andrews et 
al., 1999; McBride & Gienapp, 2000). Only two were solely community based (Hughes et 
al., 1995; Philliber et al., 2002). Three studies (Eisen et al., 1990; Paine-Andrews et al., 
1999; McBride & Gienapp, 2000; Coyle et al., 2006) were short term (less than 2 years 
follow up) and nine were long term (2-3 years follow up). Two studies (Aarons et al., 
2000; Stephenson et al., 2003) were rated as being of low intensity (less than 10 hours or 
sessions), four  ( Eisen et al., 1990; Tiezzi et al., 1997; Coyle et al., 2001; Wight et al., 
2002) as medium (10 hours/sessions to 20 hours/sessions) and three (McBride & Gienapp, 
2000; Philliber et al., 2002; Coyle et al., 2006) as high intensity interventions (more than 
20 hours/sessions).   
 
Control programmes for the nine randomized control trials were mainly teacher or health 
professional led with less activities and contact time for participants as compared to 
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intervention programmes. They also had minimal involvement of participants in the 
learning process. The comparison groups for the “before and after studies” had no related 
intervention programs of any kind going on at the time of the studies. 
 
Social marketing characteristics 
The social marketing characteristics and outcomes for the 12 included studies are provided 
in table 3.2. The main behaviour change goal in all the 12 interventions was to delay 
involvement in sexual activity or use contraceptives effectively for those already active. 
All interventions carried out baseline surveys (consumer research) before commencement 
of the main programme. Five interventions (Eisen et al., 1990; Tiezzi et al., 1997; McBride 
& Gienapp, 2000; Stephenson et al., 2003; Coyle et al., 2006)  had a more intense 
involvement of the target groups through needs assessments and pilot projects. Targeting 
and segmentation was mainly by age and academic level for all interventions. All 
interventions included sexual health lessons in their curricula. They also trained teenagers 
in skills of delaying sexual initiation and provided information on use and access to 
contraceptives for those already sexually active (product and  promotion). Others (Eisen et 
al., 1990; Paine-Andrews et al., 1999; Coyle et al., 2001; Philliber et al., 2002; Lederman 
et al., 2008) actively involved parents, relevant community and peer groups in programme 
planning and implementation (Partnerships). Six interventions ( Paine-Andrews et al., 
1999; Aarons et al., 2000; McBride & Gienapp, 2000; Coyle et al., 2001; Philliber et al., 
2002; Lederman et al., 2008;  provided tangible incentives such as t-shirts, monetary 
rewards and recreation opportunities, to encourage long term participation in their 
programmes (exchange). All interventions addressed competing behaviours and other risk 
factors that would influence negatively the sexual behaviour of teenagers 
(competition).These included, social/peer pressure, communication barriers with parents or 
teachers, substance misuse, idleness, low self esteem and cultural/religious influences. 
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Follow up period 




Intervention Social Marketing 
characteristics 
 
Study Outcomes & Baseline 
difference 
 






A School based 











512 grade 7 (Age 
12-13) students  
 
Gender 
52%  - females 
48%  - males 
 
Ethnicity 
84% - African 
American 
16% - others 
 
Allocation 
Intervention – 262 
Control – 260 
 
Randomisation  
By school  
 









8 Lessons of 45 




Led by professionals 
and partially by pupils. 
Reproductive and 
sexual health classes. 
Health risk screening.  
 
Control 




2 years period 
 
Follow up rates: 
1st follow up – 83% 
 
Behaviour change goal: To enable 
students to postpone sexual 
involvement by improving their 
attitudes towards abstinence, self-
efficacy to refuse unwanted sex and 
knowledge of reproductive health.   
 
Consumer research:  
Utilized findings from the National 
Youth risk behaviour survey and 
baseline survey 
 
Segmentation & targeting:  Targeted 
7th grade students  
 
Marketing mix:   
Promotion – curriculum based 
teaching and informal voluntary group 
discussions during lunch or midday 
free periods.  
 
Product and Place – Provided 
information on use and access of 
contraceptive services. 
 
Delayed sexual initiation 
Intervention group females had 
higher virginity rates at all the 
three follow ups. At final follow 
up the Odds ratio was 1.88 
(1.02, 3.47) 
 
Intervention group males had a 
significantly higher virginity rate 
only at first follow up: 1.46 
(0.79, 2.71) 
 
Self efficacy to refuse 
unwanted sex 
Intervention females scored 
higher in all follow ups. At final 
follow up the Odds ratio was 
1.30 (0.73, 2.30) 
 
Intervention males scored 
significantly higher only at  first 
follow up: 
1.71 (0.91, 3.19) 
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2nd follow up – 68% 




Personnel - Facilitated by health 
professionals and partially by peers 
 
Exchange:  
Enhanced communication on sexual 
issues between parents and 
teenagers. 
Enhanced knowledge about available 
contraceptive methods and services.  
Participation in contests and winners 
awarded monetary prizes.  
All participants were given t-shirt with 
theme: ‘Be smart, Don’t start.’ 
 
Competition:  
Programme identified and addressed 
risk factors such as: substance 
misuse, physical abuse, involvement 
in sexual activity and emotional 
problems. 
 
Contraceptive use at last 
intercourse  
In all follow ups intervention 
females were more likely to 
have used birth control at last 
intercourse. At final follow up 
the Odds ratio was 3.39 (1.16, 
9.95) and 1.53 (0.55, 4.26) for 
males. 
 
knowledge of reproductive 
health and contraceptives  
Intervention females had 
significantly higher knowledge 
scores than controls at final 
follow up -  19% (-0.02, 0.39) 
 
On all three follow ups 
intervention group males had 
higher scores. At final follow up 
the mean score difference was 
23% ( 0.03, 0.43) 
 
Baseline difference 
Not significant for all outcomes 
 







programme for  










Hispanics - 36% 
 
Theory 





7 sessions of 2.5 
hours 
over 4 weeks and 3 
 
Behaviour change goal: 
Increased frequency of 
communication between parents and 
teenagers on sex issues and parental 
involvement in youth activities. 
Changes in teenagers’ cognitive 




knowledge of reproductive 
health and contraceptives  
Minimal increase in knowledge 
was observed in intervention 
group at final follow up. 
(13%, p < .01) 
 
Self efficacy to refuse 
unwanted  sex 
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school youth in 
grades 6, 7 and 8 
and their parents. 
From 5 middle 
schools in 2 
different school 
districts in South 








African American – 
29% 
Caucasian – 24% 
others – 11% 
 
Allocation 
Intervention – 90 








booster sessions  
 
Components 
Led by professionals 
and partially by peers 









As intervention but 





2 years period 
 
Follow up rates not 
reported. 
Consumer research: 
Utilised findings from the national 
youth survey and baseline survey. 
 
Segmentation & targeting:   
Targeted 12 – 15 year old school 
youth in grades 6, 7 and 8 and their 
parents 
 
Marketing mix:   
Promotion & Product - Role plays, 
practice resistance skills, parent child 
discussions & curriculum based 
teaching 
 
Personnel - Sessions conducted by 
professionally trained counsellors and 
health educators. 
 
Partnership – Involved parents 
 
Exchange: 
Gift certificates given as incentives for 
participation 
Enhanced parent child relationship 
 
Competition: 
Programme addressed peer influence, 
barriers to communication, risky 
sexual behaviours, alcohol use and 
drug use. 
 
No significant difference 
between intervention and 
control group at final follow up. 
 
Baseline difference 
Not reported for both outcomes 
 
3. (Coyle et al., 
2001) 
 






Behaviour change goal: 
To reduce the number of students 
 
Contraceptive use at last 
intercourse 





A school based 
multi-component 
program for 9th 
and 10th grade 
(Age 14-16) 
students drawn 
from 10 schools 
in Northern 
California and 10 
schools in South 








48% -  males 
52% - females 
 
Ethnicity 
31% -  white 
27% -  Hispanic 
17% - African 
American 
18% -  Asian or 
Pacific islander 
7% - Others 
 
Allocation 
Intervention – 1983 
Control – 1886 
 
Randomisation   







influence theory and 









sexual health lessons. 
A safer choices peer 







A standard knowledge 
–based sexual health 





31 months period 
 
Follow up rates: 
7 months - 95%  
19 months - 83%  
31 months - 79% 
beginning to have sex and increase 
condom use among those already 
sexually active.  
 
Consumer research: 
Utilized findings from the evaluation of 
school based sexual health programs 
and baseline survey 
 
Segmentation & targeting:   
Targeted ninth and tenth grade 
students and their school and home 
environments. 
 
Marketing mix:   
Promotion and Product - Peer led 
resource area on campus with 
guidance of an adult coordinator & 
curriculum based teaching 
 
Partnership - Parents received 
newsletters three times a year on the 
program and served on health 
promotion council 
 
Product and Place - Students, 
teachers and parents received 
resource guides on available services 
in the community. 
 
Personnel - Classroom curriculum 
implemented by trained teachers 
 
Exchange:  
Better communication between 
At final follow up Intervention 
students were 1.68 (1.02, 2.76) 
times more likely to have used 
condoms (p < 0.05) and 1.76 
(1.01, 3.07) times more likely to 
have used effective pregnancy 
prevention methods (p < 0.05) 
at last intercourse as compared 
to students in comparison 
schools. 
 
Higher rate for intervention 
group at baseline (60.5% vs. 
56.3%) 
 
Delayed sexual initiation 
No statistically significant 
difference between intervention 
students and students in 
comparison schools at final 
follow up. 
 
Higher rate for intervention 
group at baseline (31.1% vs. 
25.5%) 
 
knowledge of reproductive 
health and contraceptives  
Intervention students had 
higher scores than comparison 
students - adjusted mean 
difference of 10% (p<0.05) at 
final follow up. 
 
Baseline difference not 
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parents and children on sexual issues. 
Enhanced knowledge about available 
contraceptive methods and services. 
Newsletter for parents 
 
Competition: 
Program addressed the school and 
home environment factors that 





Self efficacy to refuse 
unwanted sex 
No significant differences 
observed between groups at all 
follow ups. 
 













a four year (1997 
– 2001) period 
involving 29 










8766 - 13 to 14 year 
old pupils (year 9). 
 
Gender  and ethnic 

















No theoretical model 
 
Exposure  




Pupil led reproductive 
and sex education.  
Communication. 
Use of condom skills. 








3 year period 
Final follow up rates:  
94 % for intervention  
 
Behaviour change goal: 
To improve the younger pupil’s skills 
in sexual communication and condom 
use and their knowledge about 
pregnancy, Sexually transmitted 
infections, contraception and local 
sexual health services. 
 
Consumer research: 
The programme was piloted across 
different types of schools and needs 
assessment carried out. 
 
Segmentation & targeting: 
Targeted year 9 pupils (13-14 years)  
 
Marketing mix:   
Promotion –  
Reproductive and sexual health 
sessions 
Participatory learning strategies and 
activities used e.g. role play, quizzes, 
games, condom use demonstration. 
 
Delayed sexual initiation 
By age 16 fewer girls reported 
intercourse in the peer-led arm 
(34.7% as compared to 40.8% 
for teacher led arm - 
control.(OR 0.82, CI 0.68, 0.98) 
 
No significant difference was 
observed for boys  (32.7% vs. 




A small difference was 
observed at age 16 between 
intervention and control arms 
among females (96.7% vs. 
97.7%) 
Adjusted odds ratio was higher 
in favour of intervention 1.40 
(0.97, 2.02) 
 
Self efficacy to refuse 
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84% for control 
 
 
Product and Place – Provided 
information on access to condoms 
and contraception. 
 
Personnel - Program was designed by 
an external team of health promotion 
practitioners. Peer educators trained 
and given support in preparing and 
delivery of classroom sessions. 
 
Exchange: 
Better quality of relationship with 
current partner. 
Enhanced quality of sexual 
experience.  
Enhanced sexual health knowledge.  




Programme addressed risk factors 
such as peer influence, access to 
local sexual health services, ethnicity 
and education attainment.  
unwanted sex 
At age 16 more intervention 
arm girls were able to say no to 
unwanted sex (83.7% vs. 
79.7%) (OR 0.86 CI 0.74, 
1.00). No significant difference 
was observed among boys 




knowledge of reproductive 
health and contraceptives  
Knowledge levels were higher 
for intervention group at final 
follow up for both boys and 
girls (82.3% vs. 77.8%)  (OR 
1.34 CI 0.97, 1.84) and (68.7% 




Not reported for all outcomes 
 
 







was based in 6 
youth centres in 
 
484 disadvantaged 
children aged 12-16 
 
Gender 
268 - females  






Based on the Carrera 
model (Named after 




16 - 22 hours per 
month over 3 years 
 
Behaviour change goal: 
To delay sexual debut and increase 
contraceptive use among those 
already sexually active. 
 
Consumer research: 
Utilized findings from previous studies 
on job related interventions and 
baseline survey. 
 
Knowledge of reproductive 
health and contraceptives  
Intervention females’ 
knowledge improved by 25% 
as compared to14% (P<0.001) 
among controls. Knowledge 
levels were higher for males as 
well: 18% vs. 6% (P<0.001) at 
final follow up (3 years) 
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New York City 
run by Children’s 















26% - Hispanic 
5% - White 

















intervention – Job club 
Academic support  
Comprehensive family 
life and Sexuality 
education 
Arts and sports.  
Mental health, medical 




mainly consisting of 
recreational activities 
arts and crafts and 
help with homework. 
 
Follow up 
3 year period  
Final follow up rates: 
79% - intervention 
36% -control 
 
Segmentation & targeting:  
Targeted 13-15 year old teenagers 
and their parents. 
 
Marketing mix:   
Promotion and Product -
Comprehensive youth development 
program and curriculum based sex 
education. 
 
Place and Product – Contraceptive 
provision, Mental health care and 
medical care. 
 
Personnel- Program was delivered by 




Stipends provision, help with bank 
accounts and careers, homework 
help, exam preparation, sexual 
knowledge, talent and confidence 
development, impulse control through 
sports, counselling, free medical 




Program addressed risks such as 
idleness, lack of motivation, low self 
esteem, poor academic performance 
and access to contraceptives. 
 
 
Baseline difference not 
reported. 
 
Self efficacy to refuse 
unwanted sex 
75% of intervention female 
participants chose not to have 
sex under pressure as 
compared to 36% among 
controls (P<0.05) at final follow 
up. 
Baseline difference not 
reported. 
 
Delayed sexual initiation 
Intervention female participants 
were less likely to be sexually 
active as compared to controls 
(OR 0.5, p<0.05) at final follow 
up 
 
Higher rates were reported for 
intervention males (5%) and 




Intervention female participants 
were less likely to have 
experienced pregnancy (10% 
vs. 22%) (OR 0.3, p<0.01) at 
final follow up. 
 
Baseline difference not 










Contraceptive use at last 
intercourse 
Intervention female participants 
were more likely to have used 
contraceptives at last 
intercourse (36% vs. 20%) (OR 
2.4, p<0.05) 
 










13-19 year old 
adolescent males 
and females in 
one independent 

















52% - females 
48% - males 
 
Ethnicity 
15% - White 
24% - Black 
53% - Hispanic 




Control - 722 
 
Randomisation  




Health belief model 









Group discussions on 
values, feelings and 
emotions. 
Decision making 





Did not focus on 
 
Behaviour change goals: 
To increase teenagers’ awareness as 
regards sexual and reproductive 
health issues. 
To decrease the psychological and 
interpersonal and logistical barriers to 
abstinence and contraceptive use. 
 
Consumer research: 
The curriculum was piloted and 
participant views incorporated 
 
Segmentation & targeting:  
Targeted 13 – 19 year old adolescents  
 
Marketing mix:   
Promotion –  
Reproductive and sexual health 
sessions facilitated using a 
combination of lectures, simulations, 
leaders guided discussions, role 
 
Knowledge of reproductive 
health and contraceptives  
At immediate follow up mean 
increase of about 8 points 
(20%) for intervention group 
(from 24.7 to 32.9, P<.001) and 
6.8 points increase for control 
group  (25.6 to 32.4, p<.001) 
 
Delayed sexual initiation 
Minimal difference between 
intervention and control  at one 
year follow up (71% vs. 70 
percent, p<0.001) for males but 
highly significant for females 
(77% vs. 61%, p<.001) 
 
Contraceptive use at last 
intercourse 
At one year follow up: 
55% of males in intervention as 









teenagers and had 




1 year period 
Follow up rates: 
Immediate – 92% 
After 1 year – 61% 
playing and trigger films. 
 
Product and Place - Information on 
use of contraceptives and access 
provided.  
 
Personnel - Program facilitated by 
trained family planning agency 
educators and school staff. 
 
Exchange: 
Enhanced knowledge on adolescent 
sexuality 
Easier contraceptive access  
 
Competition: 
Programme addressed psychological, 
Interpersonal and logistic barriers to 
abstinence or consistent contraceptive 
use. 
 
compared to 65% in control 
had used effective 
contraceptive method at last 
intercourse (p<0.05).  
 
35% of females in intervention 
as compared to 65% in control 
had used effective 
contraceptive method at last 
intercourse (p<.05). 
 
Baseline difference  
Not significant for all outcomes 
 






A school and 
community based 
intervention for 14 
– 17 year old 
female 
adolescents from 
high risk group in 
 
232 adolescent 








Control - 105 
 
Randomisation  













support groups.  
Reproductive and 
 
Behaviour change goal: 
To empower young women, improve 




Needs assessment and Process 
evaluation. 
 
Segmentation & targeting:  
14 – 17 year old female adolescents 
from high risk group  
 
 
Delayed sexual initiation 
The percentage of adolescents 
who were sexually active was 
almost similar in intervention 
and control groups at final 
follow up (57% vs. 59%). The 
difference was not statistically 
significant. 
 
Contraceptive use at last 
intercourse 
The percentage of adolescents 
who had used contraceptives 
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Washington state, 
USA. (Study at 











sexual health classes. 
Counselling and 
referrals to family 
planning and 
community services.  
Mentorship by older 




Did not receive 
individualised services 
such as counselling 
and mentorship and 
had only 2 – 5 hours 
contact per year 
 
Follow up 
6 months period 
Follow up rate: 68% 
Marketing mix:  
Promotion –  
Reproductive and sexual health 
lessons 
Support groups, use of videos, guest 
speakers, counselling and mentorship. 
 
Product and Place-  
Provision of free contraceptives and 
information on future access. 
 
Personnel - Program delivered by 
trained health and sexuality educators 
and social workers. 
 
Exchange:  
Incentives for participation such as 
coupons for pizza or movies. 
Knowledge on adolescent sexuality, 
abstinence and contraceptive access 
and use. 





Programme addressed risk factors 
such as drug and alcohol misuse, low 
self esteem, educational aspirations, 
communication with parents and peer 
pressure. 
 
at last intercourse was higher 
in control than intervention 
group (100% vs. 80%) 
The difference was not 
statistically significant. 
 
Baseline difference  
Not significant for all outcomes 
 
8. (Coyle et al., 
2006) 
 
988 students  aged 





Behaviour change goal: 
To reduce the number of students 
 
Contraceptive use at last 
intercourse 





14 – 19 year old 





in four large 






597 in intervention 
group: 
 
African American – 
29% 




White – 12.2% 
Others – 14.2% 
 
Males – 61.2% 
Females – 38.8% 
 
391 in control 
group: 
African American – 
25.8% 




White – 12.3% 
others – 17.6% 
 
Males – 65% 
Females – 35% 
 
Randomisation 
By school  
 
Analysis  
By individual  
theory, theory of 
reasoned action and 








sexual health lessons 
Negotiation skills 
Condom use skills 
 
Control 
Regular programme – 
teacher led curriculum 
based sex education 
 
Follow up 
18 months period 
Follow up rate: 
6 months – 73% 
12 months – 62% 
18 months – 56% 
who have unprotected sex 
 
Consumer research: 
Program was piloted before 
implementation 
 
Segmentation & targeting:  
Targeted 14 -19 year teenagers with 
discipline, substance misuse and 
absenteeism problems. 
 
Marketing mix:   
Promotion –  
Reproductive and sexual health 
sessions involving students creating 
posters, watching videos, use of skits 
to demonstrate vulnerability, role 
playing, advice columns, group 
discussions and demonstrations.  
 
Product and Place - guided practice in 
use of condoms and information on 
contraceptive access 
 
Partnerships - Community service 
visits 
 
Personnel - Program delivered by 




Knowledge on adolescent sexuality 
and contraceptive access and use. 
 
No statistically significant 
difference between intervention 




No statistically significant 
difference between intervention 
and control groups at final 
follow up.  
 
Knowledge of reproductive 
health and contraceptives  
No statistically significant 
difference between intervention 
and control groups at final 
follow up. 
 
Self efficacy to refuse 
unwanted sex 
No statistically significant 
difference between intervention 
and control groups at final 
follow up.  
 
Delayed sexual initiation 
No statistically significant 
difference between intervention 
and control groups at final 
follow up.  
 
Baseline difference  
Higher rate of contraceptive 
use at last intercourse for 
control group (7%). Other 





Programme addressed attitudes 
towards having sex and use of 
condoms, substance misuse, poor 
school performance and reinforced 
pro-social attitudes through 
community activities. 
 
outcomes not reported. 
 






13-15 year old 
teenagers in 25 
non catholic 
schools located in 
















8430 pupils aged 13 
-15 years 
 
Intervention - 4197 
Male – 49% 
Female – 51% 
 
Control - 4233 
Male – 51% 
Female – 49% 
 
Ethnic proportions 

















Duration not specified 
 
Components: 
Delivered by trained 
teachers. 
Reproductive and 
sexual health lessons. 
Negotiation skills.  










2 year period 
 
Behaviour change goal: 
To reduce unsafe sexual behaviours, 
unwanted pregnancies and improve 
the quality of sexual relationships. 
 
Consumer research: 
The programme was piloted before 
implementation. 
 
Segmentation & targeting:  
13 -15 year old teenagers in 
secondary schools 
 
Marketing mix:   
Promotion-  
Reproductive and sexual health 
lessons 
Role playing, group work, games, 
information leaflets on sexual health 
including contraceptives and 
interactive video. 
 
Product and Place - Demonstrations 




Delayed sexual initiation  
No significant difference 
between intervention and 
control participants: Males -  
23.6% vs. 23.9% (p=0.89) 
Females - 31.8% vs. 33% 
(p=0.59) 
 
A Slightly higher rate for 
intervention group at baseline 
(4%) 
 
Contraceptive use at last 
intercourse 
No significant difference 
between intervention and 
control participants: Males - 
18.7% vs. 21% (p=0.38) and 
Females - 30.4% vs. 28% 
(p=0.48)  
 




No statistically significant 
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Follow up rate:  
Intervention – 72% 
Control – 73% 
 




Full cost coverage for training 
teachers 
Enhanced quality of sexual 
relationships for participants 
Enhanced knowledge on adolescent 
sexuality, pregnancy and 
contraceptive access and use 
 
Competition: 
Programme addressed peer and 
social pressures on sexual behaviours  
 
 
difference between intervention 
and control participants (4% vs. 
3.8%) 
 
Baseline difference not 
significant 
 
Knowledge of reproductive 
health and contraceptives  
The mean difference between 
intervention and control was 
minimal but significant – 0.7%, 
p<.05 for boys and 0.5%, 
p<.05. 
 




10. (Tiezzi et al., 
1997) 
 




Grade 6, 7 & 8 
teenagers of 
mean age 12.9 
years attending 
school based 
clinics in four 








Female -  46% 
Male – 54% 
 
Ethnicity 
Hispanic -  81% 
Black -  10% 
Other - 9% 
 
Analysis 
Univariate   

















support i.e. social 
workers, medical 
 
Behaviour change goal: 
To reduce the risk of unintended 
pregnancy by providing information, 
counselling, support and referral for 
reproductive health care. 
 
Consumer research: 
A health and risk factor survey was 
conducted and curriculum pre-tested. 
 
Segmentation & targeting:  
Targeted grade 6, 7 & 8 students. 
 
Marketing mix:   
Promotion –  
Reproductive and sexual health 
  
Unintended pregnancy 
Pregnancy rate overall in the 
four intervention schools 
dropped from 8.8 per 1000 in 
year 1 to 5.3 per 1000 in year 2 
and 6.8 per 1000 in year 3. 
 
Pregnancy rate in one school 
that dropped out of the 
programme due to funding was 
three times that of the schools 
in the programme (16.5 
pregnancies per 1000 female 
students vs. 5.8 per 1000) 
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 providers and 
psychiatrists.  
Decision making skills 
 
Follow up 
3 years period 
 




Role plays, group games, 
brainstorming exercises, audiovisual 
presentations and exploratory learning 
to discover own vulnerability 
 
Product and Place - Information on 
contraceptives, referrals and 
assistance from health educators to 
obtain contraceptives 
 
Personnel – Programme was 




Enhanced knowledge on adolescent 
sexuality, pregnancy and 
contraceptives. 
Free counselling service 




Programme addressed peer and 
social pressures on sexual behaviours 
and other risk factors such as alcohol 




Andrews et al., 
1999) 
 
Before & After 
 
Grade 9-12 students 
 
Geary – 1004 
students 
Franklin – 710 
 
Theory 
Theory of change. 
 
Exposure  
Duration not reported 
 
Behaviour change goal:  
To reduce teenage pregnancies, to 
delay the age of first intercourse and 
to increase contraceptive use among 
sexually active teenagers. 
 
Delayed sexual initiation 
In Geary county adolescents 
reporting ever having had sex 
reduced from 51% in 1st year of 
program to 38% among 






14 – 17 year old 
teenagers in 






Wichita – not 
reported 
 










Delivered by trained 
project staff. 
Sexual education for 
teachers and parents. 
Age appropriate sex 
education. 
Increased access to 
health services. 
Use of mass media. 
Community 
Involvement.  
Peer support and 
education. 
Alternative activities 
for young people. 
Involvement of the 






3 years period 
 
Follow up rates: 
Geary – 68% 
Franklin – 79% 
Wichita – not reported 
 
Consumer research: 
Programme was piloted before 
implementation. 
 
Segmentation & targeting:  
14 -17 year old females  
 
Marketing mix:   
Promotion-  
Reproductive and sexual health 
classes for teachers, students and 
parents. 
Use of mass media 
 
Product and Place-  Enhanced access 
to health services and contraceptives 
 
Partnerships- Involvement of parents, 
faith community, schools and health 




Enhanced knowledge on adolescent 
sexuality, pregnancy and 
contraceptives. 
Enhanced access to health and 
contraceptive services 
After school and holiday activities 




Programme addressed social 
females and 63% to 43% 
among males in third year 
(P<0.05). 
 
In Franklin county adolescents 
reporting ever having had sex 
increased from 33% in 1st year 
of program to 40% among 
females and 54% to 68% 
among males in third year 
(P<0.05). 
 
Contraceptive use at last 
intercourse 
There was no statistically 
significant change in Geary 
county. 
 
In Franklin county more males 
reported using condoms in 
third year (55%) as compared 
to 39% in first year (P<0.05). 
 
Unintended pregnancy 
The pregnancy rate decreased 
in Geary County - from 
63/1000 pre-intervention to 
about 56/1000 post-
intervention. Whereas the 
comparison area increased 
from 60/1000 to 69/1000 
(P<0.05) 
 
In Franklin county pregnancy 
rates reduced from 41/1000 to 
  62 
pressures on sexual behaviour, 
idleness during holidays and after 
school. 
Involved  faith community and local 
businesses 
37/1000 whereas  the 
comparison area had a minimal 
decrease from 39/1000 to 
37/1000 (P<0.05) 
 
12.(Hughes et al.,  
1995) 
 






14 -18 year old 
teenagers 
attending family 








14 – 18 year old 
adolescents from 
family planning clinic 
catchment areas 
and entire city. 
 
Catchment areas – 
907  





Females - 82% 
Males – 18% 
 
Entire city – 117 





Female - 81% 















Delivered by health 
professionals. 
After school or 
evening clinic 
services. 
Teenage walk in 
hours. 
Reduced waiting time 
for teenagers’ 
appointments. 











Behaviour change goal: 
To increase awareness of teenage 
pregnancy and encourage responsible 
sexual decision making.  
 
Consumer research: 
A baseline survey was carried before 
programme implementation. 
 
Segmentation & targeting:  
14 to 18 year old teenagers 
 
Marketing mix:   
Promotion-  
Reproductive sexual health sessions 
for teenagers and parents.   
Use of posters, public transit cards 
with program slogan – ‘Pregnancy: It’s 
not for me.’ Community fairs, radio 
programmes, newspaper articles 
 
Product and Place- After school or 
evening clinic services, teenage walk 
in hours, reduced waiting time for 
teenagers’ appointments and increase 
of hours reserved for teenagers only. 
 
Personnel – Facilitated by health 
professionals 
 
Delayed sexual  intercourse 
There was no significant 
change in the percentage of 
teenagers who reported ever 
having sex pre and post 
intervention (51% vs. 52%) 
 
Contraceptive use at last 
intercourse 
Use of contraceptive in the last 
intercourse increased slightly 




Pregnancy rate rose slightly 




There was no significant 
difference between intervention 
and comparison groups for the 
three outcomes.  







3 years period 
 




interviewed at final 
evaluation as planned. 
 
Exchange: 
Enhanced knowledge on adolescent 
sexuality, pregnancy and 
contraceptives. 
Enhanced access to sexual health 
and contraceptive services 
 
Competition: 
Programme addressed negative 
attitudes towards use of 
contraceptives,   logistic barriers to 
accessing contraceptive services and 
peer pressures on sexual behaviour 
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 (Aarons et al., 
2000)  
Moderate Strong Strong Moderate Strong Moderate 
 






Strong moderate Moderate  Strong Weak Weak  Moderate  Weak 
 (Coyle et al., 
2001) 
Strong  Strong Strong  Moderate  Strong  Moderate 
 







Strong Strong Moderate Moderate Strong Strong Strong Strong 





Strong Strong  Moderate Moderate Moderate Moderate  Strong  Moderate 
 (Eisen et al., 
1990) 
 
Moderate Strong Moderate Weak  Strong  Moderate 
 
Moderate  Strong  Moderate  
(McBride & 




Moderate Moderate  Moderate   strong Moderate Moderate  Moderate Moderate  
(Coyle et al., 
2006) 
Strong  Strong Strong  Moderate  Moderate  Weak 
 
Moderate  Moderate  Moderate  
 
 
(Wight et al., 
2002) 
 
Moderate  Strong Moderate  Strong  Moderate  Moderate Moderate  Moderate  Moderate  
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(Tiezzi et al., 
1997) 
Weak Moderate Weak  Not 
Applicable 
 
Weak  Weak 
 
Weak Moderate  Weak  
(Paine-Andrews 
et al., 1999)  
Weak Moderate Moderate  Not 
applicable 
 
Moderate  Moderate Moderate  Moderate Moderate 
 (Hughes et al., 
1995)  
Strong  Moderate Strong  Not 
Applicable 
Moderate  Moderate Moderate  Moderate  Moderate  
 
Rating 
1 Strong   (Four strong with no weak ratings) 
2 Moderate (Less than four strong ratings and one weak rating) 
3  Weak  (Two or more weak ratings)  
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Study quality  
A summary of the quality assessment for the twelve studies is shown in table 3.3. Overall 
one study (Stephenson et al., 2003) was rated as strong while the majority (Eisen et al., 
1990; Hughes et al., 1995; Aarons et al., 2000; McBride & Gienapp, 2000; Coyle et al., 
2001; Wight et al., 2002; Philliber et al., 2002; Coyle et al., 2006; Paine-Andrews et al., 
1999) were rated as moderate and two as weak (Lederman et al., 2008; Tiezzi et al., 1997). 
(For details on rating see appendices 3.1 & 3.2 and also on line at: 
http://www.ephpp.ca/PDF/QATool.pdf & http://www.ephpp.ca/PDF/QADictionary.pdf.  
 
Outcomes 
The five outcomes reported in the 12 studies were examined in turn.  These were; change 
in rate of unintended teenage pregnancies, delayed sexual initiation, contraceptive use at 
last intercourse, knowledge of contraception and reproductive health, and self efficacy to 
refuse unwanted sexual intercourse. 
 
Unintended pregnancy 
Seven studies assessed participants’ self reported incidence of unintended pregnancy. Male 
participants reported the incidence of causing a pregnancy. Two RCTs (Philliber et al., 
2002; Stephenson et al., 2003) and two “before and after studies” (Tiezzi et al., 1997; 
Paine-Andrews et al., 1999) reported significant intervention effects. The four 
interventions were all long term (two or more years). The intervention with the largest 
effect (Philliber et al., 2002) was relatively more intense than the rest (up to 22 hours 
monthly over a three year period).  In this study, female participants were up to 70% (Odds 
Ratio (OR) 0.3, P<0.01)  less likely to report having experienced unintended pregnancy at 
final follow up as compared to control group female participants. No study reported a 
significant effect among male participants. The follow up rate was relatively low in two 
out of the three studies that reported no effect. (Coyle et al., 2006) had an attrition rate of 
44% while (Hughes et al., 1995) only interviewed 20% of the participants at final follow 
up.  
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Delayed sexual initiation 
Ten studies assessed participants’ self reported incidence of sexual initiation. Four RCTs ( 
Eisen et al., 1990; Aarons et al., 2000; Philliber et al., 2002; Stephenson et al., 2003) and 
one “before and after study” (Paine-Andrews et al., 1999) reported significant intervention 
effects. Two studies with the lowest follow up rates reported no significant impact (Hughes 
et al., 1995; Coyle et al., 2006).The largest intervention effect was among females reported 
by (Aarons et al., 2000) (OR 1.88  95% Confidence Interval (CI) 1.02, 3.47). Only two 
studies (Eisen et al., 1990; Paine-Andrews et al., 1999) reported significant effects among 
male participants of 16% (P<.001) and 17% (P<.05) reduction in sexual activity since 
baseline respectively.  
 
Contraceptive use at last sexual intercourse 
Nine studies assessed participants’ self reported use of contraceptive at last sexual 
intercourse.  Three RCTs (Aarons et al., 2000; Coyle et al., 2001; Philliber et al., 2002) and 
one “before and after study” (Paine-Andrews et al., 1999) reported significant intervention 
effects. The four interventions that reported significant effects were long term whereas in 
one short term study (Eisen et al., 1990), control participants had better outcomes. Again 
the two studies with the lowest follow up rates (Hughes et al., 1995; Coyle et al., 2006) 
reported no impact.  Aarons et al. (2000) reported the largest intervention effect. In this 
study, intervention females were three times more likely to have used contraceptives at last 
sexual intercourse than control females (OR 3.39 95% CI 1.16, 9.95). Only one study 
(Paine-Andrews et al., 1999) reported a significant intervention effect among particularly 
male participants of 16% (P<0.05) increase in contraceptive use since baseline.  
 
Knowledge of reproductive health and contraceptives 
Eight randomized control trials assessed participants’ self reported knowledge of 
reproductive health and contraceptive use. Only one study (Coyle et al., 2006) did not 
report a significant impact. The largest intervention effect was among male participants in 
the study by Aarons et al. (2000) where intervention males had a mean score improvement 
of up to 23% (P<0.05) higher than those in the control group at final follow up. The same 
study had the largest effect among female participants as well (19%, P<0.05). 
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Self efficacy to refuse unwanted sex 
Five randomized control trials assessed participants’ “self efficacy to refuse unwanted 
sex.” Only one study (Philliber et al., 2002)  reported a significant effect (39%, P<0.05) 
among female participants, indicating that 39% more female participants in the 
intervention group had chosen not to have sex when pressured as compared with the 
control group. None of the studies reported any significant effect among males. Philliber’s 
intervention (Philliber et al., 2002) was community based, long term and was implemented 
for the longest duration (22 hrs monthly over a three year period).   
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3.4 Discussion 
This review assessed 12 studies conducted in USA and UK, to determine the effectiveness 
of a social marketing approach in reducing unintended teenage pregnancy and influencing 
related behaviour change. Although all studies reported interventions that fully met the 
specified social marketing criteria, the actual implementation of programmes varied in 
content, follow up periods, intensity, settings and programme content. Results showed 
variation in intervention effects across specified outcomes with nine studies out of 12 
reporting significant effects on at least one of the specified outcomes.  Overall no 
particular social marketing component or activity was independently associated with 
effective interventions except for one behavioural outcome (self efficacy to refuse 
unwanted sex) where the only intervention that reported a significant effect (Philliber et al., 
2002) appeared to have a relatively more intense marketing mix and provided more 
participant incentives (exchange). Long term interventions also appeared to be more 
effective as compared to short term ones for most outcomes. The impact on male 
participants’ sexual behaviour was minimal in most studies.  
 
The significance of employing multifaceted/multi-component approaches (marketing mix) 
in teenage pregnancy interventions has been highlighted by other similar studies 
(Cheesebrough et al., 1999; Card, 1999; DiCenso et al., 2002). These studies observed that 
interventions which combined school and community strategies, media and health service 
provision reported a greater impact on teenagers’ sexual behaviour and reduction in 
unintended pregnancies. The idea of using incentives (exchange) to encourage behaviour 
change has recently been gaining favour in public health practice (Thaler & Sustein, 2008; 
Jochelson, 2007). However, evidence on the sustainability of the behaviour change on the 
long term is limited. Some evidence suggests that financial/monetary incentives are more 
effective in changing “one off” behaviours such as keeping appointments and participating 
in programmes whereas non financial incentives that enhance individuals’ motivation, 
confidence and skills are more effective on the long term (Jochelson, 2007). Overall the 
use of incentives is recommended in motivating behaviour change especially among hard 
to reach groups (Kirby, 2001; Teenage Pregnancy Unit, 2006; Arai, 2003; Kirby, 2007).  
 
This study observed an association between programme duration and impact, a finding 
which is consistent with those of other studies (Cheesebrough et al., 1999; Card, 1999; 
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Robin et al., 2004) which have also highlighted the futility of implementing well designed 
interventions over short periods (less than two years). Rotheram-Borus et al. (1998) in their 
study on intervention programme duration also found that short session interventions 
implemented over long periods were more effective than long sessions implemented over 
short periods. Although these findings underscore the importance of long term 
interventions, in practice this might be a major challenge for institutions such as schools 
which often have limited time and resources to implement programs within an academic 
year, and have important implications for the cost-effectiveness of the approach. Although 
time limitation may not be a major challenge for community based programs, the need for 
extra resources to implement multiple sessions may be a notable barrier (Stanton et al., 
1996; Peersman & Levy, 1998; Kirby, 2007). 
 
The minimal impact on male participants’ sexual behaviour observed in this study raises 
important questions. Firstly is the appropriateness of evaluation tools used in studies 
included in this review and whether they were cognitively tested with male participants 
before actual use. Perhaps males do not know about their partners’ pregnancies and 
possibly refusal of unwanted sex is more female-related than male? What if a large 
proportion of females are using other forms of contraception which makes it unnecessary 
for males to use condoms for the purpose of pregnancy prevention? Currently evidence on 
male participation in teenage pregnancy interventions is limited. However some qualitative 
studies have indicated that most of the current approaches are mainly designed for females 
and may be inappropriate for males (Trivedi et al., 2009). These findings and related 
questions seek further investigation to establish why males appear to be highly receptive to 
sexual health messages but are unable or unwilling to put them into practice. There is need 
for more studies to help understand the male sexual behaviour and for the development of 
better intervention and evaluation strategies. 
 
The 12 included studies had several methodological limitations worth considering while 
interpreting the results of this review. Only four studies reported analysing final data either 
with “intention to treat” (Wight et al., 2002; Stephenson et al., 2003) or used multilevel 
logistic models to investigate the participant loss to follow up effect (Coyle et al., 2001; 
Coyle et al., 2006) whereas attrition rates were more than 20%  in most RCTs. In a number 
of RCTs (Aarons et al., 2000; Coyle et al., 2001; Wight et al., 2002; Philliber et al., 2002; 
Coyle et al., 2006) the baseline differences between intervention and control groups were 
  71 
significant. This might have lead to a discrepancy in measuring rates of change in 
outcomes between groups. Most of the RCTs also did not report the follow up success rates 
for control groups making it difficult to compare the effect of attrition on outcomes for the 
two arms of study. The heterogeneity in outcome measures where some studies used 
percentage and others odds ratios made it difficult to accurately compare levels of impact 
as well.  
 
The intervention program contents varied across studies despite all meeting the social 
marketing criteria. This meant it was not possible to comprehensively assess program 
intensity. This was made more difficult with some studies not specifying duration of 
intervention exposure or simply stating number of sessions. Another limitation to be 
considered here is that, in the reported RCTs, the control groups received a conventional 
intervention rather than no intervention. This means that the test applied was not whether 
social marketing interventions were effective, but whether they were more effective than 
the conventional interventions. However, this situation is not peculiar to the studies 
reviewed here, and is a problem common to many RCTs. As is also common with other 
controlled studies, the possibility of contamination across groups was high especially 
where randomization was done at individual level which might have contributed to some 
studies reporting low or null effects.  
 
This review included studies only reported in the English language and may, therefore, 
have missed studies done within Western Europe reported in other languages. Indeed, the 
studies that met the inclusion criteria were all conducted in the USA and UK.  This could 
reflect language limitations or the fact that teenage pregnancy has been viewed as a priority 
problem in the USA and UK for over a decade and therefore attracted more research 
(Imamura et al., 2007). The majority of the interventions evaluated involved participants 
from ethnic minority groups, mainly Hispanics and African American groups and the 
wider relevance of these findings beyond those groups need further consideration. 
However, in support of the wider generalisability of the results, three of the studies (Paine-
Andrews et al., 1999; McBride & Gienapp, 2000; Coyle et al., 2001) which had a majority 
of white participants, reported comparable outcomes. Lastly, the quality of two studies 
(Tiezzi et al., 1997; Lederman et al., 2008)  was rated as weak, which brings into question 
the true intervention effects. However, the low rating could have been due to under-
reporting of vital methodological details by the authors due to word limitations. All studies 
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relied mostly on participant self reported data for analysis which is a known inevitable 
source of bias for studies evaluating sexual behaviours, as there is the tendency for 
respondents to agree with statements associated with healthier behaviours or attitudes 
(McFarlane & St Lawrence, 1999; Sieving et al., 2005). However, this potential setback 
was ameliorated by participant privacy and confidentiality in most studies. 
 
Implications for Social Marketing 
The results of this study indicate that the mere application of social marketing principles in 
unintended teenage pregnancy interventions may not be adequate to consistently produce 
favourable outcomes. Other factors such as programme duration and intensity play a major 
role. In this study, long term interventions were more effective as compared to short term 
ones for most outcomes. Furthermore, the only program that reported significant effects 
across all five outcomes was long term and had the highest exposure period of up to 22 
hours a month over a period of three years (Philliber et al., 2002).This implies that the 
social marketing potential is more likely to be fully exploited when a long term approach is 
employed. However, considering the vast resources required to run such long-term 
programs, further research to inform the design of medium term and cost effective 
interventions is recommended. Philliber’s intervention was also the most intensive, 
featured a better marketing mix and used incentives extensively to encourage participation 
in its programmes. These findings underline the need for well designed social marketing 
programmes which address adequately the identified needs of a well defined target group 
while ensuring there is regular participation in intervention activities for significant effects 
to be realised. 
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3.5 Conclusion 
This is the first systematic review to assess the effectiveness of a social marketing 
approach in teenage pregnancy interventions in the developed countries. Results indicate 
that Social Marketing may be an effective approach in reducing teenage pregnancies and 
influencing related behaviour change but evidence is limited to particular outcomes/context 
and therefore inconclusive. The fact that all the included studies were not necessarily 
designed as typical social marketing interventions meant the implementation of the specific 
programme activities varied widely despite all meeting the minimum specified inclusion 
criteria, a factor which might have contributed to the inconsistent impact. There is 
therefore need for more teenage pregnancy interventions and studies that are specifically 
designed around social marketing principles which would permit a more robust evaluation 
of social marketing than the incidentally social marketing interventions currently do. The 
minimal impact of the interventions on male participants’ sexual behaviour also warrants 
further investigation.  
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Chapter 4: Factors Associated with the Use of Long 
Acting Reversible Contraceptives among Young Women 
in the United Kingdom 
 
In this chapter I present the second study on factors associated with use of Long Acting 
Reversible Contraceptives (LARC) among young women aged 16-24 in the UK. This 
study is an application of the consumer research component of social marketing. In the 
introduction section I describe the rationale for the study, policy context and include a 
discussion on evidence from other related studies. In the methods section I list the study’s 
aim and objectives and describe the data management and analysis process. In the results 
section I present the socio-demographic details of participants in the five surveys and 
include a summary table. Also included are findings from the trend analysis on use of 
LARC methods with graphs for various age groups and a section on factors associated with 
use of LARC methods. I report findings for two distinct periods i.e. the period before 
LARC guidelines were published by the National Institute of Health and Clinical 
Excellence (NICE) (2002-2005) and after (2006-2007).  The results section also includes 
findings from the analyses of reasons why women changed from LARC methods to non-
LARC and vice versa. These findings are summarised in three tables. The main findings 
from the study are also discussed and implications for public health policy and practice and 
social marketing highlighted. I also discuss study limitations and lastly draw conclusions 
and make suggestions on further research. 
 
4.1 Introduction 
The rate of unintended pregnancy among young women aged below 25 years in the UK 
has remained high over the years despite the annual increases in the prevalence of 
contraception use. Of concern has also been the associated rate of abortion which is 
relatively higher than that of older women. In 2009 for example, the abortion rate was 
highest among women of age range 20-24 (30/1000) followed by those in age range 15-19 
(23/1000) (Department of Health, 2009b). Furthermore teenage births which evidence 
shows largely result from unintended pregnancies (Department of Children, Schools and 
Families, 2010) and abortion rates in the UK are the highest in Western Europe (Family 
Planning Association, 2010). Unintended pregnancy among young women has been 
associated with disruption in formal education processes, increased vulnerability and long 
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term negative social, health and economic outcomes where there is no adequate support 
(Department of Children, Schools and Families, 2010). Unintended pregnancies not only 
affect individual women and families, they are also a major burden to the national 
economy. In the UK, it is estimated that each unintended pregnancy costs the National 
Health Service (NHS) about £1,235 which equates to approximately £500 million annually 
(National Institute for Health and Clinical excellence, 2005; Bayer Health Care & Bayer 
Schering Pharma, 2008).  
 
The UK government considers unintended pregnancy  a priority public health issue as 
highlighted in its policy documents namely, the National Sexual Health Strategy 
(Department of Health, 2001a), The National Teenage Pregnancy Strategy (Social 
Exclusion Unit, 1999) and the Choosing Health: Making Healthy Choices Easier, White 
Paper (Department of Health, 2004) all of which emphasise the provision of good quality 
contraceptive services as key to reducing unintended pregnancy rates among women of 
reproductive age. This approach is based on evidence which shows that significant 
reduction in unintended pregnancy rates can mainly be achieved through facilitating use of 
effective contraception (National Institute for Health and Clinical Excellence, 2005; 
Flemming, 2009). While the majority of young women in the UK use some form of 
contraception, the contraceptive failure rates are relatively high. This disparity has been 
associated with the choice of contraception where the tendency has been towards reliance 
on temporary methods such as condoms and pills which have higher rates of failure (Fu et 
al., 1999; Ranjit et al., 2001). It is estimated that about 90% of unintended pregnancies in 
the UK are as result of contraception not being used or being used incorrectly (Flemming, 
2009; Bury et al., 2009). This is despite the seemingly easy access to contraception in the 
UK where contraceptives have been freely available via the National Health Service since 
1974. 
 
Among young women aged 16-24 hormonal pills and male condoms have remained the 
most popular methods of contraception (The NHS Information Centre for Health & Social 
Care, 2010) even with the available evidence showing that the majority of unintended 
pregnancies  that end up in abortion in the UK are among women who report  using 
condoms or pills (Schunmann & Glasier, 2006; Rowlands, 2007). The use of long acting 
reversible contraceptives (LARC) among young women in the UK remains low in spite of 
the overwhelming evidence of their cost-effectiveness in preventing unintended 
  76 
pregnancies (The National Institute for Health and Clinical excellence, 2005; Trussell, 
2007). Long acting reversible contraceptives are defined as: contraceptives that require 
administering less than one cycle per month (National Institute for Health and Clinical 
Excellence, 2005). These include: Intra-Uterine Device (IUD), Intra-Uterine System (IUS), 
Depo-Provera injection and Implants (See Appendix 4.1 for details). Unlike the commonly 
used methods, the effectiveness of LARC is less dependent on compliance/correct use of 
method.  
 
In recognition of the importance of promoting the uptake of LARC in order to address the 
high rates of unintended pregnancies and abortions, the UK government commissioned the 
National Institute of Clinical Excellence to develop guidelines for health practitioners in 
order to encourage more prescription of LARC methods. The guidelines were published in 
2005, initially designed for England and Wales but were also adopted by Scotland. Since 
2009, General Practitioners (GPs) have also been given incentives (more funding) through 
the Quality Outcomes Framework (QOF) to provide advice on sexual health and 
contraception and in particular LARC methods (Teenage Pregnancy Independent Advisory 
Group, 2009). However, LARC uptake among young women still remains low hence the 
need for a consumer research to explore further possible explanatory factors to be 
considered in future strategy reviews. The dependence on medical practitioners to 
administer LARC has been cited as a major contributing factor to the low uptake by some 
studies (Glasier et al., 2008). Others have observed that most health professionals lack the 
necessary skills and motivation to administer LARCs and therefore end up prescribing user 
dependent methods (Wellings et al., 2007; Bury et al., 2009). The acceptability of LARC 
methods among women has also been found to be low. This has been attributed to limited 
knowledge and reliance on negative anecdotes from peers and some media about related 
risks and side effects (Glasier et al., 2008; Ruddick, 2009). 
 
Notwithstanding the interest in promoting the use of LARC in the UK and the interest in 
contraceptive choice, little research has looked at factors associated with the uptake of 
LARC methods. In the UK most of the evidence on contraceptive use and choice has been 
dependent on annual opinion surveys carried out by the Office for National Statistics 
(ONS) and the National Health Service (NHS) Contraceptive Services annual reports based 
on returns from Community Contraception Clinics. The published reports have been useful 
in the understanding of contraceptive uptake patterns in the UK but in case of the latter, the 
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limitation has been not including services provided by genitourinary medicine (GUM) 
consultants in outpatient clinics and general practitioners. The ONS Opinion Survey 
reports on the other hand prior to 2005/06 did not include multivariate modelling which is 
vital in understanding the independent association between various socio-
demographic/behavioural factors and contraceptive use/choice. Furthermore, after 2005 the 
multivariate analyses reported by ONS have been limited to the association between 
participant characteristics and use of condoms or pills. So far, no study has specifically 
investigated factors associated with the use of LARC methods among young women 
(below age 25) in the UK.  
 
In order to increase the use of LARC methods among young women in the UK, it is 
important that a consumer research is undertaken to understand the relationship between 
socio-demographic and sexual characteristics of those who choose these methods and those 
who don’t. It is also important to understand the reasons why young women choose LARC 
or non-LARC methods. This will enable health care providers to design better strategies 
that will enhance LARC uptake among young women and reduce the rate of unintended 
pregnancies. To address these areas about which little is known, the latest publicly 
available nationally representative survey data on contraceptive use in the UK collected by 
the Office for National Statistics between 2002 and 2007 are analysed.  
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4.2 Methods 
Aim 
To examine factors associated with use of LARC methods among young women aged  
16-24 in the UK.  
 
Objectives 
 To identify LARC and Non-LARC uptake trends among women who participated 
in the five surveys. 
 To examine the impact of NICE LARC guidelines on LARC uptake among 
participants. 
 To describe the association between individual socio-demographic characteristics, 
sexual behaviour and use of LARC methods. 
 To identify the main factors that influence change of contraception from non-
LARC to LARC and vice versa.  
 
Datasets description 
The 2002/03, 2003/04, 2004/05, 2005/06 and 2006/07 ONS Opinion Survey (Previously 
known as the Omnibus Survey) data sets were obtained from the UK Data Archive, 
Economic and Social Data Service (ESDS), University of Essex, Colchester, UK. The 
datasets were of the contraceptive modules carried out during the months of June, 
September, December and March for the specified years. Each month, over 1,000 adults 
(aged 16 and over) living in private households in the UK were selected using postcode 
address file as a sampling frame and interviewed. A new sample of postal sectors was 
selected each month and stratified by: region; the proportion of households renting from 
local authorities; and the proportion in which the household reference person was in a 
socio-economic group 1-3 (i.e. a professional, employer or manager). The postal sectors 
were selected with a probability proportionate to size and within each sector 30 addresses 
(delivery points) were randomly selected. If an address contained more than one 
household, the interviewer randomly selected one of the households. Within households 
with more than one adult member, just one person aged 16 or above was selected using 
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random number tables. Proxy interviews were not taken. Weighting factors were applied to 
collected data to correct for unequal probability of selection caused by interviewing only 
one adult per household, or restricting the eligibility of the module to certain types of 
respondents.  
 
The publication of NICE guidelines for health workers in the UK by the Department of 
Health in October 2005 which aimed at increasing the use of LARC methods among 
women of reproductive age was considered a potentially significant factor that might have 
impacted on LARC uptake trends. For that reason, the five survey datasets were divided 
into two subgroups to represent the periods before (Pre-NICE) and after (Post-NICE) 
NICE guidelines were issued. The Pre-NICE period included datasets for surveys done 
between June 2002 and March 2005 (2002/03-2004/05) whereas the Post-NICE period 
included datasets for surveys done between December 2005 and March 2007 (2005/06-
2006/07).The methodology for data collection and recording was sufficiently similar and 
no difficulties were experienced while combining the datasets. The five surveys collected 
information on socio-demographic details, contraceptive use, sexual relationships and 
knowledge of sexually transmitted diseases from women aged 16-49 and men aged 16-69 
(See Appendix 4.8 for sample questionnaire). This study analysed responses from women 
aged 16-24 on socio-demographic characteristics, contraceptive use and sexual 
relationships. The numbers of women who participated in the five surveys and those who 
responded to the questions on contraceptive use are shown in figure 4.1 
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Figure 4.1: Flow chart showing the number of women who participated in the 
five ONS Opinion Surveys – Contraception Modules for the period 2002-2007 
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responded to questions on contraception 
use in the five surveys (2002-2007) 
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Measures 
Explanatory variables 
Explanatory variables based on the participants’ socio-demographic characteristics and 
sexual behaviour were: 
 Age band (16-19, 20-24) 
 Ethnicity 
 Socio-economic class 
 Educational level 
 Area deprivation2 
 Marital status 
 Sexual behaviour 
- Number of partners in the last one year 
- Number of current partners 
 
Reasons for change of contraception method 
To determine reasons for change of type of contraception (LARC to Non-LARC and vice 
versa) the following response options derived from question C170.21 (Appendix 4.8) were 
used as explanatory variables: 
 Different partner 
 More reliable in preventing pregnancy 
 More convenient to use 
 Better for long term health 
 Better for protecting against infection 
The influence on change of methods by General Practitioners (GPs) and other Family 
Planning Practitioners (FPPs) was further analysed using the ‘Yes’/‘No’ binary responses 
to the question that asked respondents whether they were at all influenced to make the 
change by advice from a GP or Family Planning Practitioner (M170_22 – Appendix 8).  
 
                                                 
2
 Area deprivation was based on the percentage of Lower Super Output Areas (LSOAs) (the smallest 
government administrative areas) in the five England regions (The North, Midlands & East England, London, 
South East and South West) which fall in the most deprived 20% of LSOAs in England according to the 
Index of Multiple Deprivations (IMD) 2007. The North and London regions were categorised as most 
deprived, Midlands & East England and South West as average and South East as least deprived (See 
Appendix 2 for details). 
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Outcome variables 
Based on the questions that asked participants what methods of contraception they were 
using at the time of the interview (M170_6M – Appendix 4.8), the proportions of women 
using various types of contraception or no method were determined. In consideration of the 
small numbers of women using certain types of contraception a category named as 
‘Others’ was created. The final types of contraception used in the analyses were therefore 
reduced from the initial 13 to seven as shown below: 
 Pill 
 Intrauterine device – IUD 
 Injection 
 Implant 
 Hormonal intrauterine system – IUS 
 Male Condom 
 Others - Emergency contraception, safe period, spermicides, female condom, 
cap/diaphragm and contraception patch. 
 
The seven categories were further reduced to two (LARC and Non-LARC) as shown 
below to allow for comparison of the uptake rates for the two methods by year of survey 
and further analyses: 
 
 LARC - Intrauterine device (IUD), Injection, Implant & Intrauterine system (IUS) 
 Non-LARC – Pill, Male Condom & Others 
 
In order to determine previous methods of contraception for women who had changed 
methods in the preceding five years, the responses to the question M170_14M (Appendix 
4.8) were used. The types of contraception were reduced to two categories (LARC and 
Non-LARC) to allow for further analyses. 
Data analysis 
Data analysis was carried out using STATA Version 10 statistical software. The maximum 
number of observations available for analysis was 1,311. However, the sample size in any 
specific analysis varied due to non-response. 
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Trend analyses 
Trend analyses on the uptake of the main contraception methods (Male Condom, Pill, 
Injection, IUD, IUS and Implants) across the five year period were carried out and results 
presented in tables and graphs. Three age subgroups (16-17, 18-19 and 20-24) were 
initially analysed separately. The first two age groups were created in order to examine a 
possible impact by the Teenage Pregnancy Strategy which was initiated in 1998 with the 
aim of reducing unintended pregnancies among women aged below 18 by increasing 
contraception use among other approaches. Due to small numbers of women involved 
further analyses were therefore based on the broader categories of contraception (LARC 
and Non-LARC). Because of the potential impact of the 2005 NICE LARC guidelines, 
uptake trends for the two broad methods before and after the guidelines were analysed and 
compared. Uptake rates are presented as percentages with confidence intervals and 
Pearson’s Chi2 test for trend included.  
 
Analysis of factors associated with use of LARC methods 
Bivariate analyses were carried out utilizing cross tabulations and Chi2 tests to determine 
the significance of the association between LARC methods uptake and participants’ socio-
demographic characteristics/sexual behaviour for the two survey periods (Pre-NICE - 
2002/03-2004/05 and Post-NICE - 2005/06-2006/07). Variables that were significantly 
associated with LARC uptake (Age and Educational level) were then fitted in a logistic 
regression model and further analyses carried out to determine their relative and 
independent effects on LARC uptake. Logistic regression was preferred as it is a technique 
frequently used in analysing binary response data due to its ability to link the occurrence or 
non-occurrence of an event or outcome (use or non-use of LARC methods in current study) 
to explanatory variables (Age and Educational level) hence determining which explanatory 
variable(s) have the most significant impact on the outcome. Results are presented as 
percentages with 95% confidence intervals for bivariate analyses and adjusted and 
unadjusted odds ratios (OR) with 95% confidence intervals for logistic regression. 
 
Analysis of reasons for change to, or away from LARC methods 
By use of cross tabulations, women’s current and previous methods of contraception and 
reasons for change of methods were identified. The proportions of women changing from 
Non-LARC to LARC, No Method to LARC, No Method to Non-LARC and LARC to 
Non-LARC, were calculated and are reported as percentages with 95% confidence 
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intervals. Using Chi2 significance tests, the statistical differences in reasons reported for 
change of contraception methods were determined and P values reported. 
Ethical Consideration 
The study was entirely based on a secondary data analysis, the data are freely available for 
academic research, and no attempt was made to use the data for any purpose other than that 
for which they were intended.  There was, therefore, no requirement for approval by an 
Institutional Ethics Committee – and this was confirmed. 
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4.3 Results 
Participants’ socio-demographic characteristics 
A total of 1392 sexually active British women aged 16-24 (mean age 20) participated in 
five annual surveys carried out between the years 2002 and 2007. Table 4.1 shows the 
socio-demographic details for a maximum of 1311 whose responses were analysed in this 
study. The majority of the participants were women aged 20-24, of white ethnic 
background and with educational level below a degree qualification. More than half of the 
respondents lived either in the North, Midlands or Eastern regions of England. Three 
quarters were single while over 70% reported having only one partner in the last one year 
(i.e., in the year prior to the interview). Almost all participants reported having only one 
sexual partner at the time of the interview. Overall there were no significant differences in 
the composition of samples among the five surveys. 
 
Table 4.1: The socio-demographic characteristics of British women aged 16-
24 who participated in the five contraception use surveys carried out over 



















       
0.585 
16-19 497 (38) 120(38) 122(41) 114 (38) 58(31) 83(41)  
20-24 814 (62) 200(62) 175(59) 190 (62) 130(69) 119(59)  
Total 1311 320 297 304 188 202  
 
Ethnicity 
       
0.765 
White  1166 (89) 275(86) 270(91) 271(89) 166(88) 184(91)  
Non-White 143 (11) 45(14) 25(9) 33(11) 22(12) 18(9)  




       
0.977 
Non-Manual 415 (32) 114(36) 86(29) 93(31) 60(32) 62(31)  
Manual 383 (29) 83(26) 90(30) 96(32) 51(27 63(31)  
Unclassified 513 (39) 123(38) 121(41) 115(38) 77(41) 77(38)  
Total 1311 320 297 304 188 202  
 
Educational level 
       
0.809 
Degree or higher 157 (12) 43(13) 32(11) 38 (13) 27(14) 17(9)  
Below degree 1006 (77) 237(74) 240(81) 223 (74) 140(75) 166(82)  
No qualification 146 (11) 40(13) 25(8) 42 (14) 21(11) 18(9)  
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Total 1309 320 297 303 188 201  
 
Area of residence 
(region) 
       
0.984 
The North 351 (27) 92(29) 82(28) 81 (27) 49(26) 47(23)  
Midlands & E 
England 
321 (24) 71(22) 65(22) 78 (26) 41(22) 66(33)  
London 148 (11) 39(12) 25(8) 38 (13) 24(13) 22(11)  
South East 184 (14) 50(16) 44(15) 37 (12) 28(15) 25(12)  
South West 115 (9) 21(7) 29(10) 29 (10) 20(11) 16(8)  
Wales 71 (5) 13(4) 20(7) 18 (6) 9(5) 11(6)  
Scotland 121 (9) 34(11) 32(11) 23 (8) 17(9) 15(7)  
Total 1311 320 297 304 188 202  
 
Marital Status 
       
0.725 
Married/Cohabiting 312 (24) 79(25) 51(17) 75 (25) 52(28) 55(27)  
Single 997 (76) 241(75) 246(83) 227 (75) 136(72) 147(73)  
Total 1309 320 297 302 188 202  
 
Number of sexual 
partners in last 1 
year 
       
0.796 
One 788 (73) 193(73) 179(75) 180(70) 117(77) 119(71)  
Two or more 289 (27) 70(27) 58(25) 78(30) 35(23) 48(29)  
Total 1077 263 237 258 152 167  
 
Number of current 
Sexual Partners  
       
0.861 
One 938 (98) 231(98) 216(99) 215(97) 131(98) 145(97)  
Two or More 22 (2) 5(2) 3(1) 7(3) 3(2) 4(3)  
Total 960 236 219 22 134 149  
# Totals differ due to varying number of responses 
 
Trend analysis 
Specific contraception methods 
The use of LARC methods was consistently lower than non-LARC methods in all the five 
surveys among women aged 16-24. Injection was the most commonly used LARC method 
up to 2004/05 when Implants and IUDs uptake showed notable improvement. However in 
the fifth survey (2006/07), Injection was still the most popular method with an uptake rate 
of 5% whereas the IUS remained the least popular LARC method across the five surveys. 
The uptake of contraception in general increased over the five year period (Figure 4.2 & 
Appendix 4.3). In the fifth survey (2006/07) only 24% of women interviewed were not at 
the moment using any method as compared to 33% in 2002/03 survey. The pill was the 
most popular contraceptive up to 2004/05. Afterwards Male Condom was the most 
commonly used method.  
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LARC & Non-LARC Methods 
Although the overall uptake of LARC methods was significantly lower than that of non-
LARC methods across the five surveys (Figure 4.3 & Appendix 4.7), use of LARC 
methods increased significantly over the five year period from 6% in 2002/03 to 13% in 
2006/07 (P = 0.009). The use of Non-LARC methods also showed an upward trend up to 
2005/06. Afterwards the uptake rate dropped by about 5%, coinciding with a substantial 
rise in use of LARC methods.  
 
Figure 4.2: Current contraception use among 16-24 year old women by year 
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Chi2 test for trend (All methods): P = 0.004 
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Figure 4.3: Current use of LARC, Non-LARC & No Method among 16-24 year 
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Chi2 test for trend (LARC): P = 0.009 
 
Trends by age group 
The use of LARC methods among women aged 16-17 increased during the five year 
survey period. The largest rise was observed after 2004/05 (after the publication of NICE 
LARC guidelines) when the uptake of LARC methods rose from 1.7% to 11.6% in 
2006/07.  The uptake of Non-LARC methods dropped at the same time of LARC upsurge 
(2004/05) from 55.9% to 44.2% in 2006/07 (Figure 4.4). Appendix 4.4 shows the uptake 
rates for specific LARC and Non-LARC methods. The IUD was the most popular LARC 
method among this age group with its uptake rising from below 2% before 2005/06 to 5% 
in 2006/07. The uptake of Injection and Implant also rose from 0% to over 2% in 2006/07. 
None of the women aged 16-17 in the five surveys was using IUS. Male Condom and Pill 
were the most popular Non-LARC methods in all surveys.  
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Figure 4.4: Current use of LARC, Non-LARC & No Method among 16-17 year 
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LARC Non-LARC No Method
Proportion of women aged 16-17 using LARC, Non-LARC or No Method
 
Chi2 test for trend (All Methods): P = 0.187 
Chi2 test for trend (LARC): P = 0.053 
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Among women aged 18-19 the use of LARC methods increased threefold between 2002/03 
(4.4%) and 2006/07 (12.5%) but the majority were using Non-LARC methods. The Non-
LARC uptake declined after 2003/04 (Figure 4.5). Appendix 5 shows the uptake rates for 
specific LARC and Non-LARC methods.  Injection was the most popular contraception 
among LARC methods up to 2005/06 when the uptake rate of IUDs rose to the same level 
(5%). None of the women aged 18-19 in the five surveys was using IUS.  The Male 
Condom and Pill were the most popular Non-LARC methods in all surveys. The 
differences in contraception uptake across the five years were however not statistically 
significant (Figure 4.5). 
 
Figure 4.5: Current use of LARC, Non-LARC & No Method among 18-19 year 




















2002/03 2003/04 2004/05 2005/06 2006/07
Year of Survey
LARC Non-LARC No Method
Proportion of women aged 18-19 using LARC, Non-LARC or No Method
 
Chi2 test for trend (All Methods): P = 0.086 
Chi2 test for trend (LARC): P = 0.224 
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The use of LARC methods among women aged 20-24 increased from 7.5% in 2002/03 to 
14.3% in 2006/07 but the majority were using Non-LARC methods (Figure 4.6). Appendix 
6 shows the uptake rates for specific LARC and Non-LARC methods. The Injection and 
IUD were the most popular LARC methods up to 2004/05 after which the use of Implants 
rose to a comparable level of 4% in 2006/07. Pill and Male Condom were the most popular 
Non-LARC methods in all surveys. The differences in contraception uptake across the five 
years were however not statistically significant (Figure 4.6).  
 
Figure 4.6: Current use of LARC, Non-LARC & No Method among 20-24 year 




















2002/03 2003/03 2004/05 2005/06 2006/07
Year of Survey
LARC Non-LARC No Method
Proportion of women aged 20-24 using LARC, Non-LARC or No Method
 
Chi2 test for trend (All Methods): P = 0.127 
Chi2 test for trend (LARC): P = 0.105 
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Figure 4.7 shows LARC uptake trends over the five survey years for the three age groups. 
Overall the use of LARC methods among 16-17 & 18-19 year olds increased after 2004/05 
whereas among 20-24 year olds there was a drop in LARC uptake for a year but afterwards 
started to rise again. However the difference in LARC uptake between the three age groups 
in the five surveys was not statistically significant (P = 0.402) hence further analyses were 
based on two broad age groups as a priori i.e. 16-19 & 20-24. 
 
Figure 4.7: Current use of LARC methods among women aged 16-17, 18-19 & 




















2002/03 2003/04 2004/05 2005/06 2006/07
Year of Survey
16-17 18-19 20-24
LARC uptake by age group
 
Chi2 test for difference in trends: P = 0.402 
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Factors associated with use of LARC methods 
Pre-NICE LARC guidelines (2002/03 - 2004/05) & Post-NICE LARC guidelines 
(2005/06 - 2006/07) Periods 
During the Pre-LARC NICE guidelines period, the LARC uptake rate among 20-24 year 
old women (11%) was more than twice that of those aged 16-19 (5%). Women with a 
degree or higher qualifications had the lowest uptake rate (6%) as compared to those with 
below degree (8%) or no qualification (23%) (Table 4.2). However, there was no 
significant difference in LARC uptake rates by ethnicity, socio-economic status, area 
deprivation, marital status and number of sexual partners at the time of interview or in the 
previous one year (Table 4.2). For the Post-NICE LARC guidelines period, there was no 
significant difference in LARC uptake for all specified variables (Table 4.2). Overall the 
LARC uptake rate was higher during the Post-LARC NICE guidelines period (13%) than 
the Pre-NICE LARC guidelines period (9%) but the difference was not statistically 
significant (P = 0.063). Logistic regression results (adjusted model) showed that women 
aged 20-24 were three times more likely to use LARC methods as compared to those aged 
16-19 while women with no qualifications were up to seven times more likely to use 
LARC methods as compared to those with a degree or higher qualifications during the Pre-
LARC NICE guidelines period. Age and educational level were not significantly 
associated with LARC uptake for the Post-NICE LARC guidelines period (Table 4.3).
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Table 4.2: Factors associated with LARC uptake among British women aged 16-24 for the periods 2002/03 -2004/05 & 







2002/03 - 2004/05 2005/06 & 2006/07 
 


























Total 701 9.3 (7.3, 11.6)  312  13.1 (9.8, 17.3)  
 
Age 
   
0.008 
   
0.775 
16-19 232 5.2 (3, 8.8)  93  14 (8.4, 22.5)  
20-24 469 11.3 (8.7, 14.5)  219 12.8 (9, 17.9)  
 
Ethnicity 
   
0.701 
   
0.239 
White  633  9.2 (7.2, 11.7)  291 13.8 (10.3, 18.2)  
Non-White 66  10.6 (5.2, 20.3)  21  4.8 (0.8, 22.7)  
 
Socio-economic class 
   
0.355 
   
0.238 
Non-Manual 248  7.3 (4.6, 11.2)  106  9.4 (5.2, 16.5)  
Manual 227  11 (7.6, 15.8)  104  17.3 (11.2, 25.7)  
Unclassified 226 9.7 (6.5, 14.3)  102  12.8 (7.6, 20.6)  
 
Educational level 
   
<0.001 
   
0.155 
Degree or higher 83  6 (2.6, 13.3)  39  5.1 (1.4, 16.9)  
Below degree 539 7.8 (5.8, 10.4)  249  13.7 (9.9, 18.5)  
No qualification 78 23.1(15.1, 33.6)  23 21.7 (9.7, 41.9)  
 
Area Deprivation┼ 
   
0.508 
   
0.900 
Most deprived 268  7.5 (4.9, 11.2)  109  12.8 (7.8, 20.4)  
  95 
Average 160  10.6 (6.7, 16.4)  86  15.1 (9.1, 24.2)  
Least Deprived 157 9.6 (5.9, 15.2)  71  14.1 (7.8, 24)  
 
Marital Status 
   
0.347 
   
0.983 
Married/Cohabiting 202  10.9 (7.3, 15.9)  107  13.1 (8, 20.8)  
Single 499 8.6 (6.5, 11.4)  205 13.2 (9.2, 18.5)  
 
Number of sexual partners 
in last 1 year 
   
 
0.471 
   
 
0.901 
One 509 9.6 (7.4, 12.5)  225  12.4 (8.8, 17.4)  
Two or more 179 7.8 (4.7, 12.7)  77 13 (7.2, 22.3)  
 
Number of current Sexual 
Partners  
   
 
0.747 
   
 
0.923 
One 661  9.1 (7.1, 11.5)  276 13 (9.6, 17.5)  
Two or More 15 6.7 (1.2, 29.8)  7 14.3 (2.6, 51.3)  
 
$ 95% Confidence Interval 
§ Chi2 significance test for difference in LARC uptake between groups. 
┼ Does not include Wales & Scotland 
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Table 4.3: Odds ratios and 95% confidence Intervals of reporting current use of LARC methods by age & educational 




2002/03 - 2004/05 2005/06 - 2006/07 

















Age         
16-19 1.00 0.010 1.00 0.002 1.00 0.775 1.00 0.892 
20-24 2.34 (1.22, 4.46)  2.82 (1.45, 5.49)  0.90 (0.44, 1.83)  1.05 (0.51, 2.17)  
 
Educational level 
        
Degree or higher 1.00 <0.001 1.00 <0.001 1.00 0.180  0.182 
Below degree 1.32 (0.51, 3.43)  1.74 (0.66, 4.57)  2.93 (0.67, 12.7)  2.97 (0.67, 13.1)  
No qualification 4.68 (1.64, 13.3)  6.70 (2.30, 19.5)  5.14 (0.91, 29.1)  5.25 (0.90, 30.6)  
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Reasons for change of contraception method 
Table 4.4 shows the types of contraception in use by women at the time of interview and 
their previous methods in the preceding five year period (Appendix 4.8 – M170_14M). 
More than two thirds of women who were using LARC methods at the time of interview 
had previously used Non-LARC methods (69% for the Pre-NICE LARC guidelines period 
and 64% for the Post-NICE LARC guidelines period). A third of those who were using 
Non-LARC methods had previously used no method (34% and 33% for the two periods 
respectively). A very small percentage had changed from using LARC to Non-LARC 
methods for both periods (4% and 3% respectively).  
 
Table 4.5 shows the main reasons why women changed from LARC or No method to Non-
LARC methods. In both survey periods most women who previously used LARC methods 
cited better long term health as the main reason for change (24% & 29% respectively). For 
the Pre-NICE LARC guidelines period, most women who previously used no method 
reported reliability as the main reason for choosing Non-LARC methods. However, the 
number of responses from women who previously used no method for both periods was 
small and the differences between the two periods were not statistically significant. 
 
Table 4.6 shows the main reasons why women changed from Non-LARC methods or No 
method to LARC methods. For both periods most women who previously used non-LARC 
methods cited reliability (40% & 41% respectively) and convenience (38% & 41% 
respectively) as the main reasons for changing to LARC methods. Among women who 
previously used no method, reliability, better long term health and surprisingly ‘better for 
protection from sexually transmitted infections’ were cited as the main reasons for change. 
However, the number of responses in both periods was small and the differences between 
the two periods were not statistically significant. 
 
The proportion of women who reported having been influenced by General Practitioners or 
other family planning practitioners to change from non-LARC to LARC was slightly 
higher among women interviewed during the Pre-NICE LARC guidelines period (42%) 
than those interviewed during the Post-NICE LARC guidelines period (37%). The 
influence on women who previously used no method was minimal (16% and 14% 
respectively) (Table 4.5). The proportion of women who reported having been influenced 
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by General Practitioners or other family planning practitioners to change from LARC to 
Non-LARC methods was higher in the Pre-NICE LARC guidelines period (43%) as 
compared to the Post-NICE LARC guidelines period (29%). Among those who previously 
used no method the level of influence was small (4% and 1% respectively) (Table 4.6). 
However, the differences between the two periods in all cases were not statistically 
significant.
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Table 4.4: Current and previous use of LARC, Non-LARC & No Method by British women aged 16-24 for the periods 
2002/03 - 2004/05 & 2005/06 - 2006/07 
 






Current method  




Current method  
















LARC (65) 12 (19) 45 (69) 8 (22)β LARC (42) 7 (17) 27(64) 8 (19)β 0.924 
Non-LARC (583) 198 (34) 364 (62)β 21 (4) Non-LARC (252) 82 (33) 163 (64)β 7(3) 0.747 
 
§
 Percentages based on the total number of women currently using LARC or Non-LARC methods. 
* Chi2 Significance test for difference in previous contraception method used for the two periods. 
β Women who did not change methods 
Table 4.5: Main reasons reported by British women aged 16-24 for changing to Non-LARC methods after previously using 





Reason for change to a non-LARC 
method¥ 
2002/03 – 2004/05 2005/06 – 2006/07 
 
Percentage (95% 






CI) of women who 










CI) of women 
who previously 
used no method 
(n=198)* 
Change of partner 5 (0.8, 23) 1 (0.3, 3.6 ) 14 (2.6, 51) 0 
More reliable 10 (2.7, 29) 4 (1.2, 6.8 ) 14 (2.6, 51) 1 (0.2, 6.6) 
More convenient 10 (2.7, 29) 1 (0.3, 3.6 ) 0 1 (0.2, 6.6) 
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¥ Some women chose more than one reason and some options were not chosen hence column percentages do not add up to 100. 
§ Chi2 significance test for difference in reasons reported for change from LARC to Non-LARC methods: P < 0.001  
$ Chi2 significance test for difference in reasons reported for change from No Method to Non-LARC methods: P = 0.311  
┼ Chi2 significance test for difference in reasons reported for change from LARC to Non-LARC methods: P = 0.034  
* Chi2 significance test for difference in reasons reported for change from No Method to Non-LARC methods: P > 0.999  
Better for long term health 24 (4.1, 44 ) 0 29 (8.2, 64) 0 
Better for protection from STI 0 1 (0.3, 3.6 ) 0 0 
Influence by GP/FPP 43 (25, 64 ) 4 (2.1, 7.8 ) 29 (8.2, 64) 1 (0.2, 6.6) 
Non responders 38 (21, 60) 92 (88, 95) 43 (16, 75) 98 (92, 99) 
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Table 4.6: Main reasons reported by British women aged 16-24 for changing to LARC methods after previously using Non-






Reason for change to a LARC 
method¥ 
2002/03 – 2004/05 2005/06 – 2006/07 
 
Percentage (95% 
CI) of women who 
previously used 
Non-LARC 
methods (n=45)§  
 
Percentage (95% 
CI) of women who 
previously used 
no method (n=12)$ 
 
Percentage (95% 






CI) of women who 
previously used no 
method  
(n=7)* 
Change of partner 0 0  4 (0.7, 18) 0 
More reliable 40 (27, 55 ) 8 (1.5, 35 ) 41 (25, 59) 43 (16, 75) 
More convenient 38 (25, 52) 0 41 (25, 59) 0 
Better for long term health 4 (1.2, 15) 8 (1.5, 35 ) 7 (2.1, 23) 0 
Better for protection from STI 0 8 (1.5, 35) 0 0 
Influence by GP/FPP 42 (29, 57) 17 (4.7, 45) 37 (22, 56) 14 (2.6, 51) 
Non responders 31 (20, 46) 83 (55, 95) 41 (25, 59) 57 (25, 84) 
 
¥ Some women chose more than one reason and some options were not chosen hence column percentages do not add up to 100. 
§ Chi2 significance test for difference in reasons reported for change from Non-LARC to LARC methods: P < 0.001  
$ Chi2 significance test for difference in reasons reported for change from No Method to LARC methods: P = 0.239  
┼ Chi2 significance test for difference in reasons reported for change from Non-LARC to LARC methods: P < 0.001  
* Chi2 significance test for difference in reasons reported for change from No Method to LARC methods: P < 0.001  
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4.4 Discussion 
The use of LARC methods among young women interviewed doubled over the five year 
period, rising from 6% in 2002/03 to 13% in 2006/07. However, Non-LARC methods 
remained the most popular contraception among participants and in particular, Male 
Condom for 16-17 and 18-19 year olds and Pill for 20-24 year olds. On average there was 
an increment (4%) in use of LARC methods following the publication of the NICE LARC 
guidelines though not statistically significant (P = 0.063). Age and educational level were 
the only participant characteristics that were significantly associated with LARC uptake 
among women interviewed before the publication of NICE guidelines. Women aged 20-24 
were up to three times more likely to use LARC methods as compared to those aged 16-19 
while women with no qualifications were seven times more likely to use LARC methods  
as compared to those with a degree or higher qualifications. None of the factors including 
age and educational level were significantly associated with LARC uptake for the Post-
NICE LARC guidelines period. For both survey periods, the majority of women using 
LARC methods at the time of the interview had previously used Non-LARC methods. The 
change from LARC to Non-LARC methods was minimal. The main reasons for changing 
from Non-LARC to LARC methods were given as reliability and convenience. The 
influence by GP and other family planning practitioners on women changing contraception 
methods was substantial but the difference between the two periods was not statistically 
significant. 
 
Trend analysis by age group showed that among 16-17 year olds, the largest rise in use of 
LARC methods occurred after 2004/05 coinciding with the publication of the NICE LARC 
guidelines for health workers aimed at increasing prescription and subsequently the uptake 
of LARC methods. Among this group, LARC uptake rose from 2% in 2004/05 to 12% in 
2006/07. Although among 18-19 and 20-24 year olds there was a notable increase in 
LARC uptake over the same period, the differences were not statistically significant. 
Although a strong inference about the degree of influence by the NICE guidelines on the 
LARC uptake trends can not be drawn owing to other possible contributory effects from 
other interventions that were ongoing with similar goals such as the teenage pregnancy 
programme, the timing of the change and steady rise afterwards especially among 16-17 
and 18-19 year old women suggests a possible relationship. 
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The finding that age and educational level were the only participant characteristics 
associated with LARC uptake but only for the Pre-NICE period (2002/03-2004/05) is 
intriguing. Because of the timing, this change may be associated with the implementation 
of NICE guidelines whose main goal was to address identified barriers to access of LARC 
methods by all women of reproductive age. In support of this proposition an audit carried 
out in 2004 (Department of Health, 2007) on LARC prescription by GPs in England 
revealed that one in five Primary Care Trusts (PCT) had policies in place that restricted 
general prescription of LARC methods and in particular for young women who were single 
and nulliparous. They also had capped budgets in relation to LARC prescription due to the 
assumption that they were more expensive as compared to non-LARC methods. The 
publication of NICE guidelines in 2005 which provided the evidence on the cost 
effectiveness of LARC methods as compared to Non-LARC, as well as their safety in use 
among young women might have impacted positively on PCT policies and contraception 
prescribers. This is evidenced by the increase of LARC use after the year 2005 among 
young women and in particular those aged 16-19. This study could not determine why 
women with no qualifications were more likely to use LARC methods as compared to 
those with some qualifications. However, it is likely that women without qualifications 
might have had better access to LARC methods as they were more likely to meet the 
requirements of being in a partnership/marriage or multiparous unlike women with some 
qualifications, the majority of whom were still pursuing education and single. 
 
The majority of women who were using LARC methods at the time of interview for both 
periods had changed from Non-LARC methods in the preceding five years. The number of 
women changing from no method directly to LARC methods was minimal. This implies 
that LARC methods are rarely first choice in preventing pregnancy among young women, 
a phenomenon worth further investigation to understand. But it is also important to note 
that the change from LARC to Non-LARC was minimal probably indicating user 
satisfaction among LARC users. Although only a few women changed from LARC to 
Non-LARC methods in the two survey periods, the main concern was their long term 
health, an issue which other studies have found to be a major barrier in LARC uptake 
among women of reproductive age (Glasier et al., 2008; The National Health Service 
(NHS) Scotland, 2009) and therefore should continually be addressed in LARC 
interventions. Among those who changed from Non-LARC to LARC methods, reliability 
and convenience were the main motivating factors. This finding highlights the main 
 
   
 104 
positive attributes of LARC methods which should feature strongly in communication 
strategies that aim at increasing LARC uptake among young women. Overall, the 
differences in the proportions of women changing methods due to general practitioners’ or 
other health workers’ influence for the two periods of survey were not statistically 
significant. This implies that the increase in LARC uptake among young women after the 
publication of NICE guidelines was probably due to more awareness and availability of 
LARC methods rather than the active promotion of the LARC option by health workers. 
Other studies 
The current study is the first of its kind to investigate factors associated with the use of 
LARC methods among women aged 16-24 in the UK. The only other similar study was 
carried out in the USA by Whitaker et al. (2010). Their main findings were however a 
contrast to those of the current study. For example, they found that having been married or 
cohabited were associated with a higher uptake of LARC methods whereas in this study 
they were not. They also did not find any association between age and LARC uptake, a 
factor which was significant during the Pre-NICE LARC guidelines period in this study. 
Apart from the UK and US context being different which might partly explain the contrast, 
Whitaker et al. (2010) also included only two types of LARC methods (Injection and IUD) 
which might have excluded a significant proportion of young women using other LARC 
methods. The current study included four types of LARC methods (Injections, IUS, IUD & 
Implants) which provides a better assessment of LARC use patterns among young women. 
Whitaker et al. (2010) also did not assess the educational level of participants a factor 
which was significantly related to LARC uptake during the Pre-NICE LARC guidelines 
period in the current study. 
 
Studies that have investigated women’s perceptions (those using no method or Non-LARC 
methods) about LARC use have found that they associate use of LARC methods with 
negative health outcomes (Glasier et al., 2008; The National Health Service (NHS) 
Scotland, 2009; The Royal College of Obstetricians & Gynaecologists., 2010). Glasier et 
al. (2008) for example in their study found that most women were fearful of possible long 
term negative effects on their fertility as well as their physical wellbeing. They expressed 
preference for pills which they described as safe, effective, familiar and easy to ask for 
from health professionals. This is consistent with the findings of the current study and 
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therefore highlights the need for more awareness campaigns on the effectiveness and safety 
of LARC methods among young women. 
 
The minimal influence of general practitioners and other health workers in getting women 
to choose LARC methods was also a key finding of a study carried out by Wellings et al. 
(2007). The study which involved a large sample of GPs and nurse practitioners in the UK 
found that despite most them acknowledging LARC’s superior qualities in effectively 
preventing unintended pregnancies as compared to other methods of contraception, they 
were ambivalent towards prescribing LARC methods and also admitted that they would 
not prescribe LARC to adolescent women seeking contraception or as a first choice for 
women of all age groups.  
 
Implications for policy and practice 
This study observed a small but steady rise in LARC use among 16-24 year olds over the 
five year period of surveys (2002/03-2006/07). However, LARC methods remained a 
secondary option and women starting contraception tended to choose non-LARC methods 
first before trying LARC later on, with very few starting with LARC as a first option. The 
observed increase in LARC use was mainly among women who previously were using 
non-LARC methods rather than no method. Among women using no method, LARC 
uptake remained nearly constant over the five year period. These findings indicate a need 
to market LARC among women using no method as a safe and effective first time option. 
Based on available evidence (Wellings et al., 2007), there is need for training of family 
planning practitioners in order to enhance their motivation and confidence towards 
prescribing LARC methods for young women and in particular as a first choice.  
 
Some young women still consider LARC methods as not good for their long term health 
and fertility based on anecdotes rather than fact. There is need for a communication 
strategy that would provide correct information on LARC methods as regards their safety 
and effectiveness in preventing unintended pregnancy. Research has shown that most 
women tend to choose methods that their peers are using (The National Health Service 
(NHS) Scotland, 2009). Women using LARC methods should therefore be involved in 
communication campaigns where they can share their experiences with other women to 
dispel common myths and misconceptions about LARC use and related side effects and 
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promote LARC as a safe, effective and familiar type of contraception. As recommended by 
Glasier et al. (2008), practitioners should emphasize on long lasting protection and 
reversibility of LARC methods rather than highlighting their long acting aspect which has 
been identified as a discouraging factor. 
 
The publication of NICE guidelines in 2005 appears to have had a significant impact on 
LARC use as it addressed barriers earlier on raised by other studies as hindering LARC 
uptake among women of reproductive age such as the cost effectiveness of the methods 
and side effects. However, a study carried out by Wellings et al. (2007) in 2007 showed 
that most general practitioners still lacked the skills to safely administer LARC methods, 
were unsure and not motivated to administer LARC methods. Whereas the issue of 
motivation has been addressed through the Quality Outcomes Framework (QOF) incentive 
scheme where GPs now receive more funding if they provide information on LARC to 
women of reproductive age or/and prescribe LARC, the issue of training seems not to have 
been addressed adequately (The British Pregnancy Advisory Service, 2011). There is 
therefore need for more training opportunities for general practitioners and other health 
workers to enable them administer LARC methods safely. Furthermore there is evidence to 
show that Primary Care Trusts are still blocking the greater use of LARC methods contrary 
to the NICE recommendations ( Department of Health, 2007; National Institute for Health 
& Clinical Excellence, 2007; Teenage Pregnancy Independent Advisory Group, 2009; The 
British Pregnancy Advisory Service, 2011). To ensure that women who choose to use 
LARC methods are not denied that opportunity, PCTs should be audited regularly to 
ensure they have policies in place that support LARC use through adequate funding and 
training of practitioners. 
 
Although LARC methods have the best record of preventing pregnancy under typical use 
conditions, they provide no protection against sexually transmitted infections. The 
promotion of LARC as the most effective methods of contraception should therefore not be 
at the expense of sexually transmitted infections (STI) prevention. An increase in STI 
prevalence and associated conditions such as pelvic inflammatory disease, infertility and 
ectopic pregnancy would overshadow the LARC associated financial and health cost 
benefits (French & Cowan, 2009).Traditionally the practice has been that programmes 
which address STI/HIV prevention pay little attention to prevention of unplanned 
pregnancy and contraception use while those promoting contraception use pay little 
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attention to STI/HIV prevention. Evidence on the effectiveness of few programmes that 
address both pregnancy prevention and STI/HIV prevention in the UK and elsewhere is 
limited. However some studies have observed that younger women and those with multiple 
partners are more likely to comply with dual protection methods i.e. use of Condoms 
alongside Pills or LARC methods (Harvey et al., 2004). Use of Condoms and LARC 
methods in particular has been found to be easier to comply with as compared to daily oral 
contraception (Berer, 2006). National Institute for Health and Clinical Excellence and the 
World Health Organization (National Institute for Health and Clinical excellence, 2005; 
International Planned Parenthood Federation, 2010) recommend dual protection (use of 
condoms alongside LARC methods) for women at risk of STI such as those with multiple 
partners. The IUD however is contraindicated for women with multiple sexual partners due 
to the high risk of infection. Family planning practitioners should therefore assist women 
in assessing their likelihood of exposure to infection and where the risk is high recommend 
use of condoms alongside LARC methods as appropriate. 
 
Implications for social marketing 
This study has identified existing segments among young women in the UK and the 
variation in use of LARC methods thus providing valuable intelligence for the purpose of 
effective targeting to enhance uptake (segmentation and targeting). The study also 
identified that young women still consider LARC as not good for their long-term health 
despite the available evidence suggesting otherwise, a factor which needs to be addressed 
as a major barrier to LARC uptake (competition) while reinforcing the positive attitudes of 
reliability and convenience as part of a marketing mix (promotion). The study also 
identified GPs and Family planning practitioners, Public health policy makers (NICE 
guidelines) as key players in the promotion and provision of LARC methods (marketing 
mix Ps – partnerships, policy, and place). However a notable limitation of this study was 
the inability to identify what would motivate more young women to use LARC methods 
(exchange) which highlights the significance of a qualitative component in consumer 
research applications (French et al. 2010). 
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Study limitations 
This study has some limitations worth noting. Firstly the study is based on a series of cross 
sectional studies thus making it impossible to draw causal inferences between participants’ 
characteristics and LARC use. Secondly, the sample size of LARC users was small despite 
combining data sets, a factor which might have led to the association between LARC use 
and some factors not being statistically significant. The response rate to questions about the 
main reasons why women chose LARC or non-LARC methods was also low. Regardless 
of the stated limitations, this study presents the first multivariate analyses of LARC use 
among young British women aged 16-24 in the context of current government policy and 
provides an important insight into the characteristics of those who use LARC or Non-
LARC methods. The study also highlights main reasons why women choose LARC or 
Non-LARC methods and the influence of family planning practitioners. These are major 
determinants of effective strategies aimed at increasing the acceptability and use of LARC 
methods among young women.  
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 4.5 Conclusion 
This study examined factors associated with use of LARC methods among young women 
aged 16-24 in the UK. Five ONS Contraception module datasets of surveys carried out 
between 2002/03 and 2006/07 involving a maximum of 1311 respondents were analysed. 
Results show that use of LARC methods among women aged 16-24 doubled over the five 
year period. However Non-LARC still remained the most popular methods. 
 
The publication of NICE LARC guidelines appears to have had a small but statistically 
significant impact on the overall uptake of LARC methods among women aged 16-24. The 
guidelines seem to have addressed the disparity previously observed where older women 
(20-24) and those with no qualifications were more likely to use LARC methods as 
compared to younger women and those with qualifications. NICE guidelines specifically 
targeted barriers to access of LARC methods experienced by younger women such as the 
limited prescription of LARC methods to single and nulliparous women by family 
planning practitioners who not only lacked sufficient knowledge and skills to administer 
LARC methods safely but were also constrained by restrictive Primary Care Trusts’ 
policies on LARC use. The NICE guidelines also provided vital evidence on the safety of 
LARC methods and their cost effectiveness in preventing unintended pregnancies and 
therefore encouraged PCTs to review their policies and family planning practitioners to 
offer the LARC option to all women of reproductive age. 
 
The role of family planning practitioners in the improved uptake of LARC methods 
appears to have been minimal as the proportion of women who reported having been 
influenced by them to change to LARC methods remained the same before and after the 
publication of the guidelines. The rise in LARC use therefore is likely to have been due to 
the increased availability of LARC methods, previously inaccessible to the majority of 
women in this age group (young, single and nulliparous) as evidenced by the increase in 
use especially among those aged 16-19 and a corresponding fall in use of Non-LARC 
methods.  
 
The minimal influence by family planning practitioners on choice of LARC among young 
women is consistent with the current policy as reflected in the NICE guidelines. 
Practitioners are expected to provide information on all available methods including LARC 
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but not necessarily promote LARC use. LARC methods being unfamiliar to most young 
women and often associated with negative health outcomes are unlikely to be chosen. 
Furthermore available evidence shows that most practitioners themselves are lacking in 
knowledge and skills to effectively counsel young people interested in LARC and 
administer the methods. There is need for more training of practitioners to enable them to 
competently provide information on LARC use and to administer the methods when 
required. Regular audit of PCT policies on LARC prescription is necessary as there is 
evidence to show that some are still restricting access to these methods. 
 
The use of LARC methods among young women in the UK appears to be on the rise. 
However, the proportion of women choosing LARC remains minimal as compared to those 
choosing non-LARC methods. Indeed the rise of LARC use over the five year period was 
mainly as a result of women switching from non-LARC methods to LARC rather than 
those using no method choosing LARC as a first option. LARC methods therefore remain 
unfamiliar and unpopular among this group of young women. There is need for a 
communication and marketing strategy (Marketing mix) that would provide correct 
information on LARC methods as regards their safety and effectiveness in preventing 
unintended pregnancy as well as dispel the negative messages and myths in relation to 
LARC use (Competition). 
 
Further analysis on ONS Contraception module surveys carried out after 2006/07 when 
datasets become available is recommended  to fully understand the long-term impact of 
NICE LARC guidelines on LARC methods uptake among women aged 16-24. A large 
survey that includes a qualitative component and specifically focuses on women aged 16-
24 would be more suited in enhancing the understanding of current factors associated with 
LARC uptake as most surveys in the past (ONS and National Survey of Sexual Attitudes & 
Lifestyles) have included women of reproductive age in general with a small representation 
of this age group, yet they are the most affected by unintended pregnancies. 
 
   
 111 
Chapter 5: Factors Associated with Chlamydia Screening 
and Prevalence among Young People in the London 
Borough of Havering. 
 
In this chapter, I present the third study on factors associated with Chlamydia prevalence 
and screening uptake among young people living in the London borough of Havering. This 
study is an application of the consumer research component of social marketing. In the 
introduction section I include the rationale for the study, policy context and a brief 
description of the Chlamydia screening programme at NHS Havering. In the methods 
section I list the study’s aim and objectives and describe the research design, data 
management and analyses as well as ethical considerations. I also include a figure showing 
participant structure for the 28 young people who were involved in the qualitative study. 
The results section has two parts. In the first part I present results from the analyses of 
screening records. In the second part I present findings from interviews and focus group 
discussions. I also discuss main findings from the study under three main subheadings: 
screening uptake, Chlamydia prevalence and barriers and motivating factors. I lastly 
highlight the implications for public health policy and practice, social marketing and 




Chlamydia trachomatis is considered the most common bacterial sexually transmitted 
infection in the western world (The World Health Organization, 2009). Chlamydia remains 
a significant public health concern as the majority of infected individuals usually remain 
asymptomatic for long periods while unknowingly spreading the infection to the rest of the 
population (Mills et al., 2006a). Untreated infection can have serious and long-term 
consequences such as pelvic inflammatory disease, ectopic pregnancies and tubal factor 
infertility in women (Peipert, 2003; Pavlin et al., 2006; National Chlamydia Screening 
Programme, 2009). In men Chlamydia infection can cause non-specific urethritis, 
epididymitis and proctitis (Stamm et al., 1984), however, up to 88% of infections in men 
remain asymptomatic (McKay et al., 2003). Individuals with Chlamydia infection are 
highly susceptible to other infections such as HIV (Cohen et al., 2000; Farley et al., 2003; 
McClure et al., 2006). In England, Chlamydia trachomatis is the most commonly 
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diagnosed sexually transmitted infection among young people of ages 15 to 25 (Mills et al., 
2006b; National Chlamydia Screening Programme, 2009). The management of Chlamydia 
complications such as ectopic pregnancies and infertility in women is estimated to be 
costing the National Health Service at least £100 million per year (National Chlamydia 
Screening Programme, 2009). 
  
Due to the asymptomatic nature of Chlamydia infection, the World Health Organization 
recommends voluntary screening of vulnerable groups (The World Health Organization, 
2001). Most developed countries including the UK have Chlamydia screening programmes 
in place (Addiss et al., 1993; Herrmann & Egger, 1995; LaMontagne et al., 2004). The 
National Chlamydia screening programme in England was established in 2003. Through 
local partners, it offers free, opportunistic screening, treatment, partner management and 
prevention services to sexually active men and women under the age of 25 (National 
Chlamydia Screening Programme, 2009).The programme aims are to: 
 Prevent and control Chlamydia spread through early detection and treatment of 
infected persons 
 Reduce onward transmission to sexual partners 
 Prevent the consequences of untreated infection 
 Identify and reduce prevalence.   
 
In 2008/2009 financial year, the England National target for Chlamydia screening was to 
have at least 17% of men and women aged 15 – 24 tested in health care and non health 
care settings excluding Genito-Urinary Medical (GUM) clinics. The long-term plan is to 
achieve at least 35-50% coverage of the targeted population (National Chlamydia 
Screening Programme, 2009). The Chlamydia screening programme at NHS Havering 
where the study was undertaken began in September 2008 under the brand name ‘C2it’. By 
end of 2008/2009 financial year (March 2009), the coverage was 15.4% (4418/28688) of 
the 15 – 24 total population, which was below the national target. The NHS Havering 
programme was expected to increase its screening uptake coverage to at least 35% by end 
of March 2011 in line with the national target. 
 
The NHS Havering Chlamydia screening strategy mainly consisted of communication with 
young people about the importance of screening for Chlamydia, how to get a screening kit, 
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where to send it after giving a urine sample and what to do when they receive test results. 
Modes of communication mainly included schools and college visits and tutorials by staff, 
local magazines, a dedicated website and posters in strategic public places such as toilets. 
The main partners were local youth centres, pharmacies, schools, colleges and General 
Practice surgeries.  
 
The NHS Havering programme had not carried out any study to establish Chlamydia 
screening uptake patterns, prevalence and local factors that influence the decision to screen 
for Chlamydia among young people. However, there is some evidence showing  that 
population based screening programmes that involve inviting healthy individuals not 
attending health services to be screened for a condition may cause increased anxiety and 
reduced self-perceived health status (Mills et al., 2006a), which may in turn discourage 
target groups from taking up tests. The stigma associated with unexpected and unsolicited 
diagnosis of a sexually transmitted infection is also considered a major limiting factor 
(Low et al., 2007). Other studies have highlighted barriers to screening uptake as being 
poor general knowledge about Chlamydia and other consequences of untreated infection 
(Macmillan et al., 1999; Devonshire et al., 1999). Concerns about confidentiality regarding 
screening and results (Blake et al., 2003), fear of test results and friends finding out that 
they have been tested and fear of informing sexual partners (Fortenberry, 1997; Rietmeijer 
et al., 1998; Serlin et al., 2002; Mills et al., 2006a) have also featured as de-motivating 
factors among target groups.  
 
Gender studies have shown that women are more concerned about the stigma associated 
with being diagnosed with a sexually transmitted disease such as Chlamydia where as men 
are more concerned with the convenience of the screening exercise (Mills et al., 2006a; 
Lorimer et al., 2009). A barrier for both sexes has been identified as the underestimation of 
being at risk of Chlamydia infection (Lorimer et al., 2009).  Most men also consider 
Chlamydia a women’s disease (Chaudhary et al., 2008). On the other hand accurate 
knowledge about Chlamydia infection and consequences and realistic evaluation of 
personal risk appear to be the main motivating factors for taking up screening (Pavlin et 
al., 2006a). Studies on Chlamydia uptake and social economic factors in the UK are scarce. 
However, one study has shown that the uptake is lower among non-white populations and 
in disadvantaged areas (Macleod et al., 2005).The factors highlighted above are worth 
considering when implementing Chlamydia screening programmes. However, every 
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population is unique and perceptions may vary. In line with the consumer 
research/orientation principle of social marketing, it is vital that specific issues for a 
particular target group are understood well as a prerequisite for developing an effective 
strategy that would encourage uptake of screening services.  
 
There is a general paucity of qualitative studies on Chlamydia screening that have involved 
participants in non-clinical settings such as schools, colleges and working places. Limited 
studies that have been published have significant limitations in their reporting such as, not 
differentiating between the opinions of those who have been tested  for Chlamydia and 
those who have not (Chaudhary et al., 2008), recruiting, screening and interviewing of 
participants afterwards (Lorimer et al., 2009) thus limiting the application of their findings 
to conventional settings where individuals decide freely where to go for screening for a 
variety of reasons. Most published studies have largely focused on clinical populations 
seeking medical attention (Shahmanesh et al., 2000; Mills et al., 2006a; Heritage & Jones, 
2008). Although their findings have provided important insights and enhanced the 
understanding of Chlamydia screening uptake dynamics, their application in non-clinical 
settings has been limited considering that participants’ opinions in clinical settings may be 
biased by the outcomes of the interventions related to their main medical problems that 
prompted them in the first place to visit a particular institution. To address the above gaps, 
the current study includes participants who have been tested for Chlamydia and those who 
have not and differentiates their opinions when reporting findings. Secondly, the study 
includes participants who have tested for Chlamydia via a variety of settings (clinical and 
non-clinical) hence providing a more comprehensive and realistic evaluation of barriers 
and motivating factors in accessing Chlamydia screening services among young people.  
 
This study also combines quantitative and qualitative methods, an approach not found in 
any of the studies searched as the tendency has been either of the two. The quantitative 
aspect of this study focuses on the socio-demographic characteristics of individuals who 
get tested for Chlamydia and the association with test results (positive or negative). The 
qualitative aspect focuses on young people’s perception of barriers and motivating factors 
associated with Chlamydia screening. The two approaches were combined in order to yield 
a more robust understanding of factors associated with Chlamydia screening and 
prevalence among young people of ages 16 to 24 living within the London borough of 
Havering.  
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5.2 Methods  
Aim 
To determine the main factors associated with Chlamydia screening and prevalence among 
young people of ages 16 to 24 living within the London borough of Havering. 
Objectives 
 To describe the socio-demographic characteristics of young people who get tested 
for Chlamydia. 
 To identify any association between participants’ socio-demographic characteristics 
and screening outcomes 
 To explore in depth the Chlamydia and screening knowledge among a sample of 
young people resident in Havering. 
 To describe what young people perceive as the benefits and barriers to getting 
tested for Chlamydia. 
 To describe the experience of young people who had have been tested for 
Chlamydia and how it has affected their decision to test again in future. 
 To describe young people’s preferences as regards access to information on 
Chlamydia and screening services.  
Research design 





The data set that was used in this study was provided by the NHS Havering Chlamydia 
Screening Programme. It contained 3,764 records of young people aged between 16 and 24 
who were tested once for Chlamydia between September 2008 and August 2009. Of this, 
13 were duplicates hence a total of 3,751 records were utilized in the final analysis. No 
repeat tests were identified although it was explained by the programme coordinator that 
some young people might have taken repeat tests but deliberately provided different 
personal details so as to disguise their identity. The programme encourages young people 
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Data analysis was carried out using STATA.10 Statistical package (StataCorp, 2007) and 
maps showing variation in Chlamydia screening uptake and prevalence were drawn using 
MapInfo 10.5 Geographical Information System (GIS). Using the Chlamydia screening 
data and GLA
‡
 population estimates for Havering, screening uptake rates for 16-24 year 
olds living in Havering were calculated and reported according to gender, age group, area 
of residence (ward and IMD
§
 quintile) and ethnicity. Cross tabulations and Chi Square tests 
were done to assess the association between participant socio-demographic characteristics, 
source of screening kit, sexual behaviour and test results. Multiple 2x2 contingency tables 
were then constructed for the specified variables and results used in a Logistic regression 
model using STATA.10  statistical software to assess the effects of specified socio-
demographic characteristics of young people as a whole in Havering (predictor variables) 
and screening uptake (test or no test). Also assessed were the effects of specified socio-
demographic characteristics of young people who were tested for Chlamydia (predictor 
variables) with the test results/outcome variable (positive or negative). Unadjusted and 
adjusted odds ratios (OR) with 95% confidence intervals are reported. The socio-




 Age band ( 16-19 & 20-24) 
 Area of residence according to Ward (administrative divisions within the borough 
of Havering) 
 Area of residence according to IMD Quintile 
 Ethnicity 
 Source of Chlamydia test kits 
 Sexual behaviour  
                                                 
‡
 Greater London Authority (GLA) Population Estimates, 2008. 
§
 The Index of Multiple Deprivation 2007 combines a number of indicators, chosen to cover a range of 
economic, social and housing issues, into a single deprivation score for each small area in England. This 
allows each area to be ranked relative to one another according to their level of deprivation. 
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 New partner in the last three months.  
 Two or more partners in the last 12 months. 
 
Qualitative 
I used depth interviews and focus group discussions to collect data from 28 young people 
aged 16-24 living in the London borough of Havering. Eight interviews and four focus 
group discussions were carried out between August and December 2010. Figure 5.1 shows 
the overall participation structure. Depth interviews were preferred for young people who 
had tested for Chlamydia as they provided a private environment for discussion and 
disclosure without the risk of participants being identified or judged by others, hence 
maximising on their contribution. Available evidence shows young people are afraid of 
being known to have tested for Chlamydia or any other sexually transmitted infection due 
to the prevalent societal stigma (Blake et al., 2003; Mills et al., 2006). Focus group 
discussions were thought appropriate for those who had not tested as they were not 
expected to discuss any personal experiences but rather their general knowledge and 
perceptions. Focus group discussions also facilitated interactions between participants thus 
allowing me to observe their different perspectives and how opinions, attitudes and 
accounts as regards Chlamydia screening are shaped in a real social context.   
 
Participant recruitment 
Participants were recruited from Youth Zone Information Centre at Romford, Havering 
College at Hornchurch and Eden College at Romford. These institutions have a working 
relationship with NHS Havering and are represented on the local Chlamydia Screening 
Steering Committee. I approached the managers of the named institutions who agreed to 
make provision for interviews and focus group discussions to take place within their 
institutions at appropriate times. This was confirmed in writing. The study was advertised 
at these institutions for at least three weeks before the actual recruitment of participants 
(See advert in Appendix 5.8). Accompanied by two staff from the NHS Havering 
Chlamydia screening programme I visited the institutions after advertisement and was 
actively involved in the recruitment of interested young people. We mainly explained the 
purpose of the study, clarified any matters of concern and issued participant information 
sheets (Appendix 5.1) and response forms (Appendix 5.7) to those who expressed interest 
in participating in the study. Additionally those aged 16 and 17 were issued with 
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parent/carer forms (Appendix 5.4). A total of 67 young people agreed to participate in the 
study and were issued with the necessary documents and prepaid envelopes for sending 
them back to the researcher after filling. Only 38 returned forms confirming their 
participation. They were all contacted and provided with details on venue, date and time of 
interviews and focus group discussions. Twenty eight successfully participated in the 
study. They each received a £10 high street music voucher at the end of sessions to thank 
them for their participation. 
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Focus group discussions 
Four focus group discussions were carried out with young people who had never tested for 
Chlamydia in the past. A topic guide was used to facilitate the process (Appendix 5.5). 
Focus group discussions were held at the participating institutions’ sites for the 
convenience of participants. They took place during lunch breaks so as not to interrupt 
participants’ attendance of classes. Participants and the institutions’ management were 
involved in choosing the most suitable time. Each group discussions involved 4-6 
Focus group discussions and 
interviews involving 28 young 
people (16 aged 16-19 & 12 
aged 20-24) 
        2 Male 
Participants 
aged 16 to 19 
      5 Male 
Participants 
aged 16 to 19 
 
     2 Male 
Participants 
aged 20 to 24 
 
   4 Male 
Participants 
aged 20 to 24 
 
8 Interviews 
Young People Screened for 
Chlamydia in the Past (8) 
 
 
4 Focus Group Discussions 








aged 20 to 24 
6 Female 
Participants 
aged 16 to 19 
5 Female 
Participants 
aged 20 to 24 
67 Young people aged 16-24 
agreed to participate in the 
study and were issued with 
forms to return by post 
confirming attendance 
38 returned forms confirming 
attendance (20 aged 16-19 & 
18 aged 20-24) 
10 did not attend 
despite follow up 
(4 aged 16-19 and 
6 aged 20-24) 
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participants (Figure 5.1) and two researchers. Every young person filled in a participant 
description form (Appendix 5.4) and signed a consent form (Appendix 5.3) before 
commencement of group discussions. Discussions were held in English language and 
lasted between 60 to 75 minutes. All sessions were recorded on a digital recorder with the 
participants’ permission. I moderated the discussions while an assistant researcher 
observed and took notes. At the end of the discussions participants were issued with a 




Eight depth interviews were carried with young people who had tested for Chlamydia in 
the past (Figure 5.1). A topic guide was used to facilitate the process (Appendix 5.6). 
Interviews were held at the participating institutions’ premises during lunch breaks. Each 
young person filled in a participant description form (Appendix 5.4) and signed a consent 
form before commencement of interviews (Appendix 5.3). Interviews were conducted in 
English language and lasted about 30 minutes. All sessions were recorded on a digital 
recorder with participants’ permission. At the end of interviews participants were issued 
with a contact list for sexual health support services in case they needed help in future 
(Appendix 5.9). 
 
Data management and analysis 
Recorded materials from focus group discussions and interviews were transcribed verbatim 
and all person identifiable material anonymised. Data from transcripts were stored and 
managed in FrameWork Software (National Centre for Social Research, 2010). Analysis 
was guided by the framework approach (Ritchie & Spencer, 1996). This approach was 
preferred as it has a well defined process that is flexible and allows for reconsidering and 
reworking of ideas precisely, as the analytical steps are well documented , accessible and 
replicable (Ritchie & Spencer, 1996). It consists of five phases namely: 
 
 Familiarization, 
 Identification of a thematic framework,  
 Indexing  
 Charting  
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 Mapping and interpretation 
 
Familiarisation 
Familiarisation involved listening to the digital recordings, and re-reading the transcripts 
and making notes during focus group discussions and interviews. I ensured that all 
transcripts were well coded and labelled to differentiate data collected from various 
participants. I then imported the 12 transcripts (4 focus group discussions and 8 interviews) 
into the Framework software for analysis. 
 
Thematic Framework 
To develop a thematic framework, I used inductive and deductive coding approaches 
where data was categorized into 6 main themes derived from the interview and focus group 
discussion guides as well as from issues raised by participants during interviews and 
discussions. These were: Chlamydia knowledge, motivating factors for taking a Chlamydia 
test, barriers to testing for Chlamydia, Chlamydia test experience, preferred sources of 
Chlamydia information and test kits and recommendations for health workers.  
 
Indexing 
Indexing involved systematic application of the thematic framework to all transcripts using 
the dynamic indexing function of the Framework software. I read through all the data and 
annoted all transcripts according to the thematic framework and created numerical and 
textual codes to identify specific pieces of data within transcripts which correspond to 
differing themes and sub themes.  
 
Charting  
Indexing was followed by the charting phase where I created a summary chart within the 
Framework software displaying each participant’s details, associated verbatim text and 
relevant thematic category thus allowing for quick retrieval of the original data in the 
transcripts as well as facilitating a convenient and accurate data interrogation and analysis 
process. 
 
Mapping and interpretation 
In the mapping and interpretative phase, I examined and reviewed the summary chart by 
comparing and contrasting perceptions, accounts and experiences of various participants. I 
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also looked for patterns, associations, concepts and explanations as they relate to various 
themes and sub themes. The process was aided by visual displays and plots.  
 
Rationale for use of Framework approach 
 Prior to adopting the Framework approach, I considered other popular approaches which 
included Thematic Content Analysis (Green & Thorogood, 2009) and Grounded Theory 
(Strauss, 1987). Thematic Content Analysis is mainly inductive (relies on recurrent themes 
emerging from data) a factor which made it unsuitable for my study as I had a priori issues 
to consider in my analysis. Although it is considered good for exploratory research its 
other limitation of concern was the inadequacy to facilitate the examination of participants’ 
social context and link to theory (Green & Thorogood, 2009). The Grounded Theory 
approach is as well inductive and emphasises collection of data up to a point of saturation 
(Seale, 2004; Dixon-Woods, 2011). Grounded theory was as well not suitable for my study 
as it is mainly inductive and my research period and resources were not flexible enough to 
carry out data collection and analysis to a saturation level. The Framework approach which 
I opted for is explicitly geared towards generating policy and practice oriented findings 
(Ritchie & Spencer, 1996). Unlike Grounded Theory and Thematic Content Analysis, it 
allows issues identified a priori as was the case in my study to be systematically 
considered in the analysis (deductive) while permitting those that emerge from data to be 
included (inductive) (Dixon-Woods, 2011). The other advantage was the availability of a 
bespoke software package, FrameWork (National Centre for Social Research, 2010). The 
software enabled me to upload transcripts, summarise data and create hyperlinks to the 
verbatim text so that it was possible to move back and forth from the abstracted summary 
to the original data. Cases and themes were all displayed in a dynamic chart hence 
allowing cases to be ordered, compared and contrasted with complete flexibility and ease.  
 
Ethical Considerations 
This study was approved by the Brunel University School of Health Sciences and Social 
Care and National Health Service (NHS) North West London Research Ethics Committees 
(See appendices 5.13 & 5.14).  
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Informed consent 
During recruitment, I explained the nature and purpose of the study to potential 
participants. Those who showed interest in participating in the study were given 
information sheets with details about the study, their expected roles and how the 
information they would provide was to be managed. They were encouraged to participate 
but also informed of their right to decline at that stage. They were issued with response 
forms and prepaid envelopes to return to the researcher once they decided to participate. 
Young people aged 16 and 17 were issued with parent/carer consent forms to be sent back 
together with the response form. However, all who returned response forms declined the 
involvement of their parents/carers. As they could not be persuaded otherwise, they were 
assessed and found competent enough to participate without parental/carer consent. All 
young people who returned response forms were contacted and further details on venue, 
date and time of interview/discussion were provided. On the study day I explained the 
purpose of the study, why the participants were selected and their roles. All questions and 
concerns were addressed and participants were informed of their right to decline answering 
any question or to withdraw briefly or completely at any stage of discussion/interview if 
they felt distressed, embarrassed or anxious (See appendices 5.1 & 5.2). All participants 
signed consent forms before commencement of interviews/discussions. 
 
Confidentiality  
Participants were reassured about the confidentiality of the information they were to give 
at the beginning of each focus group discussion/interview and that care would be taken to 
ensure they are not identifiable in the final report, which involved omission of names and 
places. But they were also informed that any disclosures which would raise any concerns 
about their safety or that of others had to be passed on to appropriate authorities because of 
duty of care or in the public interest (See appendix 5.1). Participants were asked not to 
divulge information from group discussions.  
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5.3 Results 
Participant socio-demographic characteristics 
A total of 3751 young people aged 16-24 took a Chlamydia test between September 2008 
and August 2009 (Table 1). Forty five percent were of the age range 16 to 19 years and 
55% of age range 20 to 24 years. The overall mean age was 20 and the majority were 
females (64%). Among wards Gooshays had the highest number of young people screened 
for Chlamydia (9%) and Cranham the least (4%). The majority were from the most 
deprived quintile (24%) and from the White ethnic group (84%). More than a third (40%) 
reported having a new partner in the last three months and 43% two or more partners in the 
last 12 months. Most young people (67%) acquired Chlamydia test kits from the NHS 
Havering screening office at St. George’s Hospital, Hornchurch (Table 5.3).  
 
Chlamydia Screening Uptake Rate 
The average Chlamydia screening uptake rate among all young people aged 16 to 24 in 
Havering was 14.4%. Females had a higher uptake rate (18.7%) as compared to males 
(10.3%). The difference between the two age groups (16-19 & 20-24) was not statistically 
significant. Among wards, St. Andrew’s, Romford Town, Gooshays and Hacton had the 
highest uptake rates whereas Harold Wood, Pettits, Brooklands, Emerson Park and 
Cranham had the lowest (Table 5.1 & Figure 5.2). Young people from the Non-White 
ethnic groups had a higher uptake rate (16.9%) as compared to those from the White group 
(13.3%) (Table 5.1).  
 
Factors associated with Chlamydia Screening Uptake 
Young people’s gender, place of residence (ward and deprivation quintile) and ethnicity 
were significantly associated with screening uptake. Females aged 16-24 were three times 
more likely to take a Chlamydia test than males of the same age range. There was no 
significant difference between young people aged 16-19 and those aged 20-24. Place of 
residence was significantly associated with screening uptake. Young people living in St. 
Andrew’s were about two times more likely to take a test as compared to those living in 
Harold Wood. Those living in the least deprived quintile were up to 38% less likely to take 
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a test as compared to those in the most deprived quintile. Young people of Non-White 
ethnic background were 1.3 times more likely to take a test as compared to those from the 
White background (Table 5.2).  
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Figure 5.2: Chlamydia screening uptake rate (per 1,000 Population) by ward 
among 16-24 year olds living in the London borough of Havering, 2008-2009. 
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Screening uptake rate 
 %(95% CI) 
 
P value┼ 
Total  25,992 3,751  14.4 (14.0, 14.9)  
 
1. Gender 
    
<0.001 
Female 12,814 2,400 (64%) 18.7 (18.0, 19.5)  
Male 13,178 1,351 (36%) 10.3 (9.7, 10.8)  
 





16-19 11,859 1,701 (45%) 14.3 (13.7, 15.0)  
20-24 14,133 2,050 (55%) 14.5 (13.9, 15.1)  
 
3. Ward 
    
<0.001 
Brooklands 1,625 205 (5.5%) 12.6 (10.9, 14.5  
Cranham 1,259 153 (4.1%) 12.2 (10.3, 14.2  
Elm Park 1,336 187 (5.0%) 14.0 (12.1, 16.2  
Emerson Park 1,394 170 (4.5%) 12.2 (10.4, 14.2)  
Gooshays 1,930 339 (9.0%) 17.6 (15.7, 19.5)  
Hacton 1,415 244 (6.5%) 17.2 (15.1, 19.5  
Harold Wood 1,482 170 (4.5%) 11.5 (9.8, 13.3  
Havering Park 1,527 216 (5.8%) 14.1 (12.3, 16.2  
Heaton 1,249 195 (5.2%) 15.6 (13.5, 18.0)  
Hylands 1,331 193 (5.2%) 14.5 (12.5, 16.7)  
Mawneys 1,241 182 (4.9%) 14.7 (12.6, 17.0)  
Pettits 1,601 194 (5.2%) 12.1 (10.5, 13.9)  
Rainham & Wennington 1,529 222 (5.9%) 14.5 (12.7, 16.6)  
Romford Town 1,567 250 (6.7%) 16.0 (14.0, 18.1)  
 
   
 128 
South Hornchurch 1,455 211 (5.6%) 14.5 (12.6, 16.6)  
Squirrel’s Heath 1,572 201 (5.4%) 12.8 (11.1, 14.7)  
St. Andrew’s 1,304 263 (7.0%) 20.2 (17.8, 22.8)  
Upminister 1,175 156 (4.2%) 13.3 (11.3, 15.5)  
 
4. Area of Residence – IMD Quintile 
    
<0.001 
Q1- Most deprived 6,278 927 (24%) 14.8 (13.8, 15.7)  
Q2- Above average 4,528 745 (20%) 16.5 (15.3, 17.7)  
Q3- Average 5,706 688 (18%) 12.1 (11.2, 13.0)  
Q4- Below average  4,051 682 (17%) 16.8 (15.6, 18.1)  
Q5- Least Deprived 5,429 709 (19%) 13.1 (12.1, 14.1)  
 
5. Ethnicity 
    
<0.001 





170 (4.5%)  
16.9 (15.2, 18.7) 
 
 Mixed 135 (3.6%) 
Asian 57 (1.5%) 
Others 6 (0.2%) 
Unknown  228 (6.1%)   
 
┼ Chi2 significance test for difference in Chlamydia screening uptake between groups within a specified variable 
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Table 5.2: The association between Gender, Age, Area of residence, 
Deprivation, Ethnicity and decision to test for Chlamydia among young 
people living in Havering, 2008/09 
 
Predictor Variable Crude Odds 




Ratio (95% CI) 
P 
Value 
Gender  <0.001  <0.001 
Male 1.00  1.00  







Not in model 16-19 1.00   















Not in model§ 
Harold Wood 1.00  
Pettits 1.06(0.85, 1.32)  
Cranham 1.07(0.85, 1.35)  
EmersonPark 1.07(0.85, 1.34)  
Brooklands 1.11(0.90, 1.38)  
Squirrels Heath 1.13(0.91, 1.41)  
Upminister 1.18(0.93, 1.49)  
Elm Park 1.26(1.00, 1.57)  
Havering Park 1.27(1.03, 1.58)  
Hylands 1.30(1.05, 1.63  
Rainham&Wennington 1.31(1.06, 1.62)  
South Hornchurch 1.31(1.05 1.63)  
Mawneys 1.32(1.06, 1.66)  
Heaton 1.42(1.14, 1.78)  
Romford Town 1.46(1.19, 1.81)  
Hacton 1.61(1.30, 1.99)  
Gooshays 1.64(1.35, 2.00)  




<0.001  <0.001 
Q1- Most deprived 1.00  1.00   
Q2- Above average 1.14(1.02, 1.26)  1.11 (1.00, 1.22)  
Q3- Average 0.79(0.71, 0.88)  0.80 (0.73, 0.88)  
Q4- Below average  1.17(1.05, 1.30)  1.27 (1.15, 1.40)  







Not in model¥ White 1.00  
Non-White 1.32(1.18, 1.49)  
 
§ Not included because of collinearity with Deprivation variable. 
¥ Not included because of lack of ethnic population data at ward/deprivation quintile level 
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Factors associated with positive Chlamydia tests 
The mean rate of testing positive for Chlamydia for all young people (3751) who were 
screened was 5.3%. The age, gender, deprivation and ethnicity differences in prevalence 
rates were not statistically significant (Table 5.3). 
 
Area of residence (Ward) 
Overall, young people living in Rainham & Wennington, South Hornchurch and Pettits had 
the highest Chlamydia prevalence rates whereas those in Hylands had the lowest (2.1%) 
(Table 5.2 & Figure 5.3). The association between area of residence (Ward) and 
Chlamydia prevalence was significant. Young people living in Rainham & Wennington 
were 5 times more likely to test positive for Chlamydia as compared to those in Hylands 
(Table 5.3).  
 
Source of test kit 
Young people who acquired test kits from Pharmacy had the highest prevalence rate (12%) 
whereas those from Colleges had the lowest rate (1.9%). The association between source 
of test kit and Chlamydia prevalence was significant. Young people who acquired test kits 
from pharmacy were nine times more likely to test positive for Chlamydia as compared to 
those who got theirs from colleges (Table 5.3). 
 
Sexual Behaviour 
Young people who reported having a new partner in the last three months or two or more 
partners in the last 12 months had higher Chlamydia prevalence rates as compared to those 
who did not (7.8% and 7.3% respectively).  The association between the above sexual 
behaviours and Chlamydia prevalence was significant. Young people who reported having 
a new partner in the last three months or two or more partners in the last 12 months were 
about two times more likely to test positive for Chlamydia as compared to those who did 
not (Table 5.3). 
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Figure 5.3: Chlamydia prevalence rate (per 1,000 Population) by ward among 
16-24 year olds living in the London borough of Havering, 2008-2009. 
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Table 5.3: Chlamydia prevalence and its association with young people’s socio-demographic characteristics, source of 
















Total 3751 5.25     
 
Gender 





Not in Model 
Female 2,400 5.42 1.00  
Male 1,351 4.96 0.91 (0.67,1.23)  
 
Age Band 
    
0.695 
16-19 1,701 5.41 1.00  
20-24 2,050 5.12 0.94 (0.71,1.26)  
 
Ward  




Hylands 193 2.07 1.00  1.00   
Heaton 195 2.56 1.24 (0.33, 4.70)  1.25 (0.33, 4.79)  
St. Andrew’s 263 3.04 1.48 (0.44, 5.00)  1.64 (0.48, 5.58)   
Upminister 156 3.21 1.56 (0.41, 5.92)  1.36 (0.33, 5.58)  
Hacton 244 3.28 1.60 (0.47, 5.40)  1.66 (0.49, 5.65)  
Squirrel’s Heath 201 3.48 1.70 (0.49, 5.92)  1.87 (0.53, 6.54)  
Brooklands 205 3.90 1.91 (0.57, 6.48)  1.96 (0.58, 6.68)  
Romford Town  250 4.00 1.97 (0.61, 6.38)  1.64 (0.49, 5.46)  
Cranham 153 5.23 2.61 (0.77, 8.83)  2.63 (0.77, 9.01)  
Mawneys 182 5.49 2.75 (0.85, 8.92)  2.28 (0.67, 7.79)  
Harold Wood 170 5.88 2.95 (0.91, 9.60)  3.49 (1.07, 11.4)  
Havering Park 216 6.02 3.03 (0.97, 9.44)  3.07 (0.97, 9.67)  
Emerson Park  170 6.47 3.27 (1.02, 10.5)  3.17 (0.98, 10.3)  
Gooshays 339 6.49 3.28 (1.11, 9.66)  3.66 (1.23, 10.9)  
Elm Park  187 8.02 4.12 (1.34, 12.7)  4.74 (1.53, 14.7)  
Pettits 194 8.25 4.25 (1.39, 12.9)  4.40 (1.43, 13.5)  
South Hornchurch  211 8.53 4.41 (1.46, 13.3)  5.28 (1.74, 16.1)  
Rainham & Wennington 222 8.56 4.42 (1.48, 13.2)  5.35 (1.77, 16.2)  
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Deprivation    0.491  
 
 
Not in Model 
Q1- Most deprived 927 6.15 1.00  
Q2- Below average 745 5.10 0.82 (0.54, 1.25)  
Q3- Average 688 4.65 0.74 (0.48, 1.16)  
Q4- Above average  682 5.72 0.93 (0.61, 1.42)  
Q5- Least Deprived 709 4.37 0.70 (0.44, 1.09)  
 
Ethnicity 
    
0.292 
White 3,155 5.45 1.00  
Non-white 368 4.89 0.89 (0.54, 1.47)  
Unknown 228 3.07 0.55 (0.25, 1.18)    
 
Source of test kit 




College 493 1.93 1.00  1.00   
Sexual Health Clinic 43 2.33 1.21 (0.15, 10.1)  1.39 (0.16, 11.8)  
Local Hospital/Social Services 21 4.76 2.54 (0.30, 21.6)  3.19 (0.35, 28.7)  
GP Surgery 362 4.93 2.63 (0.98, 7.01)  3.19 (1.14, 8.96)  
NHS Screening Office 2515 5.17 2.76 (1.28, 5.96)  3.07 (1.39, 6.78)  
Youth/Child Centres 493 6.90 3.76 (1.65, 8.59)  3.64 (1.57, 8.41)  
Pharmacy 114 12.3 7.10 (2.79, 18.1)  9.11 (3.45, 24.0)   
 
Sexual Behaviour 
      
(a) Had a new partner in the last 3 months    <0.001  0.002 
No 1,876 3.14 1.00  1.00   
Yes 1,503 7.78 2.60 (1.89, 3.58)  1.99 (1.36, 2.90)  
Unwilling to disclose 355 5.35 1.74 (1.03, 2.96)  1.35 (0.48, 3.80)  
(b) Had 2 or more partners in the last 12 
months 
   <0.001 1.00  0.020 
No 1,730 3.18 1.00  1.72 (1.17, 2.52)  
Yes 1,616 7.30 2.40 (1.73, 3.33)  1.83 (0.67, 4.98)  
Unwilling to disclose 385 5.45 1.76 (1.05, 2.94)    
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Interview & Focus Group Discussion participants 
Twenty eight young people participated in the qualitative phase of this study. Eight 
reported having taken a test for Chlamydia in the past whereas 20 had not. Those who had 
taken a test were interviewed in one to one sessions whereas the 20 who had not were 
involved in focus group discussions. Fifteen were female and 13 were male. Most of the 
participants were White (13). The rest were either Black (9) or Asian/Mixed (6). The 
majority were college and A’ level students (26). No major difference in responses from 
young people aged 16-19 and those aged 20-24 was observed hence results are reported for 
the whole group (16-24). Results are summarized in six main sections: Chlamydia 
knowledge level, motivating factors for Chlamydia testing, barriers to Chlamydia testing, 
experience of testing for Chlamydia, preferred source of information and test kits and 
suggestions on improving Chlamydia test uptake. In each section, findings relating to 
young people who had been tested for Chlamydia and those who had not are reported 
separately. A conceptual model emerging from the interviews and focus group discussions 
is illustrated in figure 5.2. For correct knowledge and facts about Chlamydia see Appendix 
5.12.   
Chlamydia Knowledge  
Young people who had taken a test for Chlamydia  
All participants who had taken a test understood that Chlamydia was a sexually transmitted 
disease. Despite having taken a Chlamydia test two participants (male and female) did not 
know what kind of symptoms a person infected with Chlamydia would present with. The 
six who expressed knowledge of the symptoms correctly understood that there may be no 
symptoms initially and that on long term Chlamydia could affect an individual’s fertility. 
However a half (two male and two female) thought only women developed symptoms and 
in particular would have their fertility affected: 
 
“Well, errrm, I'm not too sure really, but I'm sure, well I'm not sure, that people can 
have it for like years and not know about it. But boys I don't think have any 
consequences, they are just carriers of it. It's only girls that, it doesn't like decrease 
boys fertility or anything, I don't think. I'm not definitely sure, this is just what I think I 
know (laughs).” (Interview 1: Female, 17 years) 
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Six out of the eight participants understood the type of Chlamydia symptoms which may 
manifest following a long term infection such as pain on passing urine, abnormal 
discharge, vaginal thrush and itchiness around the genitalia but none mentioned the 
increased vulnerability to other STDs such as HIV. Knowledge of Chlamydia transmission 
and treatment was limited among participants. Whereas they all understood that Chlamydia 
could be spread through sexual intercourse and was treatable, they were unsure of any 
other means of transmission and type of treatment.  
 
The most cited sources of knowledge about Chlamydia were leaflets sent to home 
addresses by the Chlamydia programme at NHS Havering and sexual health sessions in 
schools. Other sources included the internet, youth clubs and posters in public places. All 
participants perceived Chlamydia as a common and serious problem among young people. 
This was mainly based on the campaign messages accessed by participants from various 
forms of media such as posters, internet, television and school. However they were unsure 
if the same applied to their local area (Havering) (Box1). As expected all participants knew 
about how Chlamydia tests are done. Two had taken a Chlamydia test via their local GP 
surgery whereas six had received information and a test kit via the post from the NHS 
Havering Chlamydia office. After sending of urine samples to the laboratory for testing, 
they received their results via mobile phone text or email messages.  
 
Box 1: Source of Chlamydia Knowledge 
 
1. “Because we have so many talks about it at school. Like Form Tutor period we 
have it like loads of people talking about sex and drugs and alcohol and stuff 
and they always talk about Chlamydia. That's why I wanted to get the test, coz 
they convinced me, well not convinced me but I thought like oh, maybe I 
should check it (laughs).” (Interview 3: Female, 17 years) 
 
2. “Yeah - I do not know if it definitely is, but it gets like advertised as if it is, 
there’s a lot of advertisements and stuff about it and a lot more, trying to make 
you aware about it now so which makes me think it’s more of a problem now. 
But, and they say it is one of the most common sexually transmitted diseases 
but I don’t know if it is in Havering or not, probably (laughs).” (Interview 2: 
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 Young people who had never taken a test for Chlamydia  
All participants who had never taken a test understood that Chlamydia was a sexually 
transmitted disease. However one of the male participants reported having never heard 
about Chlamydia prior to getting involved in the study. Participants in all focus groups 
were uncertain about whether a person with Chlamydia would have noticeable symptoms 
or not.  A few thought there would be symptoms but were not sure of the presentation. 
However it was not clear whether the expressions of ignorance were deceptive or real as 
some of the participants were noticeably guarded as if not to give an impression they knew 
too much, may be for fear of other group members thinking they had Chlamydia infection 
in the past, for example: 
 
“It hurts when you are passing urine, like it is sore. I did not have it I just know that 
(laughing).” (Focus Group 3: Female, 18 years) 
 
There was consensus in all focus groups about Chlamydia being spread mainly through 
sexual intercourse but none of the participants were certain about other means. All 
participants in focus groups thought there was treatment for Chlamydia infection but were 
as well not sure about the type of treatment. The most cited sources of information among 
participants in focus groups were television and sexual health sessions in school. Others 
included GP, Connexions, parents and friends. As was the case for participants who had 
taken a test in the past, there was a general consensus about Chlamydia being a common 
problem but mainly based on the observed intensity of Chlamydia campaign messages 
mainly in the form of posters in public places, internet and television. However some 
participants said they were not sure about the validity of the Chlamydia campaign 
messages as they did not know any one who had tested positive for Chlamydia (Box 2). 
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Box 2: Perception of Chlamydia prevalence 
 
1. “I don’t really know. I know there’s a lot of statistics out there saying it’s a rise but 
also screening for it is on the rise as well. There’s a lot more people screening for 
it, there could have been just as many before the adverts as after the adverts or 
before these studies were done. It’s more publicly known now, so I think people are 
more aware of it, whether it’s more common or not now, I don’t know.” (Focus 
Group 2: Male, 24 years) 
 
2. “I honestly don’t know anyone who has had Chlamydia. There are no symptoms, 
yeah so you wouldn’t know how many there are out there would you? So you could 
not be 100% sure how many.” (Focus Group 3: Female, 19 years) 
 
 
Most of the participants in the four focus groups had limited knowledge about Chlamydia 
testing procedures. Whereas they all understood that one had to provide a urine sample to a 
health worker, none was sure of what followed afterwards i.e. where the urine sample is 
taken to, the notification of results and treatment: 
 
“I have not got a clue. You pee in a pot, they send it off, they could be doing 
voodoo on it (laughs).They could just be dipping litmus paper in it and it could 
come out a different colour if you’ve got. It could possibly be under a microscope 
or something else.” (Focus Group1: Male, 16 years) 
 
Motivating factors for taking a Chlamydia test 
The eight participants who had taken a Chlamydia test did so because it was offered to 
them, it was convenient and they thought it was a good opportunity to know their status. 
Among female participants, the majority (3/4) reported fear for their fertility as the other 
main reason for their decision to have a test. In all focus groups involving participants who 
had never taken a test, there was a general believe that those who test for Chlamydia 
consider themselves at a greater risk of infection for example: 
 
“Because if you are having sex with many people like you have got to know where 
you stand, because you might have but you don’t know so it is better to go and get 
tested (Focus Group 4: Female, 20 years) 
 
“May be because they have recently slept around and not worn a condom or they 
realize something bad, like their partners have been sleeping around as well so they 
get checked just in case.” (Focus Group 2: Male, 24 years) 
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Barriers to testing for Chlamydia 
Participants in interviews and focus group discussions shared their perceptions about 
barriers to Chlamydia testing among young people in general rather than their personal 
experiences as agreed a priori. 
 
Young people who had taken a test for Chlamydia  
Fear and ignorance were cited as the main barriers to testing for Chlamydia among young 
people. Five participants said most young people decline Chlamydia tests because they fear 
the embarrassment that might result from being diagnosed with a sexually transmitted 
disease. Fear of being found out by close acquaintances was also identified as a major 
barrier. Four participants thought most young people do not test for Chlamydia due to 
ignorance and lack of understanding of the seriousness of the infection and how they can 
be affected. The asymptomatic nature of Chlamydia in itself they thought was a barrier  as 
young people who might be aware of the disease may still assume they are safe even when 
infected due to lack of visible  symptoms. Three participants were of the opinion that most 
young people were aware of Chlamydia and how it can affect them but simply ignored the 
advice to test as they perceived the process of testing and the possibility of positive results 
as a threat to their pride and dignity (Box 3). 
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Box 3: Barriers to testing for Chlamydia (Opinions of young people who had taken a 
test) 
 
1. “I think people are embarrassed about it. I think people get the impression it 
implies that you have been sleeping around if you’ve got a sexually transmitted 
disease. But now you can do it at the clinic and you can do at the doctors, it is more 
private and if people know about it, they are more likely to do it. I think people get 
embarrassed.” (Interview 2: Female, 18 years) 
  
2. “I would say, because a lot of them, just don’t really know what Chlamydia 
is and how it’s caught really, and emmm… convenience, that’s why a lot of people 
can’t be bothered to actually go and get themselves screened coz they think that 
they wouldn’t have anything coz they don’t really know how they would catch it? 
So they don’t think they’ve got it, so they think, why bother going to get screened.” 
(Interview 5: Male, 24 years) 
 
3. “I think a lot of people are scared of knowing well, they don’t wanna know whether 
they’ve got it or not to be honest. There’s a lot of people out there who would 
rather not know, yeah just try and put it to the back of their head maybe. Obviously 
if the symptoms were there, they are gonna need to, other than that, if it’s dormant 
then they don’t really want to know.” (Interview 4: Male 22 years) 
 
 
Young people who had never taken a test for Chlamydia  
Young people who had never tested for Chlamydia highlighted loss of dignity/ pride, 
doubts about confidentiality and fear of being find out by close acquaintances as the main 
barriers to taking Chlamydia tests among young people. In one of the focus groups 
involving males aged 16-19, participants described offers for tests in public as being 
offensive. They thought accepting such offers would be a compromise on personal dignity 
and pride as it indicated lack of confidence in an individual’s sexual lifestyle and health. 
The suspicion that young people who test for Chlamydia have their details stored in some 
government database which can be accessed by other people was highlighted as a possible 
barrier by participants in a focus group involving males aged 16-19. Fear of parents and 
other acquaintances finding out that a young person had taken a Chlamydia test was also 
cited as a discouraging factor in all focus groups. Some participants also felt taking a test 
was a public declaration that an individual was sexually active whereas most young people 
would like to keep issues about their sexuality confidential (Box 4). 
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Box 4: Barriers to testing for Chlamydia (Opinions of young people who had never 
taken a test) 
 
1. “I personally haven’t, I’m not sure whether you can say I’m stuck up or if I have a 
bit too much dignity, but I don’t want to pee in a pot in public to be honest. I don’t 
like the idea of handing my urine to some random person I don’t know.” (Focus 
Group 2: Male, 18 years) 
 
2. “Maybe, about information even though they said its all private, and like they have 
said it loads of time its private, it’s private. I think people may feel like no this is 
just the government trying to get our names and if we have it they put us down on 
the naughty list!” (Focus Group 1: Male, 19 years) 
 
3. “May be they are shy, scared or they lack confidence. Like for example you go to a 
sexual health clinic for stuff (test kit) and other people who know you see you there 
and they will think you have it.” (Focus Group 4: Female, 21 years) 
 
4. “Young people do not want to be known they are having sex, so they might meet 
someone they know at a testing place and they might say humm!! So you are 
having sex (all laughing).” (Focus Group 3: Female, 17 years) 
 
 
Chlamydia test experience 
Young people who had taken a test for Chlamydia  
The eight participants who had tested for Chlamydia reported that results just confirmed 
what they thought as they were not involved in any risky sexual behaviour. They all said 
their results were negative. Two said they shared test results with their partners while six 
saw no need as they were negative. All participants said they would take a Chlamydia test 
again in future only if they felt they were in a risky relationship.  
 
Young people who had never taken a test for Chlamydia  
Participants were asked about how they thought they would feel if they took a test and 
results turned positive. They were also asked if they would inform their partners.  All 
participants described negative emotional reactions. They said they would feel 
disheartened, disgusted, dirty, embarrassed and upset if they tested positive for Chlamydia 
but as it is not terminal they would not be too worried. In all focus groups, participants said 
they would feel embarrassed telling their partners about positive results. However in two 
focus groups involving 20-24 year olds, there was a consensus about informing a partner if 
a relationship was long-term.  
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Preferred sources of Chlamydia information & test kits 
Young people who had taken a test for Chlamydia  
Sending information about Chlamydia to all young people via postal address was 
considered the most effective way of creating awareness among young people. Five out of 
the eight participants who preferred this method explained that it was the only method that 
guaranteed privacy and confidentiality a factor which most young people are concerned 
about (The NHS Havering Chlamydia office sent information about Chlamydia and 
screening to postal addresses of all young people aged 16-24 living in Havering when the 
programme was initiated in 2008 and continue to do so periodically). But three disagreed 
and rather recommended use of posters and other forms of media such as television, radio 
and internet. They argued that unsolicited materials sent via postal addresses are rarely 
read and often get discarded: 
 
“I would just say on the bus, shelters and things like that, just have posters there. I’m 
also thinking of television and stuff, I don’t really think if you send it through the post, 
people will just throw it in the bin, and wouldn’t really look into it, I think. I think 
somewhere, big where people walk past and they can actually spend time looking at it. 
I think that’s probably the best way.” (Interview 1: Female, 17 years) 
 
School as a source of information was considered effective by half of the participants but 
the rest thought otherwise. They believed most young people wouldn’t bother to collect the 
information and though they might attend sessions where Chlamydia is discussed (as part 
of school curriculum) they were unlikely to benefit much due to lack of interest. Posters 
were considered better than leaflets which involve taking away and most young people did 
not want to be seen carrying or reading them due to the associated stigma: 
 
“Like posters would be good. Like I don’t think leaflets and stuff, coz I think people, if 
they are seen reading it and stuff, they would feel embarrassed, but if you had posters 
and stuff, then that’s like, coz you can read it without being obvious that you are 
reading it and don’t have to feel self conscious about it but can be gaining information. 
Sort of places like the bus stops as well are good places as  a lot of people young 
people get on the bus and if they have got posters at the bus stop you can glance at that 
and read. (Interview 3: Female, 17 years) 
 
Requesting test kits from the NHS Havering Chlamydia screening office or other sources 
via the telephone or internet were preferred by all participants due to their confidential 
nature. Most participants considered schools, hospitals and other public places as unlikely 
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test kit sources for the majority of young people due to the effort required and 
inconvenience involved (Box 5). 
 Box 5: Preferred sources of test kits (Opinions of young people who had taken a test) 
 
1.  “Most of them will not go in and speak to a person face to face. A lot of young 
people won’t want to go in and say, can I have a Chlamydia testing kit? You see 
Connexion is better because it is confidential. And you just ring them and they put 
your name in the system and send it to you” (Interview 2: Female, 18 years)  
 
2. “Places like schools, hospitals and stuff, they’re unlikely to go there. I don’t think 
young people would go out of their way to get one. I don’t think they would go out 
of their way to go to a hospital and get one. If the test kit is coming to them like in 
post, then it’s right on there, then they are more likely to just take it up coz it’s 
there isn’t it?” (Interview 7: Male, 19 years)  
 
 
Young people who had never taken a test for Chlamydia  
Participants in focus groups suggested the internet, television and postal address as the best 
channels of communication because they did not involve personal interaction. They 
thought public outreach programmes were not effective as they involved taking a risk of 
being seen by acquaintances while in attendance which would lead to embarrassment. 
They were of the opinion that most public outreach programmes only tended to attract 
young people who don’t live in targeted local areas: 
 
“You have got these events like Romford road show, a lot of people go to them, but 
it’s really quite a minority of the population of the area that will go into the 
Chlamydia tent.” (Focus Group 1: Male, 17 years) 
 
 Some participants said the age of a health professional was significant in engaging young 
people at an individual level with preference to younger professionals whom young people 
would find easy to identify and engage with in discussions about sexual health issues. All 
participants agreed about the online or phone request system for test kits being the best 
option due its confidentiality which most young people value. However a few participants 
thought the issuing of test kits after health talks to all young people was also effective as it 
avoided singling out individuals which most young people dislike. Some considered GP 
practice and colleges as not good options due lack of confidentiality, for example: 
  
“I don’t know probably my GP but I can’t go to the GP without my mother 
knowing.” (Focus Group 3: Female, 17 years) 
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“People would rather take it from like, you know them places, like the sex 
education for young people events or whatever and they give you at the end. It’s 
better than if it is in college yeah, that’s an open place and everyone will see that 
you’re asking for something.” (Focus Group 1: Male, 19 years) 
 
Recommendations for health workers  
The following were the main recommendations made by interview and focus group 
discussion participants on how to boost Chlamydia screening uptake (Box 6).  
 Create more awareness about Chlamydia screening among young people and allay 
fears about possible embarrassment by reassuring them about the confidentiality of 
the service 
 Provide incentives to encourage more young people to take Chlamydia tests. 
 Educate young people about how Chlamydia is spread and the symptoms as most 
young people do not understand the seriousness and how common Chlamydia is 
and those who know do not believe. 
 Ensure the service is confidential and utilise the postal method more by sending test 
kits to young people’s addresses rather than offering them in public. 
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Box 6: Recommendations on increasing Chlamydia screening uptake (All participants) 
 
1. “Say, may be posters to sort of initiate awareness of actually how often, how many 
people sort of get Chlamydia and the reasons why it’s important to get tested. Put 
those all around and then obviously if something like came through the door, then 
well, like for me it’s even better, it’s easy and convenient. So, it’s not out of your 
way to go and get tested. It’s a private thing as well, so it’s like not as, there is no 
one else that is involved sort of thing it’s just you.” (Interview 5: Male, 24 years) 
 
2. “Yeah, may be give them a free condom or something as an incentive. So give out 
some incentives to encourage them to screen like if they handed out vouchers that 
would be a good incentive as well for them.” (Interview 6: Male, 18 years) 
 
3. “Well what did it for me was when the woman said that like in 12 people and 6 
people have it and I was like ooohhhh!! That’s what made me think like...I think its 
one in 10 I got it wrong, I think it is one in 10. And I've got like a group of 10, 10 
of like my friends and we were like one of us has it or gonna have in the end so we 
better get tested. So say like how common it is, how you might get it and how like 
there's hardly any symptoms so you might not know you had it at all. And you 
might still have it and definitely talk about how it decreases fertility in girls, 
because I think a lot of girls will worry about things like that, from what I know 
anyway.” (Interview 3: Female 17 years) 
 
4. “Make it more private. Like you send it to the house, so when you are weeing in the 
pot and you seal it then you send to the lab by post, you know no one is seeing you, 
no one is looking at you. That’s more anonymous, you’re outing your details but 
you don’t have the psychological thing of handing it physically to another person 
even though you know some scientist is going to open it up and do whatever they 
want to.” (Focus Group 4: Female, 22 years) 
 
Summary of factors associated with Chlamydia screening uptake 
Figure 5.4 gives a summary of factors that were associated with Chlamydia screening 
uptake as reported by participants and also highlights key determinants/factors based on 
the majority view. Convenient access to information and test kits was considered a key 
factor that would enhance the possibility of a young person taking a Chlamydia test (the 
majority who had taken a test: 6/8 received information and test kits at their home 
addresses). Knowledge about the consequences of Chlamydia infection was also identified 
as a key factor that would stir more young people to take a test. However this appeared to 
apply mainly to female participants who considered loss of fertility as a consequence of 
Chlamydia infection a significant issue (3/4 female participants who had tested for 
Chlamydia cited this as a key motivating factor). The belief that only promiscuous people 
were at risk of Chlamydia infection and only women were affected were identified as  key 
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barriers based on the views of all participants who had never taken a test. Those who had 
taken a test also said they would only consider taking a test again in future if they got 
involved in a risky sexual relationship. Fear of parents, peers or other close acquaintances 
knowing that one was sexually active and concerned about their sexual health was 
considered a key barrier by all participants. Fear of positive results and the embarrassment 
of being associated with a sexually transmitted disease were also highlighted as key 
deterrents.   
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Figure 5.4: A conceptual model of factors associated with Chlamydia 
screening uptake among young people in Havering 
Chlamydia Test Motivating Factors  
Knowledge of Chlamydia. 
Knowledge of Chlamydia testing 
procedures. 
Desire to know status. 
Realisation of being at risk.  
Fear of loss of fertility. 
Peer group / friends taking Chlamydia 
tests.  
Convenient access to Chlamydia 
information. 
Convenient access to Chlamydia test 
kits. 
Knowledge about confidential test 
results notification. 
Tangible incentives e.g. cash/high 
street vouchers, condoms. 
 
Barriers to taking a Chlamydia test 
Lack of/distorted knowledge about 
Chlamydia and testing procedures. 
Believe that only women are affected. 
Believe that only promiscuous people 
are affected. 
Stigma associated with sexually 
transmitted infections. 
Fear of possible positive results and 
related embarrassment. 
Fear of being found out by parents and 
peers. 
Fear of personal details being stored in 
a government database and accessed 
in future. 
Unwillingness to discuss sexual issues 
























Believe that only 
promiscuous 
people / women 
are affected. 
 
Fear of being 
found out by close 
acquaintances. 
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5.4 Discussion 
Results from this study show that gender, area of residence (ward), deprivation and 
ethnicity were the main predictors of screening uptake whereas area of residence, source of 
test kits and sexual behaviour were the main predictors of prevalence. The main barriers to 
taking a Chlamydia test were identified as: inadequate knowledge about Chlamydia and 
test procedures, underestimation of individual’s infection risk, stigma associated with 
sexually transmitted diseases, fear of positive test results and related embarrassment, fear 
of being found out by significant others and personal details being stored in a government 
database. Motivating factors included adequate knowledge of Chlamydia and test 
procedures, realistic assessment of individual’s infection risk, fear of loss of fertility 




The overall Chlamydia screening uptake rate was 14.4% which was slightly lower than the 
England national average (15.9%) and significantly lower than the London area average 
(18.1%). (National Chlamydia Screening Programme, 2009). Although this may be viewed 
as underperformance, the NHS Havering programme was by then relatively new having 
been initiated in late 2008. The uptake rates should therefore be considered in that context 
as evidence shows that it takes several years of aggressive and comprehensive health 
marketing strategies to reach out to target groups and to realize high screening volumes 
(Herrmann & Egger, 1995; Kretzschmar et al., 1996; Honey et al., 2002; Levine et al., 
2004; National Chlamydia Screening Programme, 2009). 
 
The analysis of screening uptake by gender showed that females were twice more likely to 
take a Chlamydia test as compared to males. This is consistent with the national (Females 
23.6% vs. Males 15.9%) and London area (Females 25.6% vs. Males 18.1%) uptake rates 
for the same period of study (2008/09) (National Chlamydia Screening Programme, 2009). 
Generally Chlamydia screening uptake among males has remained low nationally since 
inception of the programme. Some of the factors that have been attributed to low uptake 
include: settings offering screening being more likely to be visited by females 
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(contraceptive services and sexual health clinics), some health professionals being 
reluctant to offer test kits to males (Boekeloo et al., 2002), lower likelihood of 
asymptomatic young men as compared to women in seeking a test (Andersen et al., 2002) 
and low awareness about Chlamydia  and screening among men (Adams et al., 2004b). 
Although this study did not specifically investigate gender disparity in relation to screening 
uptake, results from the qualitative component showed that most young people still 
consider Chlamydia as mainly affecting females and of little or no consequence to males. 
In England, the National Chlamydia Screening Programme has been implementing a 
strategy entitled, ‘Men Too’ since 2007 (National Chlamydia Screening Programme, 
2007). The strategy aims at addressing the gender disparity in uptake of screening by 
mainly raising young men’s awareness of Chlamydia and the screening programme, 
ensuring provider commitment and reviewing, evaluating and developing good practice in 
working with young men based on local initiatives and research. In line with the “men too” 
strategy, NHS Havering needs to develop a local strategy to raise awareness about 
Chlamydia and screening and address the misperception inherent among young people that 
Chlamydia affects only females. 
 
Young people of Non-White ethnic background were more likely to take a Chlamydia test 
as compared to those of White background. Many studies in the UK have examined the 
association between Chlamydia prevalence and ethnicity ( Low et al., 2001; LaMontagne 
et al., 2004; Macleod et al., 2005; Das et al., 2005; Monteiro et al., 2005; Stein et al., 2008) 
but very few have looked at the association between screening uptake and ethnicity. One 
study (Macleod et al., 2005) found that uptake was low among ethnic minority groups. 
However, this study relied on records of young people who volunteered to take a test as 
part of the study on one occasion unlike the current study which looked at one year records 
of young people who took tests at varied times and sites. Whereas it is not clear why the 
uptake of Chlamydia tests is relatively lower among white young people, some studies in 
the USA have suggested that they are overlooked while non-white individuals tend to be 
over targeted by health workers who believe they are at a higher risk (Tebb et al., 2005; 
Centres for Disease Control and Prevention, 2010). But it is also possible that young 
people from the white ethnic group assume they are at low risk and therefore ignore offers 
to take a test. There is need for further research for a better understanding of this disparity 
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and for the development of better strategies that will increase uptake among young people 
from the all ethnic groups. 
 
Young people from the least deprived quintiles were less likely to take a Chlamydia test as 
compared to those from the most deprived quintile. This was further confirmed with ward 
analysis which showed that young people from the St. Andrews ward which belongs to the 
most deprived quintile were up to two times more likely to take a test as compared to those 
in Harold Wood, a relatively less deprived ward.  This disparity may be partly linked to 
ethnicity as the most deprived wards in Havering have a larger proportion of non-white 
young people whom this study found are more likely to take a Chlamydia test as compared 
to those from the white group. Evidence around deprivation and Chlamydia screening 
uptake is limited but some studies have linked use of incentives to the higher uptake rates 
among deprived groups (Zenner et al., 2010).  It is argued that often the incentives 
involved in Chlamydia screening are of low value and therefore mainly attract young 
people from deprived homes. The NHS Havering programme has consistently used 
incentives as part of its strategy of increasing screening uptake, hence the need for an 
evaluation of this approach to determine its impact on the target population and ensure a 
more balanced approach as this study did not find any significant difference in Chlamydia 
prevalence among the various deprivation quintiles.  
 
The most popular source for test kits was the NHS Havering Chlamydia screening office 
(67%). This was in contrast with the national outlook where similar sites accounted for 
only 5.4% of tests done over the same period (2008/09) (National Chlamydia Screening 
Programme, 2007; National Chlamydia Screening Programme, 2009). National statistics 
show that contraceptive and sexual health clinics are the most popular sites (25%) followed 
by GP practices (16%). The two only accounted for about 6% of all tests done at NHS 
Havering. Another significant source nationally is the outreach programme. This is not in 
place at NHS Havering which might be a factor contributing to low uptake of screening 
services as evidence shows it is the most popular source of test kits among males 
nationally (National Chlamydia Screening Programme, 2009). Overall there is need to 
strengthen other screening sites within Havering apart from the main screening office in 
order to increase target population coverage. However it is important to note that most 
young people who participated in the qualitative component of this study expressed 
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preference for sites that do not require their physical presence and keep them anonymous 
such as the NHS Havering screening office and Connexions where request for kits are done 
on line or by telephone. 
Chlamydia Prevalence 
The Chlamydia prevalence rate based on the total number of young people who were 
screened was 5.3%. This was lower than the national average (7.3%). Although high levels 
of Chlamydia prevalence have been linked with deprivation and minority ethnic groups 
(Shahmanesh et al., 2000; Winter et al., 2000; Low et al., 2001; Monteiro et al., 2005; 
Simms et al., 2009; Centres for Disease Control and Prevention (CDC), 2008), this study 
found no significant association. However, the general low uptake of screening services 
means the reported prevalence rates might not be accurate. NHS Havering needs to address 
identified barriers to screening uptake in order to boost overall uptake and therefore 
determine the true prevalence rates. 
 
Chlamydia prevalence was highest among young people who got tested via pharmacy. This 
finding is consistent with other studies that have found that Chlamydia prevalence in 
healthcare settings tends to be higher than in general population settings as they are more 
likely to be visited by individuals who are symptomatic and possibly seeking treatment, the 
majority of whom accept to be tested (Pimenta et al., 2003). Pharmacy in particular might 
be preferred to for example a sexual health clinic or hospital where usually extensive 
history taking, documentations and examinations are done, which some young people may 
find embarrassing, tedious and intimidating. Overall these findings underline the 
significance of Pharmacy sites in identifying and treatment of young people who have 
Chlamydia and in the reduction of overall prevalence within the population. 
 
Colleges had the lowest Chlamydia prevalence in this study. This is not unusual as 
evidence shows that non-health care settings tend to have lower prevalence rates (Adams et 
al., 2004a; Simms et al., 2009) compared to health care settings where the visiting 
population might be more sexually active such as in contraceptive services or already 
symptomatic as in sexual health clinics  and pharmacy (Department of Health, 2001; 
Pimenta et al., 2003). But this could also be due to more awareness about safe sex and 
general sexual health as colleges tend to be more targeted by health education and sexual 
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health campaigns due to their large sexually active populations. On the other hand, the 
English National Study on Chlamydia screening (2007/08) (Simms et al., 2009) found that 
prevalence was low in educational settings because most tests were done during the 
beginning of semesters when actual sexual interactions had not started. The approach is 
similar at NHS Havering where staff visit local institutions at the beginning of academic 
years mainly to target freshers who tend to be more receptive to Chlamydia information 
and test offers. It is therefore recommended that Chlamydia screening campaigns be 
staggered through the academic semester period in order to determine the true prevalence 
and for appropriate intervention. 
 
Risk of Chlamydia infection was strongly associated with having a new partner in the last 
three months and two or more partners in the last 12 months. This is consistent with most 
studies on Chlamydia prevalence (Fenton et al., 2001; LaMontagne et al., 2004; Simms et 
al., 2009). These findings highlight the need for health education on risky sexual behaviour 
for young people as an integral part of Chlamydia prevalence reduction efforts. This study 
also observed that young people who did not disclose information on sexual partnerships 
were also at a higher risk of Chlamydia infection than those who were not involved in risky 
sexual behaviour. It is therefore quite likely that this group of young people was actually 
involved in risky sexual behaviour but felt embarrassed about disclosing this information. 
The qualitative component of the current study and other  studies have found that young 
people are generally reluctant to engage in Chlamydia screening because of its associated 
embarrassment among peers and the unwillingness to disclose details about their sexual 
lives (Blake et al., 2003; Chaudhary et al., 2008). There is need to create more awareness 
and reassure young people about the confidentiality of the Chlamydia screening service in 
order to encourage more participation and disclosure of details  that are vital for 
surveillance and development of effective intervention strategies. 
 
Evidence on Chlamydia and other sexually transmitted diseases shows that significant 
prevalence reduction can only be reached where there is an effective strategy of contacting 
and treating of partners of positive individuals (Cowan et al., 1996; Welte et al., 2001; 
LaMontagne et al., 2004). At the moment partner notification data in Havering is not 
linked to the screening volume and coverage data set. The linking of the two data sets 
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would enhance analytical capability and provide a better understanding of the screening 
programme impact on the target population.  
Barriers & Motivating factors 
The difference in knowledge about Chlamydia among participants who tested and those 
who had not was minimal. However those who had tested as expected had better 
knowledge of the testing process. A factor that might be considered a barrier to Chlamydia 
screening was the belief among participants who had never tested that those who take tests 
are engaged in high risk sexual activity. This finding implies that there is need for more 
awareness campaigns among young people in order to improve their general knowledge 
about Chlamydia and screening services and correct this misperception. 
The Stigma associated with sexually transmitted diseases was highlighted as a major 
barrier among young people responsible for their reluctance to publicly engage in any 
Chlamydia associated events such as local awareness campaigns and accepting test kits 
when offered in public. This was also evident during recruitment of participants at partner 
institutions. Most young people were shy to engage with me and the team from NHS 
Havering. The interviews and focus groups were also problematic to hold as most young 
people did not attend as scheduled or failed to attend completely. Hence the data collection 
process took over three months to complete. Some young people who were interviewed 
said they had taken a test because it was a group decision a factor which appears to have 
lessened the stigma involved as the fear of being found out or perceived negatively was 
removed. This finding highlights the significance of targeting young people as groups 
rather than individuals as a strategy of de-stigmatizing Chlamydia screening and 
encouraging testing. 
  
Most participants had taken a test because it was convenient and it did not involve personal 
effort. They were pleased with the process of testing which involved test kits being send to 
their homes and they simply provided a sample and send it back by post to the laboratory. 
Results were sent as a coded text or email messages. Convenience, privacy and 
confidentiality were highlighted as the key factors that would encourage more young 
people to test if they were guaranteed. They believed this would also address related fears 
such as being found out by parents or peers or personal details being stored in some 
government data base of “naughty people”. Chlamydia information and test kits being sent 
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to home addresses was reported as the most preferred method that would ensure more 
young people take a test. Therefore, for NHS Havering to boost screening uptake they need 
to create more awareness about this option and the process involved. Some participants 
thought providing some tangible incentives such as cash/high street vouchers would 
encourage more young people to take tests. However the evidence around use of incentives 
in the UK is inconclusive as studies show mixed results (Kane et al., 2004; Sutherland et 
al., 2008; Zenner et al., 2010). The National Chlamydia Screening Programme discourages 
use of incentives due to lack of firm evidence and its own surveillance records that show 
minimal impact of financial incentives where they have been used. There is also concern 
that young people might engage in multiple tests for the sake of receiving the specified 
incentives hence increasing screening volumes but overall having no impact on reducing 
Chlamydia prevalence (National Chlamydia Screening Programme, 2010). 
 
Several other qualitative studies have examined barriers and motivating factors among 
young people. Most have identified poor knowledge about Chlamydia and screening, 
concerns about confidentiality regarding screening and results (Blake et al., 2003), fear of 
being found out by friends (Rietmeijer et al., 1998; Serlin et al., 2002; Mills et al., 2006) 
and underestimation of  individual infection risk (Lorimer et al., 2009) as major barriers to 
screening, factors which are consistent with my study. However, these studies mainly 
focused on those attending clinical settings for other medical reasons ( Devonshire et al., 
1999; Shahmanesh et al., 2000; Mills et al., 2006; Heritage & Jones, 2008) or did not 
involve participants who had been screened at a variety of settings or those not screened at 
all (Lorimer et al., 2009; Chaudhary et al., 2008). Some studies have reported that women 
are more concerned about the stigma associated with Chlamydia diagnosis than men (Mills 
et al., 2006; Lorimer et al., 2009) whereas men are mainly concerned about convenience. 
This is a contrast with my study where these were universal issues. The difference may 
again be attributed to the involvement of only individuals who had undergone tests in 
specific settings unlike the current study which involved young people who had tested in 
different settings and those who had not.  
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Policy & Practice Implications 
This study has demonstrated the significance of understanding target populations 
(consumer research) in order to design interventions that are relevant to specific segments 
and consequently maximizing on outcomes and efficiency. The use of both quantitative 
and qualitative methods provided vital insight into current Chlamydia screening uptake and 
prevalence patterns and the perception of the intervention by a sample of the target group. 
The finding that screening uptake among least deprived and white ethnic groups was low 
raises questions on current screening promotion strategies and their relevance to the target 
population as a whole. Although the study did not evaluate the role of incentives in 
Chlamydia screening uptake, evidence shows higher rates have been reported especially 
among deprived communities where incentives are used (Molinar & Nardone, 2009; 
Zenner et al., 2010). It is therefore important that incentive schemes where in use are 
evaluated regularly to ensure they are not drivers of screening service inequity. 
 
This study also found that individualistic approaches to Chlamydia awareness campaigns 
such as offering test kits to young people in public and issuing them with information 
leaflets are unlikely to have an impact on target groups and screening uptake due to 
societal stigma on sexually transmitted diseases that remains persistent. The evidence from 
this study supports targeting peer groups and other existing groups such as classmates in 
schools or youth club members as a more effective way of creating awareness about 
Chlamydia screening. This approach encourages more young people to take tests as it does 
not single out individuals, an issue young people highlighted as a major barrier to 
accessing information and test kits. 
 
Remote testing where individuals don’t have to go to a screening site appears to be the 
most appealing method of screening among young people as it protects their privacy and 
confidentiality. In particular information being sent to young people’s addresses and use of 
phones and internet for requesting kits as well as communicating results were found to be 
the most popular methods and was supported by both the quantitative and qualitative 
results. The UK government policy supports this approach and has recommended a 
national website where young people can access information and request for kits as a cost 
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effective way of increasing screening uptake (House of Commons Committee of Public 
Accounts, 2010). 
 
Implications for social marketing 
This study identified segments of the young people who are unlikely to access screening 
services and those who experience a high prevalence of Chlamydia infection (segmentation 
and targeting). Also identified were young people’s knowledge, attitudes and beliefs as 
regards Chlamydia prevalence and screening as well as their perceptions of what motivates 
(exchange) or discourages (competition) young people from testing for Chlamydia, a 
combination of factors which can be utilised in developing or improving Chlamydia 
intervention strategies (marketing mix).  This study however did not include service 
providers due to resource and time limitation. Their perception and experiences of the key 
factors associated with screening uptake would have enhanced the understanding of uptake 
patterns and contributed immensely towards the development of effective intervention 
strategies (marketing mix). 
 
Study strengths & limitations 
This study had several limitations worth considering in the interpretation of its findings. 
Firstly, like other cross sectional studies, the study was only able to establish associations 
between participant characteristics and Chlamydia screening uptake and prevalence but not 
a cause and effect relationship. Secondly, because of lack of population data for areas of 
residence by ethnicity, I was not able to include the ethnicity variable in the adjusted 
logistic regression model for Chlamydia screening uptake.  
 
Thirdly, I tried to ensure the selection of young people to participate in interviews and 
focus groups was reflective of the Havering demographic profile but it was not possible to 
have equal representation due to the difficulty in finding young people interested in the 
study and who also kept their appointments. Fourthly, I had no way of verifying those who 
had tested and those who had not. However, the responses to guiding questions during 
interviews and focus groups were a reflection of the expected differences between the two 
groups. 
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Despite the above limitations, this is the first study that has combined quantitative and 
qualitative methods and included young people who have an experience of being tested for 
Chlamydia and those who don’t. These approaches have provided a more robust 
understanding of existing Chlamydia screening uptake and prevalence patterns among 
young people aged 16-24 and also their perception of barriers and motivating factors that 
influence the decision to take a Chlamydia test. The findings and recommendations from 
this study therefore provide vital intelligence for program redesign at NHS Havering and 
may be applicable to other similar contexts. 
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5.5 Conclusion 
This study was a consumer research (social marketing component) application which 
utilized a mixed method approach to examine factors associated with Chlamydia screening 
uptake and prevalence among young people living in the London borough of Havering. 
Results from this study show that gender, area of residence, deprivation and ethnicity were 
the main predictors of screening uptake whereas area of residence, source of test kits and 
sexual behaviour were the main predictors for prevalence.  
 
The main barriers to taking a Chlamydia test (competition) were identified as, inadequate 
knowledge about Chlamydia and test procedures, underestimation of individuals’ infection 
risk, stigma associated with sexually transmitted diseases, fear of positive test results and 
related embarrassment, fear of being found out by significant others and personal details 
being stored in a government database. Motivating factors (exchange) included adequate 
knowledge of Chlamydia and test procedures, realistic assessment of individuals’ infection 
risk, fear of loss of fertility among females, convenience in access to test kits, 
confidentiality in results notification and tangible incentives. 
 
The low uptake of screening services among males was linked to the misperception that 
Chlamydia is a female problem. As males are major players in the reduction of Chlamydia 
prevalence in the population, there is need for sustained efforts in educating them about the 
basics of Chlamydia infection and screening and to correct this common misperception, 
clarify their role in spread of infection and encourage them to take tests regularly. 
 
The high prevalence of Chlamydia infection among young people screened via pharmacy 
highlights the significance of the partnership between the NHS Havering screening 
programme and pharmacies (partnership - marketing mix). There is need to collectively 
develop a strategy that will increase uptake of screening services in these sites.  
 
Individualistic approaches to Chlamydia awareness and screening campaigns which also 
involve offering of test kits in public were reported as repulsive among young people and a 
major barrier. Findings from this study instead support targeting peer groups as way of 
overcoming societal stigma on sexually transmitted diseases (marketing mix). 
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Convenience, privacy and confidentiality were highlighted as central in increasing 
screening uptake among young people. Remote testing where individuals request test kits 
on line, receive them in their homes and they in turn send urine samples by post to the 
laboratory and test results/advice are communicated via text or email messaging was 
considered the best screening option (marketing mix). 
 
The ethnic and socioeconomic disparity in relation to screening uptake among young 
people in Havering and its possible relationship with provision of incentives requires 
further investigation to understand and act upon. Its recommended that service providers 
be included in future studies in order to capture their experiences and perceptions of the 
factors associated with screening uptake and utilize them in developing effective 
intervention strategies (marketing mix).    
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Chapter 6: Discussion 
In this chapter, I discuss key findings from my three studies in light of the available 
evidence and draw out implications for public health policy and practice. The three studies 
were carried out to determine the effectiveness of a social marketing approach in reducing 
unintended teenage pregnancies and the applicability of consumer research (a foundational 
component of social marketing) in understanding young people’s sexual health needs and 
perceptions in relation to use of LARC methods and Chlamydia screening service. 
 
The effectiveness of a social marketing approach 
Findings from the systematic review indicate that social marketing may be effective in 
influencing specified sexual behaviour change (delayed sexual initiation, contraceptive use 
at last intercourse, knowledge of contraception and reproductive health and efficacy to 
refuse unwanted sex) and may consequently reduce unintended teenage pregnancies 
especially where interventions are implemented over long periods. These findings are 
consistent with those of Tanner et al. (2009) and Messers et al. (2011), the only studies 
available that have evaluated unintended teenage pregnancy interventions in developed 
countries described as social marketing. Tanner et al. (2009) in  their evaluation of a social 
marketing abstinence programme involving 11-16 year olds in the USA observed that 
participants’ duration of attendance at the abstinence programme was positively associated 
with the marketed knowledge, beliefs, attitudes and intensions. However they also 
concluded that social marketing was effective in reducing teenage pregnancy without 
reporting the teenage pregnancy rates before and after implementation. 
 
 Messers et al. (2011) on the other hand carried out a study to demonstrate the application 
of consumer research in developing an effective teenage pregnancy intervention for 
students aged 11-13 years. The study successfully collected vital information about the 
target population which was utilised in designing and implementing a teenage pregnancy 
prevention programme. In contrast to studies included in my review, they did not report 
baseline sexual characteristics and perceptions of the target group nor related post 
implementation outcomes. They instead carried out random informal interviews with some 
target community members and based on their findings concluded that social marketing 
was effective in supporting behaviour change and normative misperceptions about teenage 
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pregnancy. The method of evaluation therefore raises questions on the objectivity of the 
process and validity of reported findings. 
  
The applicability of consumer research 
In my second study which was a consumer research application I examined factors 
associated with use of LARC methods among young women in the UK and considered the 
impact of NICE LARC guidelines published in 2005.  I identified factors associated with 
LARC use as age and educational level for the period before the publication of NICE 
guidelines, observed a positive impact of the NICE LARC guidelines as evidenced by 
increase in LARC uptake among younger women (below 20 years) and those in education 
after 2005. I also identified reasons why women change contraception methods (reliability, 
convenience, influence by health workers and fear of side effects).  
 
Only two other studies have explored the applicability of consumer research in designing 
interventions aimed at improving contraception uptake among women of reproductive age 
in developed countries (Bertrand et al. 1987 & Tanfer, 2000). However, only Tanfer et al. 
(2000) specifically investigated factors associated with LARC uptake. In their study they 
analysed data from the US national survey of women carried out between 1991 and 1995 
to identify why the uptake of LARC methods among women aged 20-39 was low. Their 
findings were consistent with mine as regards the majority of women not using LARC 
methods mainly due to fear of side effects. My study however explored further the 
association between type of contraception and participant characteristics, included all 
LARC methods as compared to only two in the case of Tanfer et al. (2000) and also 
included teenage women who evidence shows are most affected by unintended pregnancy.  
 
My third study (factors associated with Chlamydia screening uptake and prevalence) also a 
consumer research application, identified segments of the young people who are less likely 
to access screening services (males, white and those from affluent areas) and those who 
experience a high prevalence of Chlamydia infection (those testing via pharmacy or 
involved in risky sexual behaviour). Also identified were young people’s knowledge, 
attitudes and beliefs as regards Chlamydia prevalence and screening as well as their 
perceptions of what motivates (exchange) (realisation of being at risk of Chlamydia 
infection, convenient access to information and test kits and fear of loss of fertility) or 
  161 
discourages (competition) (belief that only promiscuous people/women are affected by 
Chlamydia, fear of being found out by close acquaintances and fear of positive results) 
young people from testing for Chlamydia.   
 
Only one other study has explored the applicability of consumer research in designing a 
Chlamydia screening intervention (National Social Marketing Centre, 2011). Consistent 
with my study, this study also identified being male, lack of knowledge about screening 
sites, fear of test results and fear of being found out by acquaintances as the main factors 
associated with low uptake of Chlamydia screening services. Unlike my study which 
stopped at consumer research, this study used their consumer research findings to design 
and implement a complete social marketing intervention featuring all components. 
Evaluation results showed that the intervention was able to increase the uptake of 
Chlamydia screening in both target areas (North Lincolnshire and North East Lincolnshire, 
England). Three other similar studies (Futterman, 2001; Montoya 2005; Plant 2008) 
explored the applicability of consumer research in designing interventions aimed at 
increasing screening for syphilis and HIV among men who have sex with men. All the 
three studies reported increased awareness about screening among target groups. However 
only one (Futterman, 2001) reported increase in screening uptake. This may be attributed 
to the short implementation periods which did not allow for marketed behaviour change 
(testing for specified sexually transmitted diseases) to develop. 
 
Limitations of the consumer research studies 
My two consumer research studies (LARC & Chlamydia) had some limitations worth 
noting. Firstly, I utilised secondary data in determining factors associated with LARC 
uptake, Chlamydia prevalence and screening uptake whereas the data collection processes 
were not designed with consideration of my research questions hence limiting the choice of 
variables used in analyses. There being some evidence suggesting an association between 
women’s parity (Baldwin et al., 2012; Jokin et al., 2011), influence by existing partners  
(Jokin et al., 2011; Frost & Darroch, 2008) and contraception choice, it would have been 
more informative to include the two variables in my LARC study. The Chlamydia data set 
also lacked information on young people’s individual socioeconomic status, those who 
tested more than once over the one year period (2008/09) and partner follow up, screening 
and treatment for those who tested positive. An analysis including these factors would have 
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enhanced the understanding of Chlamydia prevalence patterns in Havering. However, 
considering time and resource limitations it would have been nearly impossible to collect 
data and process similar datasets from scratch. Despite the highlighted limitations the data 
sets utilised in the two studies contained sufficient information to determine key factors 
associated with LARC and Chlamydia screening uptake as well as prevalence.  
 
Implications for Public Health Policy & Practice 
The study on effectiveness of social marketing in reducing unintended teenage pregnancy 
provides an insight into the application of specified social marketing components in 
interventions and what works in reducing unintended teenage pregnancy. Though not 
conclusive, the study highlights the significance of implementing long-term multifaceted 
programmes with adequate intensity in order to realise desirable outcomes. This is 
consistent with the current UK Public Health strategy for addressing health behaviour 
change among young people that is currently moving away from short term public 
information campaigns that aim at influencing behaviours directly to focusing on long term 
interventions that aim at tackling antecedents to observed problem behaviours and reaching 
out to a broader audience (marketing mix) (Department of Health, 2009d; Department of 
Health, 2011). For unintended teenage pregnancy interventions this means addressing 
behaviours such excess alcohol use, poor school performance, poor access to contraception 
and reaching out to more players involved such as: parents, male and female teenagers, 
teachers, health workers, social workers, faith groups and media. 
 
The two studies on LARC and Chlamydia have demonstrated the significance of 
understanding target groups through consumer research so as to design programmes that 
are likely to have a positive impact and tackle inequalities in disease burden and access to 
health services. For example, the LARC study showed that before NICE guidelines were 
published younger women were disadvantaged in accessing more reliable methods of 
contraception (LARC), probably due to unfavourable policies by Primary Care Trusts 
which restricted prescription of LARC methods for younger women and those without 
children  yet they were the most affected by unintended pregnancies. The Chlamydia study 
also highlighted a low uptake of screening services among males and young people from 
affluent areas in Havering. This insight can further be enhanced by investigating the 
underlying factors associated with the observed disparity among the specified groups and 
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addressing them in order to improve target population coverage. However the two studies 
did not assess the magnitude of influence by consumer research on intervention quality 
and outcomes hence the need for more studies that feature all the six components to 
determine the effectiveness of a social marketing approach in increasing the uptake of 
LARC and Chlamydia screening.  
 
The evidence on social marketing effectiveness and applicability remains scanty in the UK 
despite social marketing being the official approach to health behaviour change 
(Department of Health, 2008a; Department of Health, 2009d; Department of Health, 2011). 
The National Social Marketing Centre which is the main institution charged with the 
responsibility of providing guidance on programme implementation as well as capacity 
building in the public sector is also responsible for developing an evidence base that is 
expected to be utilised in informing policy and improving practice around health behaviour 
change. Despite being in existence since 2006, it has only managed to document three 
successful social marketing sexual health projects  carried out in partnership with Primary 
Care Trusts (“Are You Getting It,” COAST & DASH) (National Social Marketing Centre, 
2011).  
 
Apart from bureaucracy being a hindrance to carrying out research within Primary Care 
Trusts and NHS in general (Department of Health, 2011), lack of capacity among staff has 
also been highlighted (Gabbay & May, 2004; Cooke, 2005). Another factor has been 
identified as limited funding for public health research with the bulk of funding being 
allocated to secondary care institutions to carry out clinical research (Chen & Majeed, 
2005). However the recent establishment of the School for Public Health Research within 
the National Institute for Health Research (the main body responsible for research within 
the Department of Health) (The National Institute for Health Research, 2011) provides 
some hope that more opportunities for research around public health and social marketing 
might be available in future. 
 
Overall there is need for the National Social Marketing Centre and the National Institute 
for Health Research to support Primary Care Trusts who are currently the main 
implementers of social marketing projects with essential skills and resources necessary to 
enable them include a research/evaluation component in their programmes. This is vital not 
  164 
only in ascertaining the effectiveness of a social marketing approach but also for 
improvement and modification of implementation strategies that would lead to better 
sexual health for young people in the UK. The future of social marketing as the preferred 
approach to health behaviour change by the UK Government however faces significant 
challenges. In its effort to reduce overall expenditure within the Department of Health, the 
Government has recently declared its intention to fund only social marketing interventions 
that have documented evidence of efficacy (Department of Health, 2011). This is a shift 
from the previous approach where the National Social Marketing Centre was given the 
mandate to work with primary care trusts in setting pilot projects to test the effectiveness 
of social marketing in various health behaviour change interventions including sexual 
health. It is not clear what will happen to programmes such as those addressing unintended 
teenage pregnancy where the evidence on efficacy is still limited. 
 
There also exists some confusion on the preferred Government approach to behaviour 
change as currently “Nudge,” a behavioural change model based on the theory by Thaler & 
Sustein (2008) appears to feature prominently in Government plans. The Government has 
even gone further to establish a ‘Nudge Unit’ otherwise referred to as the Behavioural 
Insight Team currently based in the Cabinet Office whose remit include advising the 
Department of Health on the implementation of health behaviour change interventions 
based on the Nudge theory (French, 2011; Cabinet Office, 2011). At the moment it is not 
clear if any collaboration between the “Nudge Unit” and the National Social Marketing 
Centre exists at all. Therefore there is a possibility of future duplication of activities and 
confusion on what health behaviour change models should be adopted at local levels. 
 
Another significant development within the UK government that has an impact on social 
marketing is the transfer of Public Health responsibility from Primary Care Trusts to Local 
Authorities as from April 2013 (Department of Health, 2011). This means the local 
authorities will be responsible for the implementation of public health programmes 
including social marketing interventions. This poses a challenge to the future of social 
marketing as local authorities will be new partners who will need time to assimilate the 
idea of social marketing and actively engage and commit their limited finances to 
associated public health interventions.  
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However a favourable development for social marketing has been the Government 
statutory requirement that the commissioning of all health and social care interventions   in 
future will be based on Joint Strategic Needs Assessments (JSNA) involving local 
authorities, clinical commissioning groups, the voluntary sector and patient groups. 
Representatives from these groups will form what will be known as the Health and 
Wellbeing Boards. These boards will be responsible for tackling inequalities in health and 
wellbeing and will support local partners in the implementation of interventions and 
improving health and social outcomes for local populations (Department of Health, 2012). 
The JSNA therefore presents a great opportunity for the application of Consumer research 
and Segmentation/Targeting components of social marketing as means of needs assessment 
and identifying inequalities within local populations.  
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Chapter 7: Conclusion 
Unintended pregnancy and sexually transmitted infections among young people are 
considered priority public health issues in the UK and other developed countries due to 
their known impact on individuals, families and the wider society (Nicoll et al., 1999; 
Tripp & Viner, 2005; Department of Health, 2009c). Social marketing as an approach to 
addressing these issues and sexual health behaviour change in general is currently 
preferred in the UK and other developed countries. However, sufficient evidence on its 
effectiveness and applicability is lacking. The three studies reported in this thesis therefore 
addressed this gap by firstly assessing the effectiveness of a social marketing approach in 
reducing unintended teenage pregnancies (systematic review). Secondly, by exploring the 
application of consumer research (a social marketing component) in the understanding of 
factors associated with use of Long Acting Reversible Contraceptives, Chlamydia 
screening uptake and Chlamydia prevalence among young people. 
 
In the first study I carried out a systematic review of 12 unintended teenage pregnancy 
studies done in the UK and the USA while in the second I examined factors associated 
with use of LARC methods among young women aged 16-24 in the UK by analysing five 
datasets of ONS contraception opinion surveys (2002-2007). In the third study, I 
investigated factors associated with Chlamydia screening uptake and prevalence among 
young people (age 16-24) living in the London borough of Havering by analysing 
screening records for the period between September 2008 and August 2009 and conducting 
focus group discussions and interviews with 28 young people. 
 
Results from the first study (unintended teenage pregnancy) indicate that a social 
marketing approach can be an effective approach in reducing unintended teenage 
pregnancies especially when implemented on long term (at least two years). However, this 
is not conclusive as the studies included in the review were not specifically designed as 
social marketing interventions even though they met the set criteria. As a consequence, the 
implementation of activities in included studies was highly varied in content, intensity and 
the impact of various interventions inconsistent. There is therefore need for well designed 
teenage pregnancy interventions that specifically utilize social marketing principles by 
intent to enable more robust evaluations. 
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The second and third studies (LARC & Chlamydia) explored the application of consumer 
research in understanding of young people’s sexual health needs and perceptions in order 
to design appropriate and effective interventions. Although consumer research by itself is 
not a unique concept in public health as it is similar to other approaches such as baseline 
surveys and health needs assessments, when linked to the other components of social 
marketing, consumer research provides a valuable framework for intervention design, 
planning and implementation. Based on the emerging framework I was able to highlight 
segments within the young people population that need to be targeted in order to improve 
the uptake of LARC and Chlamydia screening services (segmentation and targeting), the 
competing messages, attitudes and beliefs that discourage young people from accessing 
LARC methods and Chlamydia screening services (competition), what would motivate 
more young people to take Chlamydia tests (exchange) and what marketing/intervention 
strategies need to be developed that would enhance the use of LARC methods and 
Chlamydia screening services (marketing mix). 
 
Findings from three studies have notable implications on public health policy and practice 
in relation to young people’s sexual health in the UK. The first study on unintended 
teenage pregnancies highlights the need to invest in long-term multifaceted programmes 
(marketing mix) with adequate intensity in order to realise desirable outcomes. Though this 
has financial implications as well, it is consistent with the current UK strategy for 
addressing health behaviour change among young people (Department of Health, 2009d; 
Department of Health, 2011). The two studies on LARC and Chlamydia highlight the 
significance of understanding target groups through consumer research so as to design 
programmes that are likely to have a positive impact. However the two studies did not 
assess the magnitude of influence by consumer research on intervention quality and 
outcomes hence the need for more studies that feature all the six components to determine 
the effectiveness of a social marketing approach in increasing uptake of LARC and 
Chlamydia screening.  
 
Overall evidence on the effectiveness and applicability of social marketing in sexual health 
interventions among young people remains limited in the UK. The climate for producing 
the required evidence is likely to be challenging due to the current restructuring of the 
public health institution, changing Government policies and limited resources and capacity 
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at local level. There is need for the Government to commit more resources and support for 
Primary Care Trusts and Local Authorities to enable them implement social marketing 
interventions that have inbuilt research components. This will help in developing an 
evidence base which can be utilised in shaping future policy and practice around health 
behaviour change interventions. 
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Appendix 2.1:  Literature Search Strategy: Social 
Marketing and Sexual Health in Developed countries 
 
I searched for studies on social marketing and sexual health in developed countries 
reported between 1980 and 2011 in the following data bases: PUBMED, COCHRANE 
Library, SCOPUS, CINAHL, TRIP, MEDLINE, Centre for Disease Control & Prevention 
(CDC), National Social Marketing Centre (NSMC) Evidence Database and manually 
searched bibliographies of relevant articles. Combinations of the following search terms 
were used: social marketing, health marketing, marketing, sexual health, reproductive 
health, family planning, contracept*, birth control, Chlamydia, sexually transmitted 
infection/disease, screen*, test*, teen* pregnancy, adolescen*, youth. 
Inclusion criteria 
Studies were included if they were described as social marketing and either evaluated the 
applicability or effectiveness of social marketing ( one or more of the specified elements) 
in the area of sexual health and young people. They also had to have been carried out in 
Western Europe, USA, Canada, Australia, New Zealand or Canada.  
Exclusion Criteria 
Studies were excluded if they did not describe themselves as social marketing or did not 
report a sexual health intervention or if not done in selected developed countries 
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 Figure 2.1: Study search and selection process 
 
 
Records recovered by 
search (n= 733) 
Studies excluded because they 
did not evaluate sexual health 
interventions (n=459) 





Studies included in the 
literature review (n=10) 
Studies excluded because: 
- Not carried out in selected 
countries (n=212) 
- Duplicates (n=34) 
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Appendix 3.1:  Quality Assessment Tool for Quantitative 
Studies Dictionary  
 
The purpose of this dictionary is to describe items in the tool thereby assisting raters to 
score study quality. Due to under-reporting or lack of clarity in the primary study, raters 
will need to make judgements about the extent that bias may be present. When making 
judgements about each component, raters should form their opinion based upon 
information contained in the study rather than making inferences about what the authors 
intended.  
 
A) SELECTION BIAS  
(Q1) Participants are more likely to be representative of the target population if they are 
randomly selected from a comprehensive list of individuals in the target population (score 
very likely). They may not be representative if they are referred from a source (e.g. clinic) 
in a systematic manner (score somewhat likely) or self-referred (score not likely).  
 
(Q2) Refers to the % of subjects in the control and intervention groups that agreed to 
participate in the study before they were assigned to intervention or control groups.  
 
B) STUDY DESIGN  
In this section, raters assess the likelihood of bias due to the allocation process in an 
experimental study. For observational studies, raters assess the extent that assessments of 
exposure and outcome are likely to be independent. Generally, the type of design is a good 
indicator of the extent of bias. In stronger designs, an equivalent control group  
is present and the allocation process is such that the investigators are unable to predict the 
sequence.  
 
Randomized Controlled Trial (RCT)  
An experimental design where investigators randomly allocate eligible people to an 
intervention or control group. A rater should describe a study as an RCT if the 
randomization sequence allows each study participant to have the same chance of receiving 
each intervention and the investigators could not predict which intervention was next. If 
the investigators do not describe the allocation process and only use the words ‘random’ or 
‘randomly’, the study is described as a controlled clinical trial.  
See below for more details.  
 
(Q1) Was the study described as randomized?  
 
Score YES, if the authors used words such as random allocation, randomly assigned, and 
random assignment. Score NO, if no mention of randomization is made.  
 
(2) Was the method of randomization described?  
 
Score YES, if the authors describe any method used to generate a random allocation 
sequence. Score NO, if the authors do not describe the allocation method or describe 
methods of allocation such as alternation, case record numbers, dates of birth, day of the 
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week, and any allocation procedure that is entirely transparent before assignment, such as 
an open list of random numbers of assignments.  
If NO is scored, then the study is a controlled clinical trial.  
 
(3)Was the method appropriate?  
 
Score YES, if the randomization sequence allowed each study participant to have the same 
chance of receiving each intervention and the investigators could not predict which 
intervention was next. Examples of appropriate approaches include assignment of subjects 
by a central office unaware of subject characteristics, or sequentially numbered sealed, 
opaque envelopes. Score NO, if the randomization sequence is open to the individuals 
responsible for recruiting and allocating participants  
or providing the intervention, since those individuals can influence the allocation process, 
either knowingly or unknowingly. If NO is scored, then the study is a controlled clinical 
trial.  
 
Controlled Clinical Trial (CCT) 
An experimental study design where the method of allocating study subjects to 
intervention or control groups is open to individuals responsible for recruiting subjects or 
providing the intervention. The method of allocation is transparent before assignment, e.g. 
an open list of random numbers or allocation by date of birth, etc.  
 
Cohort analytic (two group pre and post)  
An observational study design where groups are assembled according to whether or not 
exposure to the intervention has occurred. Exposure to the intervention is not under the 
control of the investigators. Study groups might be non-equivalent or not comparable on 
some feature that affects outcome.  
 
Case control study 
A retrospective study design where the investigators gather ‘cases’ of people who already 
have the outcome of interest and ‘controls’ who do not. Both groups are then questioned or 
their records examined about whether they received the intervention exposure of interest.  
 
Cohort (one group pre + post (before and after)  
The same group is pretested, given an intervention, and tested immediately after the 
intervention. The intervention group, by means of the pre-test, act as their own control 
group.  
 
Interrupted time series  
A time series consists of multiple observations over time. Observations can be on the same 
units (e.g. individuals over time) or on different but similar units (e.g. student achievement 
scores for particular grade and school). Interrupted time series analysis requires knowing 
the specific point in the series when an intervention occurred.  
 
C) CONFOUNDERS  
By definition, a confounder is a variable that is associated with the intervention or 
exposure and causally related to the outcome of interest. Even in a robust study design, 
groups may not be balanced with respect to important variables prior to the intervention. 
The authors should indicate if confounders were controlled in the design (by stratification 
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or matching) or in the analysis. If the allocation to intervention and control groups is 
randomized, the authors must report that the groups were balanced at baseline with respect 
to confounders (either in the text or a table).  
 
D) BLINDING  
(Q1) Assessors should be described as blinded to which participants were in the control 
and intervention groups. The purpose of blinding the outcome assessors (who might also 
be the care providers) is to protect against detection bias.  
 
(Q2) Study participants should not be aware of (i.e. blinded to) the research question. The 
purpose of blinding the participants is to protect against reporting bias.  
 
E) DATA COLLECTION METHODS  
Tools for primary outcome measures must be described as reliable and valid. If ‘face’ 
validity or ‘content’ validity has been demonstrated, this is acceptable. Some sources from 
which data may be collected are described below:  
Self reported data includes data that is collected from participants in the study (e.g. 
completing a questionnaire, survey, answering questions during an interview, etc.).  
Assessment/Screening includes objective data that is retrieved by the researchers. (e.g. 
observations by investigators). Medical Records/Vital Statistics refers to the types of 
formal records used for the extraction of the data. Reliability and validity can be reported 
in the study or in a separate study. For example, some standard assessment tools have 
known reliability and validity.  
 
F) WITHDRAWALS AND DROP-OUTS  
Score YES if the authors describe BOTH the numbers and reasons for withdrawals and 
drop-outs. 
Score NO if either the numbers or reasons for withdrawals and drop-outs are not reported. 
The percentage of participants completing the study refers to the % of subjects remaining 
in the study at the final data collection period in all groups (i.e. control and intervention 
groups). 
 
G) INTERVENTION INTEGRITY  
The number of participants receiving the intended intervention should be noted (consider 
both frequency and intensity). For example, the authors may have reported that at least 80 
percent of the participants received the complete intervention. The authors should describe 
a method of measuring if the intervention was provided to all participants the same way. 
As well, the authors should indicate if subjects received an unintended intervention that 
may have influenced the outcomes. For example, co-intervention occurs when the study 
group receives an additional intervention  
(other than that intended). In this case, it is possible that the effect of the intervention may 
be over-estimated. Contamination refers to situations where the control group accidentally 
receives the study intervention. This could result in an under-estimation of the impact of 
the intervention.  
 
H) ANALYSIS APPROPRIATE TO QUESTION  
Was the quantitative analysis appropriate to the research question being asked?  
An intention-to-treat analysis is one in which all the participants in a trial are analyzed 
according to the intervention to which they were allocated, whether they received it or not. 
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Intention-to-treat analyses are favoured in assessments of effectiveness as they mirror the 
non-compliance and treatment changes that are likely to occur when the intervention is 
used in practice, and because of the risk of attrition bias when participants are excluded 
from the analysis.  
 
  
COMPONENT RATINGS OF STUDY:  
For each of the six components A – F, use the following descriptions as a roadmap.  
 
A) SELECTION BIAS  
Strong: The selected individuals are very likely to be representative of the target 
population (Q1 is 1) and there is greater than 80% participation (Q2 is 1).  
Moderate: The selected individuals are at least somewhat likely to be representative of the 
target population (Q1 is 1 or 2); and there is 60 - 79% participation (Q2 is 2). ‘Moderate’ 
may also be assigned if Q1 is 1 or 2 and Q2 is 5 (can’t tell).  
Weak: The selected individuals are not likely to be representative of the target population 
(Q1 is 3); or there is less than 60% participation (Q2 is 3) or selection is not described (Q1 
is 4); and the level of participation is not described (Q2 is 5).  
 
B) DESIGN  
Strong: will be assigned to those articles that described RCTs and CCTs.  
Moderate: will be assigned to those that described a cohort analytic study, a case control 
study, a cohort design, or an interrupted time series.  
Weak: will be assigned to those that used any other method or did not state the method 
used.  
 
C) CONFOUNDERS  
Strong: will be assigned to those articles that controlled for at least 80% of relevant 
confounders (Q1 is 2); or (Q2 is 1).  
Moderate: will be given to those studies that controlled for 60 – 79% of relevant 
confounders (Q1 is 1) and (Q2 is 2).  
Weak: will be assigned when less than 60% of relevant confounders were controlled (Q1 is 
1) and (Q2 is 3) or control of confounders was not described (Q1 is 3) and (Q2 is 4).  
 
D) BLINDING  
Strong: The outcome assessor is not aware of the intervention status of participants (Q1 is 
2); and the study participants are not aware of the research question (Q2 is 2).  
Moderate: The outcome assessor is not aware of the intervention status of participants (Q1 
is 2); or the study participants are not aware of the research question (Q2 is 2); or blinding 
is not described (Q1 is 3 and Q2 is 3).  
Weak: The outcome assessor is aware of the intervention status of participants (Q1 is 1); 
and the study participants are aware of the research question (Q2 is 1).  
 
E) DATA COLLECTION METHODS  
Strong: The data collection tools have been shown to be valid (Q1 is 1); and the data 
collection tools have been shown to be reliable (Q2 is 1).  
Moderate: The data collection tools have been shown to be valid (Q1 is 1); and the data 
collection tools have not been shown to be reliable (Q2 is 2) or reliability is not described 
(Q2 is 3).  
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Weak: The data collection tools have not been shown to be valid (Q1 is 2) or both 
reliability and validity are not described (Q1 is 3 and Q2 is 3).  
F) WITHDRAWALS AND DROP-OUTS - a rating of:  
Strong: will be assigned when the follow-up rate is 80% or greater (Q2 is 1).  
Moderate: will be assigned when the follow-up rate is 60 – 79% (Q2 is 2) OR Q2 is 5 
(N/A).  
Weak: will be assigned when a follow-up rate is less than 60% (Q2 is 3) or if the 
withdrawals and drop-outs were not described (Q2 is 4).  
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Appendix 3.2: Quality Assessment Tool for Quantitative 
Studies   
 
COMPONENT RATINGS  
 
A) SELECTION BIAS  
(Q1) Are the individuals selected to participate in the study likely to be representative of 
the target population?  
1  
Very likely  
2  
Somewhat likely  
3  
Not likely  
4  
Can’t tell  
 
(Q2) What percentage of selected individuals agreed to participate?  
1  
80 - 100% agreement  
2  
60 – 79% agreement  
3  
less than 60% agreement  
4  
Not applicable  
5  
Can’t tell  
 
RATE THIS SECTION STRONG MODERATE WEAK  
See dictionary 1 2 3  
 
B) STUDY DESIGN  
Indicate the study design  
1  
Randomized controlled trial  
2  
Controlled clinical trial  
3  




Cohort (one group pre + post (before and after))  
6  
Interrupted time series  
7  
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Other specify ____________________________  
 
8  
Can’t tell  
Was the study described as randomized? If NO, go to Component C.  
 
No Yes  
 
If Yes, was the method of randomization described? (See dictionary)  
No Yes  
If Yes, was the method appropriate? (See dictionary)  
No Yes  
RATE THIS SECTION STRONG MODERATE WEAK  
See dictionary 1 2 3  
 
C) CONFOUNDERS  






Can’t tell  














Health status  
8  
Pre-intervention score on outcome measure  
(Q2) If yes, indicate the percentage of relevant confounders that were controlled (either in 
the design (e.g. stratification, matching) or analysis)?  
1  
80 – 100%  
2  
60 – 79%  
3  
Less than 60%  
4  
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Can’t Tell  
 
RATE THIS SECTION STRONG MODERATE WEAK  
See dictionary 1 2 3  
 
D) BLINDING  







Can’t tell  






Can’t tell  
 
RATE THIS SECTION STRONG MODERATE WEAK  
See dictionary 1 2 3  
 
E) DATA COLLECTION METHODS  






Can’t tell  






Can’t tell  
RATE THIS SECTION STRONG MODERATE WEAK  
See dictionary 1 2 3  
 
F) WITHDRAWALS AND DROP-OUTS  
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No  
3  
Can’t tell  
(Q2) Indicate the percentage of participants completing the study. (If the percentage differs 
by groups, record the lowest).  
1  
80 -100%  
2  
60 - 79%  
3  
less than 60%  
4  
Can’t tell  
 
RATE THIS SECTION STRONG MODERATE WEAK  
See dictionary 1 2 3  
 
G) INTERVENTION INTEGRITY  
(Q1) What percentage of participants received the allocated intervention or exposure of 
interest?  
1  
80 -100%  
2  
60 - 79%  
3  
less than 60%  
4  
Can’t tell  






Can’t tell  
(Q3) Is it likely that subjects received an unintended intervention (contamination or co-






Can’t tell  
 
RATE THIS SECTION STRONG MODERATE WEAK  
See dictionary 1 2 3  
 
H) ANALYSES  
(Q1) Indicate the unit of allocation (circle one)  
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community organization/institution practice/office individual  
(Q2) Indicate the unit of analysis (circle one)  
community organization/institution practice/office individual  
 






Can’t tell  
(Q4) Is the analysis performed by intervention allocation status (i.e. intention to treat) 






Can’t tell  
RATE THIS SECTION STRONG MODERATE WEAK  




COMPONENT RATINGS  
Please transcribe the information from the component ratings of each section here 
(STRONG, MODERATE, WEAK).  
 
A. SELECTION BIAS  
B. STUDY DESIGN  
C. CONFOUNDERS  
D. BLINDING  
E. DATA COLLECTION METHODS  
F. WITHDRAWALS AND DROPOUTS  
 
GLOBAL RATING FOR THIS PAPER (circle one):  
 
1 STRONG (four STRONG ratings with no WEAK ratings)  
2 MODERATE (less than four STRONG ratings and one WEAK rating)  
3 WEAK (two or more WEAK ratings)  
 
With both reviewers discussing the ratings:  
Is there a discrepancy between the two reviewers with respect to the component (A-F) 
ratings?  
No  Yes  
If yes, indicate the reason for the discrepancy  
1 Oversight  
2 Differences in interpretation of criteria  
3 Differences in interpretation of study  
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Final decision of both reviewers (circle one):  
1 STRONG  
2 MODERATE  
3 WEAK  
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Appendix 3.3: Published Journal Article 
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A full version of this article is freely accessible via URL: 
http://dx.doi.org/10.1080/15245004.2010.546941 
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Appendix 4.1: Methods of contraception in use in the UK 
and their effectiveness 
 
Methods of Contraception Description Effectiveness 
Emergency Contraceptive Used by women to prevent pregnancy after having 
unprotected sex, or if a method of contraception has failed. 
There are two methods of emergency contraception: 
 The emergency contraceptive pill (the morning-after 
pill). Available as  Levonelle and ellaOne in the UK 
 The copper intrauterine device (IUD)  
 
The effectiveness of the 
emergency contraceptive pill 
decreases over time. If it is taken 
within 24 hours of having 
unprotected sex, it is effective in 
preventing 95% of pregnancies. 
 
The IUD stops sperm from 
reaching an egg and fertilising it. 
It is the most effective method of 
emergency contraception and 
prevents up to 99% of 
pregnancies. 
Male and Female 
Condoms 
Condoms are a form of barrier contraception. They prevent 
pregnancy by stopping sperm from reaching an egg. 
 
There are many different varieties and brand names of the 
male condom. At the moment there is only one brand of 
female condom available in the UK, called Femidom. 
If used correctly, male condoms 
are 98% effective in preventing 
pregnancy. Female condoms are 




The combined oral contraceptive pill is usually just called the 
Pill. It contains synthetic (artificial) versions of the female 
hormones oestrogen and progesterone, which women 
produce naturally in their ovaries. There are mainly three types 
in use in the UK: 
 Monophasic 21-day pills (the most common type). 
Each pill has the same amount of hormone in it. 
Examples include; Microgynon, Brevinor and 
Cilest. 
 Phasic 21-day pills. Phasic pills contain two or three 
different amounts of hormones. Examples include; 
Binovum and Logynon.  
 Every Day (ED) pills. There are 21 active pills and 
seven inactive (dummy) pills in a pack. Examples 
are Microgynon ED and Logynon ED.  
 
When taken correctly, the Pill is 




There are two different types of progestogen-only pills, which 
must be taken at different times of the day: 
 The three-hour progestogen-only pill - must be 
taken within three hours of the same time each 
day. Examples are Femulen, Micronor, Norgeston 
and Noriday.  
 The 12-hour progestogen-only pill (Cerazette) - must 
be taken within 12 hours of the same time each 
day. It is less commonly used than the three-hour 
pill.  
When taken correctly, the 
progestogen-only pill is over 99% 
effective at preventing 
pregnancy. 
Contraceptive Implants 
and Injections  
Implants 
There is currently one type of contraceptive implant used in 
the UK called Implanon. Implanon is a small (4cm), thin 
flexible tube. It is implanted under the skin of a woman’s 
upper arm by a doctor or nurse. Implanon works for up to 
three years before it needs to be replaced.  
 
Injections 
The contraceptive injection is usually given intramuscularly. 
There are two types available:  
 Depo-Provera is the most commonly used injection 
in the UK and is effective for up to 12 weeks, after 
which another injection is given.  
 Noristerat is effective for up to eight weeks.  
 
Contraceptive implants and 
injections are long-acting, 
effective methods of 
contraception. They are over 
99% reliable in preventing 
pregnancy. 
Contraceptive patch The contraceptive patch is a small, thin, beige patch about 
5cm by 5cm in size. It is stuck onto the skin and it releases 
two hormones – oestrogen and progestogen – through the 
skin and into the bloodstream. These are the same 
hormones as those used in the combined oral contraceptive 
pill. The hormones prevent ovaries releasing an egg 
If used properly, the 
contraceptive patch is over 99% 
effective in preventing pregnancy. 
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(ovulation) and stops pregnancy. The patch needs to be 
changed for a new one each week.  
 
Diaphragms and Caps Diaphragms and caps stop sperm reaching an egg by 
covering the cervix. To be effective in preventing pregnancy, 
they need to be used in combination with spermicide, a 
chemical that kills sperm. 
 
If used correctly and in 
combination with spermicide, 
diaphragms and caps are 
estimated to be 92-96% effective 
in preventing pregnancy. 
 
Intrauterine device (IUD) An IUD is a small, T-shaped contraceptive device made from 
plastic and copper that fits inside the womb (uterus). It used 
to be called a coil or a loop. An IUD stops sperm from 
reaching the egg. It does this by releasing copper into the 
body, which changes the make-up of the fluids in the womb 
and fallopian tubes. These changes prevent sperm from 
fertilising eggs. IUDs may also stop fertilised eggs from 
travelling along the fallopian tubes and implanting in the 
womb. 
 
An IUD is 98–99% effective at 
preventing pregnancy. Newer 
models that contain more copper 
are the most effective (over 99% 
effective). 
Intrauterine System (IUS) An IUS is a small, T-shaped contraceptive device that fits 
inside the womb (uterus) and releases the female hormone 
progestogen into the body. The IUS that is available in the 
UK is called Mirena and works for up to five years after being 
fitted.  
The IUS is over 99% effective in 
preventing pregnancy. 
Vasectomy Vasectomy or 'male sterilisation' is a simple and reliable 
method of contraception. It is usually considered permanent, 
although in some cases the procedure can be reversed - for 
example, if the male decides to have children later on in life. 
A vasectomy is normally 
permanent, so once it has been 
carried out successfully and 
semen tests have shown there is 
no sperm present, it is over 99% 
effective. 
 
Vaginal ring The vaginal ring is a small, soft plastic ring that is placed 
inside the vagina for 21 days at a time. It’s about 4mm thick, 
and 5.5cm in diameter. The ring continually releases 
oestrogen and progestogen, which are synthetic versions of 
the hormones that are naturally released by the ovaries. This 
reduces ovulation and thickens vaginal mucus, which makes 
it more difficult for sperm to get through, and thins the lining 
of the womb so that an egg is less likely to implant there.  
 
 
If used correctly, the vaginal ring 
is more than 99% effective. 
Female sterilisation Female sterilisation is an effective and permanent form of 
contraception. The operation usually involves cutting, sealing 
or blocking the fallopian tubes, which eggs travel through 
from the ovaries to the womb. This prevents the eggs from 
reaching the sperm and becoming fertilised. 
 
Female sterilisation is more than 
99% effective, and only one in 
200 women will become pregnant 
after the operation 
Source: http://www.nhs.uk/conditions/contraception/Pages/Introduction.aspx 
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Appendix 4.2: Number & Percentage of Most Deprived 
Areas in the London Borough of Havering 
The number and percentage of Lower Super Output Areas (LSOAs) that fall in the 
most deprived 20% of LSOAs in England according to the Index of Multiple 
Deprivations (IMD) 2007 by region. 
 
Region Number of 
LSOAs in ‘most 
deprived 20% 
of LSOAs in 
England 
Number of 
LSOAs in the 
Region 
% of LSOAs in 
each Region 
falling in ‘most 
deprived 20% 













































England’s most deprived 20% of LSOAs have the following characteristics on 
average: 
 Just over a third of people (35.4%) are income deprived 
 One in five of women aged 18 to 59 and men aged 18-64 (20.3%) are 
employment deprived 
 Just under half of children (48.8%) live in families that are income deprived 
 37.5% of older people are income deprived 
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Appendix 4.3: Current contraception use among 16-24 year old women by year of survey: 
2002/03 - 2006/07 
 
1. 95% Confidence Interval 
2. Not in heterosexual relationship, sterile or partner sterile, pregnant or trying to get pregnant 
























 33.4(21.7, 31.3) 29(24.1, 34.4) 26(21.4, 31.2) 25(19.4, 31.6) 24.3(18.9, 30.6) 
 
Male Condom 26.3(21.7, 31.3) 30(25, 35.4) 29.3(24.4, 34.6) 33(26.7, 40) 32.2(26.1, 38.9) 
 
Pill 31.6(26.7, 36.8) 31.6(26.6, 37.1) 31.3(26.3, 36.7) 30.9(24.7, 37.8) 27.2(21.6, 33.7) 
 
IUD 2.2(1.1, 4.4) 1(0.3, 2.9) 2(0.9, 4.2) 0.5(0.1, 3.0) 3.5(1.7, 7.0) 
 
IUS 0.6(0.2, 2.2) 0.7(0.2, 2.4) 0.3(0.1, 1.8) 0 1(0.3, 3.5) 
 
Injection 2.8(1.5, 5.3) 4(2.3, 6.9) 7.6(5.1, 11.1) 3.2(1.5, 6.8) 5(2.7, 8.9) 
 




 3.1(1.7, 5.7) 3.7(2.1, 6.5) 3.3(1.8, 5.9) 3.2(1.5, 6.8) 3(1.4, 6.3) 
Total number of  women 320 297 304 188 202 
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Appendix 4.4: Current contraception use among 16-17 year old women by year of survey: 
2002/03 - 2006/07 
 
 
1. 95% Confidence Interval 
2. Not in heterosexual relationship, sterile or partner sterile, pregnant or trying to get pregnant 
























 56.6(43.3, 69) 46.0(34.3, 58.2) 42.4(30.6, 55.1) 44.1(28.9, 60.5) 44.1(30.4, 58.9) 
 
Male Condom 22.6(13.5, 35.5) 23.8(15.0, 35.6) 32.2(21.7, 44.9) 41.2(26.4, 57.8) 32.6(20.5, 47.5) 
 
Pill 18.9(10.6, 31.4) 19.0(11.2, 30.4) 23.7(14.7, 36) 2.9(0.5, 14.9) 11.6(5.1, 24.5) 
 
IUD 0.0 1.6(0.3, 8.5) 1.7(0.3, 9.0) 0.0 4.7(1.3, 15.5) 
 
IUS 0.0 0.0 0.0 0.0 0.0 
 
Injection 0.0 3.2(0.9, 10.9) 0.0 2.9(0.5, 14.9) 2.3(0.4, 12.1) 
 




 1.9(0.3, 9.9) 4.8(1.6, 13.1) 0.0 2.9(0.5, 14.9) 2.3(0.4, 12.1) 
Total number of  women 53 63 59 34 43 
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 Appendix 4.5: Current contraception use among 18-19 year old women by year of survey: 
2002/03 - 2006/07 
 
 
1. 95% Confidence Interval 
2. Not in heterosexual relationship, sterile or partner sterile, pregnant or trying to get pregnant 
























 34.3(24.1, 46.3) 28.8(18.8, 41.4) 27.3(17.3, 40.2) 29.2(14.9, 49.2) 32.5(20.1, 48.0) 
 
Male Condom 28.4(19.0, 40.1) 33.9(23.1, 46.6) 29.1(18.8, 42.1) 37.5(21.2, 57.3) 37.5(24.2, 53.0) 
 
Pill 28.4(19.0, 40.1) 35.6(24.6, 48.3) 30.9(20.3, 44.0) 20.8(9.2, 40.5) 17.5(8.7, 31.9) 
 
IUD 1.5(0.3, 8.0) 0 0 0 5(1.4, 16.5) 
 
IUS 0 0 0 0 0 
 
Injection 3(0.8, 10.2) 1.7(1.3, 9.0) 7.3(2.9, 17.3) 4.2(0.7, 20.2) 5(1.4, 16.5) 
 




 4.5(1.5, 12.4) 0 3.6(1.0, 12.3) 0 0 
Total number of  women 67 59 55 24 40 
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Appendix 4.6: Current contraception use among 20-24 year old women by year of survey: 
2002/03 - 2006/07 
 
 
1. 95% Confidence Interval 
2. Not in heterosexual relationship, sterile or partner sterile, pregnant or trying to get pregnant 

























 26.9(21.2, 33.4) 22.6(17.1, 29.3) 20.5(15.4, 26.8) 19.2(13.4, 26.8) 17.6(11.8, 25.5) 
 
Male Condom 26.4(20.8, 32.9) 50.3(43.0, 57.6) 28.4(22.5, 35.2) 30(22.8, 38.4) 30.3(22.7, 39.0) 
 
Pill 35.8(29.5, 42.7) 53.1(45.8, 60.3) 33.7(27.3, 40.7) 40(32.0, 48.6) 36.1(28.1, 45.1) 
 
IUD 3(1.4, 6.4) 1.1(0.3, 4.0) 2.6(1.1, 6.0) 0.8(0.1, 4.2) 2.5(0.9, 7.2) 
 
IUS 1(0.3, 3.6) 1.1(0.3, 4.0) 0.5(0.1, 2.9) 0 1.7(0.5, 5.9) 
 
Injection 3.5(1.7, 7.0) 5.1(2.7, 9.4) 10(6.5, 15.1) 3.1(1.2, 7.6) 5.9(2.9, 11.6) 
 




 3(1.4, 6.4) 2.3(0.9, 5.7) 4.2(2.1, 8.1) 2.3(0.8, 6.6) 2.5(0.9, 5.7) 
Total number of  women 200 175 190 130 119 
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Appendix 4.7: Current use of LARC or Non-LARC methods among 16-24, 16-19 & 20-24 
year old women by year of survey: 2002/03 - 2006/07 





























 60.9(55.5, 66.1) 65.3(59.7, 70.5) 63.8(58.3, 69) 67(60, 73.3) 62.4(55.5, 68.8) 









 43.4(31, 56.7) 49.2(37.3, 61.2) 55.9(43.3, 67.8) 50(34.1, 65.9) 44.2(30.4, 58.9) 









 61.2(49.2, 72) 69.5(56.9, 79.7) 65.5(52.3, 76.6) 62.5(42.7, 78.8) 60(44.6, 73.7) 









 65.5(58.7, 71.7) 69.7(62.5, 76.0) 66.1(59.1, 72.5) 72.3(64.1, 79.3) 69.7(61.0, 77.3) 
Total number 200 175 190 130 119 
 
1. 95% Confidence Interval 
2. Intrauterine device (IUD), Intrauterine system (IUS), Injection & Implant 
3. Male Condom, Pill & Others 
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Appendix 4.8: The ONS Opinion Contraception Module 
Survey Questionnaire 
 
IF: Men under 70 OR women under 50 
Introduction  
The next set of questions are for you to fill in yourself on the computer. I will show you how to answer the first two 
questions and then be here if you need any help.  
This section is being asked on behalf of the Department of Health and begins with ways of preventing pregnancy.  
EXPLAIN THAT INSTRUCTIONS WILL APPEAR ON THE SCREEN AND THEN WORK THROUGH THE FIRST 
2 QUESTIONS WITH THE INFORMANT. IF THE INFORMANT MAKES A MISTAKE TAKE HIM/HER BACK TO 
THE QUESTION AND ALLOW HIM/HER TO KEY IN THE RIGHT ANSWER.  
IF RESISTANCE/DISTRESS ABOUT USING THE COMPUTER THEN YOU CAN SUGGEST THAT YOU CARRY 
ON ASKING THE QUESTIONS  
(1) Self-completion accepted and completed  
(2) Completed by interviewer  
(3) Section refused  
 
ASK IF: Men under 70 OR women under 50  
AND: Elected self-completion  
Pract1  
This is the first time I have used a computer  
(1) Yes  
(2) No  
 
ASK IF: Men under 70 OR women under 50 
AND: Elected self-completion  
Pract2  
On which days of the week do you watch television?  
SET [9] OF  
(1) Monday  
(2) Tuesday  
(3) Wednesday  
(4) Thursday  
(5) Friday  
(6) Saturday  
(7) Sunday  
(8) I do not have a television/don’t watch the television  
(9) I mostly only listen to the radio  
 
ASK IF: Men under 70 OR women under 50  
M170_1  
Have you had a vasectomy? / 
Have you ever been sterilised - I mean have you ever had an operation intended to prevent you getting pregnant?  
(DO NOT INCLUDE HYSTERECTOMIES) 
(1) Yes  
(2) No  
 
ASK IF: Men under 70 OR women under 50 
AND: Has had an operation to prevent pregnancy  
M170_2  
Was that operation carried out under the NHS or not?  
(1) Yes  
(2) No  
 
ASK IF: Men under 70 OR women under 50 
AND: Has had an operation to prevent pregnancy  
M170_3  
Was the operation more or less than two years ago, that is before or after June 2002?  
(1) More than 2 years ago  
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ASK IF: Men under 70 OR women under 50 
AND: NOT (has had an operation to prevent pregnancy)  
M170_4  
Have you had any other operation which prevents you getting someone pregnant / becoming pregnant?  
(1) Yes  
(2) No  
 
ASK IF: Men under 70 or women under 50 
AND: NOT (Has had an operation to prevent pregnancy)  
AND: Had other operation preventing pregnancy  
M170_5  
Was the operation more or less than two years ago, that is before or after June 2002  
(1) More than 2 years ago  
(2) Less than 2 years ago  
 
ASK IF: Women under 50 
AND: No operation  
M170_6M  
SHOWCARD C170.6  
Here is a list of possible ways of preventing pregnancy. Which, if any, do you (and your partner) usually use at present?  
SET [3] OF  
(1) No method used – no sexual relationship with someone of  
the opposite sex 
(2) No method used – partner sterilised / had a vasectomy  
(3) No method used – other reasons  
(4) Withdrawal  
(5) Male sheath/condom  
(6) Safe period/rhythm method/Persona  
(7) Cap/Diaphragm  
(8) Pill  
(9) IUD/coil/intra-uterine device  
(10) Hormonal IUS – MIRENA  
(11) Foams/gels/sprays/pessaries (spermicides)  
(12) Going without sexual intercourse to avoid pregnancy  
(13) Female condom  
(14) Injections/implants 
(15) Emergency contraception (morning after pill)  
(16) Another method  
 
ASK IF: Women under 50 
AND: No operation  
AND: Used another method  
SPEC6  
What other method is used?  
 
ASK IF: Women under 50 
AND: No operation  
AND: Used the pill  
M170_7  
SHOWCARD C170.7  
Is the pill you take one of the brands listed here: (Micronor, Noriday, Femulem, Microval, Norgesten, Neogest?)  
These are progestogen only pills (sometimes known as the mini- pill) as opposed to combined pills.  
(1) Yes  
(2) No  
(3) Not sure  
 
ASK IF: Women under 50 
AND: No operation  
AND: More than one method used  
M170_8  
You have mentioned that you usually use more than one method. Do you use them in combination or do you sometimes 
use one and sometimes the other?  
(1) In combination  
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ASK IF: Women under 50 
AND: No operation  
AND: More than one method used  
AND: Sometimes one, sometimes other  
M170_9  
SHOWCARD C170.9  
Which one do you use most often?  
(4) Withdrawal  
(5) Male sheath/condom  
(6) Safe period/rhythm method/Persona  
(7) Cap/Diaphragm  
(8) Pill  
(9) IUD/coil/intra-uterine device  
(10) Hormonal IUS – MIRENA  
(11) Foams/gels/sprays/pessaries (spermicides)  
(12) Going without sexual intercourse to avoid pregnancy  
(13) Female condom  
(14) Injections/implants  
(15) Emergency contraception (morning after pill)  
(16) Another method  
 
 
ASK IF: Women under 50 
AND: No operation  
AND: Have a heterosexual relationship  
M170_10  
How long have you not been using a method / has this method been your usual one / have these methods been your usual 
ones?  
(1) Less than 3 months  
(2) At least 3 months, less than 6 months  
(3) At least 6 months, less than 1 year  
(4) At least 1 year, less than 2 years  
(5) At least 2 years, less than 5 years  
(6) 5 years or more  
 
ASK IF: Women under 50  
AND: No operation 
AND: Have a heterosexual relationship  
AND: No method used (Other reason) 
M170_11  
SHOWCARD C170.11  
Here is a list of reasons why people do not use any method for preventing pregnancy. Which of these reasons applies to 
you?  
CODE MAIN REASON ONLY  
(1) I am pregnant  
(2) I want to become pregnant  
(3) Unlikely to conceive because of the menopause  
(4) Unlikely to conceive because possibly infertile  
(5) Don’t like contraception/Find methods unsatisfactory  
(6) My partner doesn’t like – or won’t use – contraception 
(7) Don’t know where to obtain contraceptives / advice  
(8) Find access to contraceptive services difficult  
(9) Some other reason  
 
ASK IF: Women under 50 
AND: No operation  
AND: Have a heterosexual relationship  
AND: No method used  
AND: Some other reason in M170_11 
SPEC11  
RECORD OTHER REASON  
 
ASK IF: Women under 50 
AND: No operation  
AND: No method used or no heterosexual relationship  
M170_12  
Have you used any method of contraception in the last 2 years?  
(1) Yes  
(2) No  
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ASK IF: Women under 50  
AND: No operation  
AND: No method used or no heterosexual relationship  
AND: Has used methods in last 2 years  
M170_13M  
SHOWCARD C170.13  
Which method(s) did you usually use?  
SET [3] OF  
(4) Withdrawal  
(5) Male sheath/condom  
(6) Safe period/rhythm method/Persona  
(7) Cap/Diaphragm  
(8) Pill  
(9) IUD/coil/intra-uterine device 
(10) Hormonal IUS – MIRENA  
(11) Foams/gels/sprays/pessaries (spermicides)  
(12) Going without sexual intercourse to avoid pregnancy  
(13) Female condom  
(14) Injections/implants  
(15) Emergency contraception (morning after pill)  
(16) Another method  
 
 
ASK IF: Women under 50 
AND: Operation less than 2 years ago, or heterosexual relationship now  
and usual method less than 5 years 
M170_14M  
SHOWCARD C170.14  
Which method(s) of contraception / if any did you use immediately before that?  
SET [3] OF  
(1) No method used – no sexual relationship with someone of  
the opposite sex 
(2) No method used – partner sterilised / had a vasectomy  
(3) No method used – other reasons  
(4) Withdrawal  
(5) Male sheath/condom  
(6) Safe period/rhythm method/Persona  
(7) Cap/Diaphragm  
(8) Pill  
(9) IUD/coil/intra-uterine device  
(10) Hormonal IUS – MIRENA  
(11) Foams/gels/sprays/pessaries (spermicides)  
(12) Going without sexual intercourse to avoid pregnancy  
(13) Female condom  
(14) Injections/implants  
(15) Emergency contraception (morning after pill)  
(16) Another method  
 
ASK IF: Women under 50 
AND: Operation less than 2 years ago, or heterosexual relationship now and usual method less than 5 years 
AND: Used the pill (at M170_14M) 
M170_15  
SHOWCARD C170.15  
Is the pill you took one of the brands listed on this card? These are progesterone only pills (sometimes known as the 
mini-pill) as opposed to combined pills?  
(1) Yes  
(2) No  
(3) Not sure  
 
ASK IF: Women under 50 
AND: No operation and method used  
AND: Method at 6 not the same as method at 14  
M170_16  
Did the change in method happen because you began a relationship with a different partner?  
(1) Yes  
(2) No  
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ASK IF: Women under 50 
AND: No operation and method used  
AND: Method at 6 not the same as method at 14  
M170_17  
[*] Compared with the method(s) you used before, do you think the method(s) you are using now is/are:  
More reliable in preventing pregnancy?  
(1) Yes  
(2) No  
 
ASK IF: Women under 50 
AND: No operation and method used  
AND: Method at 6 not the same as method at 14  
M170_18  
[*] (Compared with the method(s) you used before, do you think the method(s) you are using now is/are:)  
...more convenient to use?  
(1) Yes  
(2) No  
 
ASK IF: Women under 50 
AND: No operation and method used  
AND: Method at 6 not the same as method at 14  
M170_19  
[*] (Compared with the method(s) you used before, do you think the method(s) you are using now is/are:)  
...better for your long-term health?  
(1) Yes  
(2) No  
 
ASK IF: Women under 50  
AND: No operation and method used  
AND: Method at 6 not the same as method at 14  
M170_20  
[*] (Compared with the method(s) you used before, do you think the method(s) you are using now is/are:)  
...better for protecting against sexually transmitted infections (including HIV/AIDS)?  
(1) Yes  
(2) No  
 
ASK IF: Women under 50 
AND: No operation and method used  
AND: Method at 6 not the same as method at 14  
M170_21  
SHOWCARD C170.21 
Which was the main reason for changing your method of contraception?  
(1) Different partner  
(2) More reliable in preventing pregnancy  
(3) More convenient to use  
(4) Better for long-term health  
(5) Better for protecting against infections  
(6) Some other reason 
 
ASK IF: Women under 50 
AND: No operation and method used  
AND: Method at 6 not the same as method at 14  
M170_22  
Were you at all influenced to make the change by advice from a GP or Family Planning Clinic?  
(1) Yes  
(2) No  
 
ASK IF: Women under 50 who have not had operation or had operation less than 2 years ago  
M170_23  
Some of the previous questions referred to emergency contraception after unprotected sex. There are two kinds of 
emergency contraception. One is a pill based method, sometimes known as the ‘morning after’ pill. The other is an IUD 
(intra-uterine device) method. Before reading about it here, had you heard of the pill method of emergency contraception 
after intercourse?  
(1) Yes  
(2) No  
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ASK IF: Women under 50 who have not had operation or had operation less than 2 years ago  
AND: Has heard of emergency pill  
M170_24  
SHOWCARD C170.24  
[*] If no other method of contraception has been used, how long after sexual intercourse has taken place do you think that 
the pill method of emergency contraception can be used?  
(1) Up to 12 hours  
(2) Up to 24 hours  
(3) Up to 72 hours  
(4) Up to 5 days  
(5) Over 5 days  
(6) Don’t know  
 
ASK IF: Women under 50 who have not had operation or had operation less than 2 years ago  
AND: Has heard of emergency pill  
M170_24M  
SHOWCARD C170.24M  
[*] Which of the following statements about emergency contraception do you think is true?  
SET [7] OF  
(1) The emergency pill has no identified harmful long-term side-effects  
(2) The emergency pill can still be effective taken at any time up to 72 hours after intercourse  
(3) The emergency pill can sometimes cause nausea / make you feel sick  
(4) The emergency pill is more effective the sooner it is taken after intercourse  
(5) The emergency pill is safer and more effective than it has been in the past  
(6) The emergency pill protects against sexually transmitted infections (STIs) 
(7) The emergency pill protects against pregnancy until the next period 
(8) None of these  
 
ASK IF: Women under 50 who have not had operation or had operation less than 2 years ago  
AND: Has heard of emergency pill  
M170_25  
SHOWCARD C170.25 
Have you used the emergency contraception pill in the last year?  
(1) Yes  
(2) No  
 
ASK IF: Women under 50 who have not had operation or had operation less than 2 years ago  
AND: Has heard of emergency pill  
AND: Has used emergency pill  
M170_26  
SHOWCARD C170.26  
On how many occasions in the last year have you used the emergency contraception pill?  
1...50  
 
ASK IF: Women under 50 who have not had operation or had operation less than 2 years ago  
AND: Has heard of emergency pill  
AND: Has used emergency pill  
M170_27M  
SHOWCARD C170.26  
Where did you go for this?  
SET [7] OF  
(1) Your own GP or practice nurse 
(2) Another GP or practice nurse 
(3) Family Planning Clinic, (including Brook Clinics)  
(4) Hospital Accident & Emergency Department  
(5) Directly to a chemist or pharmacy 
(6) A walk-in centre or minor injuries unit 
(7) Somewhere else  
 
ASK IF: Women under 50 who have not had operation or had operation less than 2 years ago  
AND: Has heard of emergency pill  
AND: Has used emergency pill 
M170_27A  
On the most recent occasion, did you have any difficulty in obtaining the emergency pill when you needed it?  
(1) Yes  
(2) No  
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ASK IF: Men aged 16–69 or women aged 16–49  
AND: Interviewing  
AND: Women aged 16 to 49 who have not had operation or had less than 2 years ago 
AND: Has heard of emergency pill  
AND: has used emergency pill 
AND: got emergency pill directly to a chemist or pharmacy  
M170_27B 
Did you buy the emergency pill yourself or did the pharmacist supply it to you free of charge under NHS arrangements?  
(1) Bought emergency pill  
(2) NHS Supplied free of charge under NHS arrangements 
 
ASK IF: Women under 50 who have not had operation or had operation less than 2 years ago  
AND: Has heard of emergency pill  
AND: Has not used emergency pill 
M170_28M  
SHOWCARD C170.28  
If someone were to need the emergency contraception pill where do you think they would be able to obtain it?  
SET [7] OF  
(1) Your own GP or practice nurse 
(2) Another GP or practice nurse 
(3) Family Planning Clinic (including Brook Clinics)  
(4) Hospital Accident & Emergency Department  
(5) Directly from a chemist or pharmacy 
(6) A walk-in centre or minor injuries unit 
(7) Somewhere else 
(8) Would not use  
 
ASK IF: Women under 50 who have not had operation or had operation less than 2 years ago  
M170_29  
Before (I mentioned it/you read about it here), had you heard of the IUD method of emergency contraception after 
intercourse?  
(1) Yes  
(2) No  
 
ASK IF: Women under 50 who have not had operation or had operation less than 2 years ago  
AND: Has heard of emergency IUD  
M170_30  
SHOWCARD C170.24  
[*] If no other method of contraception has been used, how long after sexual intercourse has taken place do you think that 
an IUD can be fitted as an emergency method of contraception?  
(1) Up to 12 hours  
(2) Up to 24 hours  
(3) Up to 72 hours  
(4) Up to 5 days  
(5) Over 5 days  
(6) Don’t know  
 
ASK IF: Women under 50 who have not had operation or had operation less than 2 years ago  
AND: Has heard of emergency IUD 
M170_31  
SHOWCARD C170.31  
Have you had an IUD fitted for emergency contraception in the last year?  
(1) Yes  
(2) No  
 
ASK IF: Women under 50 who have not had operation or had operation less than 2 years ago  
AND: Has heard of emergency IUD 
M170_35M  
SHOWCARD C170.35  
Where did you go for this? / Where would someone go for this?  
SET [6] OF  
(1) Your own GP  
(2) Another GP  
(3) Family Planning Clinic (including Brook Clinics)  
(4) Hospital Accident and Emergency Department  
(5) Somewhere else  
(6) Would not use  
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ASK If: Women aged 16 to 49 who have not had operation or had operation less than 2 years ago  
AND: Has used emergency pill or had emergency IUD fitted  
M170_35B  
SHOWCARD C170_35B 
On the most recent occasion, what was your main reason for using emergency contraception?  
(1) Condom failure  
(2) Missed pill/ forgot to take the pill  
(3) Other routine contraceptive failure  
(4) Condom not available  
(5) I or my partner did not want to use a condom  
(6) Other reason  
 
ASK IF: Women aged 16 to 49 who have not had operation or had operation less than 2 years ago  
AND: Has used emergency pill or had emergency IUD fitted  
AND: M170_35B = Other Reason 
SPEC35B  
RECORD OTHER REASON  
ASK IF: Men under 70  
AND: Not had operation which prevents pregnancy  
M170_36M  
SHOWCARD C170.36  
Here is a list of possible ways of preventing pregnancy. Which, if any, do you (and your partner) use at present?  
SET [4] OF  
(1) The contraceptive pill  
(2) Male condom  
(3) The Female condom  
(4) Emergency contraception (morning after pill)  
(5) Another method of protection  
(6) No method  
(7) No sexual relations with a woman currently  
 
ASK IF: Men under 70  
M170_37  
SHOWCARD C170.36  
Which of the following best describes your situation?  
(1) I have had sex only with women  
(2) I have had sex only with men  
(3) I have usually had sex only with women but have had sex at  
least once with a man 
(4) I have usually had sex only with men but have had sex at  
least once with a woman  
(5) I have not (yet) had a sexual relationship  
 
ASK IF: Men under 70 or women under 50  
M170_38M  
SHOWCARD C170.38 
Have you been to any of the following to obtain contraception, for advice on contraception or preventing pregnancy, or 
for family planning purposes within the last 5 years?  
SET [6] OF  
(1) Family planning clinic (including Brook Clinics)  
(2) Your own GP or practice nurse 
(3) Another local GP or practice nurse 
(4) Directly to a chemist or pharmacy 
(5) A walk-in centre or minor injuries unit 
(6) Somewhere else 
(7) None of these  
 
ASK IF: Men under 70 or women under 50 
AND: Has been somewhere for family planning last 5 years  
AND: More than one place visited (If only one place visited then data is carried forward) 
M170_39  
Which did you visit most recently for these purposes?  
(1) Family planning clinic (including Brook Clinics)  
(2) Your own GP or practice nurse 
(3) Another local GP or practice nurse 
(4) Went directly to a chemist or pharmacy 
(5) A walk-in centre or minor injuries unit 
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(6) Somewhere else  
 
ASK IF: Men under 70 or women under 50 
AND: Has been somewhere for family planning last 5 years  
M170_40  
When did you last go there for these purposes?  
(1) Less than 3 months ago  
(2) At least 3 months but less than 6 months ago  
(3) At least 6 months but less than 1 year ago  
(4) Or at least 1 year but less than 5 years ago  
 
ASK IF: Men under 70 or women under 50 
AND: Not currently in a sexual relationship or has had an operation 
M170_50  
SHOWCARD C170.50  
Have you had any sexual partners in the last year?  
(1) Yes  
(2) No  
 
ASK IF: Men under 70 or women under 50 
AND: Currently in a sexual relationship/ had a sexual relationship in last 12 months 
AND: Has not said uses condoms (Imputed if has used condoms) 
M170_51  
SHOWCARD C170.51  
May I just check, do/did you (and/or your partner) use a condom in the last 12 months?  
Please include either male or female condoms  
(1) Yes  
(2) No  
 
ASK IF: Men under 70 or women under 50 
AND: Currently in a sexual relationship/ had a sexual relationship in last 12 months 
AND: Uses a condom  
M170_52  
SHOWCARD C170.52  
Why do/did you use a condom?  
(1) To prevent pregnancy  
(2) To prevent infection  
(3) Both to prevent pregnancy and infection  
(4) Some other reason  
 
ASK IF: Men under 70 or women under 50 
AND: Currently in a sexual relationship/ had a sexual relationship in last 12 months 
AND: Uses a condom  
M170_53  
SHOWCARD C170.53  
How regularly do/did you use a condom?  
(1) Whenever I have sexual intercourse  
(2) Usually when I have sexual intercourse  
(3) Sometimes when I have sexual intercourse  
 
ASK IF: Men under 70 or women under 50 
AND: Currently in a sexual relationship/ had a sexual relationship in last 12 months (Has had sexual partner in the last year OR 
Woman – no operation and not said no sex as reason for contraception OR Man – no operation and not said never had a sexual 
relationship)  
M170_54M  
SHOWCARD C170.54  
Has what you have heard about HIV and AIDS and other sexually transmitted infections influenced your behaviour?  
SET [3] OF  
(1) When I have sexual intercourse I use a condom more often  
than I used to  
(2) I have fewer one-night stands  
(3) When I change partners I have a test for sexually transmitted  
infections  
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ASK IF: Men under 70 or women under 50 
AND: Currently in a sexual relationship/ had a sexual relationship in last 12 months (Has had sexual partner in the last year OR 
Woman - no operation and not said no sex as reason for contraception OR Man - no operation and not said never had a sexual 
relationship) 
M170_55  
SHOWCARD C170.55  
(May I just check), How many sexual partners have you had in the last year?  
(1) 1  
(2) 2 or 3  
(4) 4 or more 
 
ASK IF: Men under 70 or women under 50 
AND: Currently in a sexual relationship/ had a sexual relationship in last 12 months (Has had sexual partner in the last year OR 
Woman - no operation and not said no sex as reason for contraception OR Man - no operation and not said never had a sexual 
relationship) 
AND: Currently in a sexual relationship 
AND: Not only one partner in M170_55 (In this case data for M170_56 are imputed) 
M170_56  
SHOWCARD C170.56  
May I just check, How many sexual partners do you currently have?  
(1) 1  
(2) 2  
(3) 3  
(4) 4 or more  
 
ASK IF: Men under 70 or women under 50  
AND: Currently in a sexual relationship/ had a sexual relationship in last 12 months (Has had sexual partner in the last year OR 
Woman – no operation and not said no sex as reason for contraception OR Man – no operation and not said never had a sexual 
relationship) 
AND: Has had 2 or more sexual partners in past 12 months and uses condom  
M170_57  
SHOWCARD C170.57  
(And may I just check), Do/did you use condoms with all your sexual partners, or with only one/some of them?  
Please include either male or female condoms.  
(1) Used condoms with all partners  
(2) Used condoms with only one/some partners  
 
ASK IF: Men under 70 or women under 50  
M170_41  
SHOWCARD C170.41  
There has been a lot of information in recent years about HIV/AIDS and about other sexually transmitted infections. 
From which source would you say you have learnt most about these?  
(1) TV advertisements  
(2) TV programmes  
(3) Newspapers, magazines or books  
(4) Your GP  
(5) Family Planning Clinic (including Brook clinics)  
(6) GUM or sexual health clinic in a hospital  
(7) Friends or family  
(8) Government information leaflet  
(9) Internet 
(10) School or college 
(11) Somewhere else  
 
ASK IF: Men under 70 or women under 50  
M170_58  
Please hand the computer back to the interviewer now.  
ASK IF: Men under 70 or women under 50  
M170_59  
INTERVIEWER: PRESS 1 TO CONTINUE 
1.2 
ASK ALWAYS:  
M170_60M  
SHOWCARD C170.60  
Which of the following are sexually transmitted infections?  
CODE ALL THAT APPLY  
SET [6] OF  
(1) Tuberculosis  
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(2) Gonorrhoea  
(3) Listeria  
(4) Chlamydia  
(5) Diabetes  
(6) None of these  
 
ASK IF: Recognised Chlamydia as STI at M170_60M  
M170_49M  
SHOWCARD C170.49  
Which of the following statements about Chlamydia do you think are true?  
CODE ALL THAT APPLY  
SET [5] OF  
(1) Chlamydia does not always cause symptoms  
(2) Chlamydia is easily treated with antibiotics  
(3) Chlamydia has no serious effects  
(4) Chlamydia can cause infertility and ectopic pregnancy if  
untreated  
(5) Chlamydia only affects men  
(6) None of these 
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Appendix 5.1: Participant Information Sheet  
 
                                                      
  
 
Title of Research Study:  Factors associated with Chlamydia screening and prevalence 
among young people in Havering. 
 
Dear Participant, 
You are being invited to take part in a research study. Before you decide whether to 
participate, it is important for you to understand why the research is being done and what it 
will involve. Please take time to read the following information carefully and ask me if 
there is anything that is not clear or if you would like more information. Take time to 
decide whether or not you wish to take part. 
 
What is the purpose of the study? 
This study is being undertaken in part fulfilment of a Doctorate in Public Health for the 
researcher (Anthony Wakhisi) who is a student at Brunel University. He is also an 
employee of NHS Havering where he works as a Public Health Information Analyst. The 
study aims to identify barriers and motivating factors among young people as regards their 
decision to get tested for Chlamydia. This will enable health workers at NHS Havering to 
facilitate more effective services that encourage more young people to get tested and 
improve their sexual health. 
 
Why have I been chosen? 
You have been chosen to take part in this study because you are within the age category of 
individuals who are most affected by Chlamydia infection (16 – 24 years). 
 
What will I have to do if I take part? 
You will participate in a group discussion which will involve about five other young 
people and two researchers if you have never been screened for Chlamydia. If you have 
been screened in the past, you will be taking part in an interview with a researcher. Group 
discussions/interviews will be held during your free time. This is likely to be in the 
evenings on weekdays or Saturday so as not to interrupt your attendance of other organized 
activities. The venue will be at either Havering college in Hornchurch or the Youth zone 
Information Centre at Romford. Sessions will be will last approximately 60 to 90 minutes 
and will mainly be about the existing barriers and motivating factors as regards access to 
Chlamydia screening for young people in Havering, and what can be done to improve the 
same. The researcher would like to use direct quotations in the write up and possible 
publication of this study. He will therefore request you and other participants to sign a 
consent form to indicate that you understand this will happen and have no objection. In 
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order to ensure the information is accurate, the session will be recorded on a digital voice 




What are the possible benefits of taking part? 
There is no direct benefit resulting from your participation in this study. However your will 
be offered a £10 gift voucher at the end of the study as a token of appreciation for your 
participation. Otherwise your contribution in this study will help health workers at NHS 
Havering to improve Chlamydia screening services for you and other young people living 
in Havering.  
 
What are the possible disadvantages or risks of taking part? 
There is no discomfort or disadvantage involved in this study. The researcher will expect 
you to respond to questions or get involved in discussion topics that you are comfortable 
with. However in case the interview/discussion raises issues you may find embarrassing or 
upsetting, you will be at liberty to leave if you so wish. In case you require further support 
at any stage or at the end of the session, the researcher will intervene and provide contacts 
for local institutions that may provide further help. All that will be discussed during the 
interview or in groups will be confidential. However, any disclosures which raise concerns 
about your safety or that of others will have to be passed on to appropriate authorities 
because of duty of care or in the public interest. At the end of focus group discussions, one 
of the researchers will read out the emerging key issues to be confirmed by members of the 
group. 
 
Do I have to take part? 
You are under no obligation to participate in this study. If you do decide to take part, you 
are free to withdraw at any time without giving a reason. If you do not take part or 
withdraw from the study at a later date, it will not disadvantage you in any way. 
  
What will happen to the information collected from the discussions?  
Your participation in this study and all information collected will be kept strictly 
confidential. The consent form you will be asked to sign will be the only written record of 
your full name associated with your participant record. Written records of the discussion 
will be labelled with your participant code only to ensure confidentiality. The digital voice 
recording of the discussions will be stored on a computer at NHS Havering and will only 
be accessed by the researcher. The voice recording will be deleted after a maximum period 
of five years. Consent forms will be kept in a locked filing cabinet at NHS Havering for a 
maximum of five years as well, after which time they will be shredded/ destroyed. All 
other information about you which is shared with others, for example any quotes that you 
may say during the discussion will be included in the dissertation write up and any 
subsequent publications will have your name and any other details about you removed so 
that you can not be recognized from it. This information will be identified by your 
participant code only. 
 
What will happen to the results of this research? 
The findings from this study will be utilized by the Havering Chlamydia screening team to 
improve their screening services for young people. The findings will also be used for the 
researcher’s doctorate dissertation and may later be submitted for publication in a peer 
reviewed journal.  
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Who has approved this research? 
This study has been approved by the School of Health Sciences and Social Care Research 
Ethics Committee, Brunel University and the Outer North East London National Health 
Service Research Ethics Committee. 
 




Public Health Directorate, NHS Havering, St. Georges Hospital, Suttons Lane, 
Hornchurch, RM12 6RS, Tel. 01708465610 
Email: anthony.wakhisi@havering.nhs.uk 
 
Academic Supervisor’s Contact: 
Dr Geraldine Barrett 
School of Health Sciences & Social Care, Brunel University, Uxbridge, Middlesex, UB8 
3PH 
Tel: 01895268740 Email: geraldine.barrett@brunel.ac.uk 
NHS Havering Supervisor’s Contact: 
Dr Louise Dibsdall 
Public Health Directorate, NHS Havering, St. Georges Hospital, Suttons Lane, 
Hornchurch, RM12 6RS, Tel: 01708465610 
Email: louise.dibsdall@havering.nhs.uk 
 
If you have any concerns or complaints about the conduct of this research, please 
contact: 
Elizabeth Cassidy, 
Chair, School of Health Sciences and Social Care Research Ethics Committee,  
Brunel University  
Tel: 01895 268736 
Email: elizabeth.cassidy@brunel.ac.uk  
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Appendix 5.2: Participant Consent Form 
                                                      
 
Title of research study: Factors associated with Chlamydia screening and prevalence 
among young people in Havering. 
 
 Initial box to agree 
 
I understand that my participation in this study is completely voluntary and 
that I can withdraw at any time without giving reason 
 
     
I confirm that I have read and understood the information sheet provided 
for this study 
 
     
I confirm that the researcher has explained the nature and purpose of the 
study and I have had an opportunity to ask questions 
 
     
I give permission for any quotes taken from the discussions to be used in 
the final report 
 
     
I understand that I will only be identified by my participant code printed at 
the bottom of this sheet 
 
     
I understand that this consent form and CD recording of the discussion will 
be kept in a locked filing cabinet according to the Data Protection Act 1998 
 
     
I know who to contact if I have any question/concerns about participation 
and I have their contact details 
 
     
I hereby fully and freely consent to take part in this study 




_____________________________              _____________________    ______________ 





_____________________________              _____________________  _______________ 
            PRINT NAME    SIGNED   DATE 
 
Participant code _________________________________________ 
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Appendix 5.3: Parent/Carer Consent Form 
                                                          
 
Title of research study:  Factors associated with Chlamydia screening and prevalence 
among young people in Havering. 
 
 
 Initial box to agree 
 
I understand that the participation of my child in this study is completely 
voluntary and that he/she can withdraw at any time without giving reason 
 
     
I confirm that I have read and understood the information sheet provided 
for this study 
 
     
I confirm that the researcher has explained the nature and purpose of the 
study and I have had an opportunity to ask questions 
 
     
I give permission for any quotes taken from the discussions to be used in 
the final report 
 
     
I understand that my child will only be identified by his/her participant 
code printed at the bottom of this sheet 
 
     
I understand that consent form and CD recording of the discussion will be 
kept in a locked filing cabinet according to the Data Protection Act 1998 
 
     
I know who to contact if I have any question/concerns about my child’s 
participation and I have their contact details 
 
     
I hereby fully and freely give  consent for my child to take part in this study 
      
PARTICIPANT 
 
_____________________________        _________________    _______________ 




_____________________________          _________________     _______________ 
            PRINT NAME   SIGNED  DATE 
 
Participant code _________________________________________ 
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Appendix 5.4: Participant Description 
 



























For official use only 
 
Venue of FGD/Interview -------------------------------------------------------------------------------
--- 
 
Date & Time of FGD/Interview -----------------------------------------------------------------------
--- 
 
Tape recorded? Yes / No 
 
Identification number of FGD/Interview (This number should be used on all pages of notes 
and transcripts of this FGD/Interview) --------------------------------------------------------------
---- 
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Appendix 5.5: Focus Group Discussion Topic Guide 
Background information 
 Reminder on voluntary participation 
 Discuss confidentiality. 
 Purpose of group discussion 
 Introductions  
Main topics 
About Knowledge of Chlamydia 
 What is your understanding of the term Chlamydia? 
 What are the symptoms of Chlamydia infection 
 How is Chlamydia spread? 
 Can Chlamydia be treated? 
 How did you know about Chlamydia? 
 Do you think Chlamydia is a common problem among young people in Havering? 
 
About Chlamydia Screening 
 What do you know about screening tests for Chlamydia? 
 Why do some young people get tested for Chlamydia? 
 What discourages other young people from getting tested for Chlamydia? 
 What can health workers do to encourage more young people to get tested for 
Chlamydia? 
 
About emotional reaction to Chlamydia diagnosis 
 If you were tested for Chlamydia and found positive, how would you feel? 
 How would you feel about telling your partner? 
 What kind of support would you need from health workers? 
 
About access to information and services 
 What do you think you and other young people should be told about Chlamydia? 
 Where would you like to access this information? 
 
About Chlamydia screening sites 
 What are the places you can get a screening kit in Havering? 
 Where would you be comfortable acquiring one? (pharmacy, GP surgery, 
School/college nurse, youth club, sexual health clinic, local hospital) 
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Appendix 5.6: Interview Topic Guide 
Background information 
 Introduction 
 Reminder on voluntary participation  
 Reassurance of confidentiality 
 Purpose of  interview 
 
Main topics 
About Knowledge of Chlamydia 
 What is your understanding of the term Chlamydia? 
 What are the symptoms of Chlamydia infection 
 How is Chlamydia spread? 
 Can Chlamydia be treated? 
 How did you know about Chlamydia? 
 Do you think Chlamydia is a common problem among young people in Havering? 
 
About Chlamydia Screening 
 What do you know about screening tests for Chlamydia? 
 Why did you get tested for Chlamydia? 
 Will you go for another test in future, if not why? 
 What discourages other young people from getting tested for Chlamydia? 
 What can health workers do to encourage more young people to get tested for 
Chlamydia? 
 
About emotional reaction to Chlamydia diagnosis 
 How did you feel when you received your results? 
 Did you tell your partner? 
 What kind of support did you get from health workers after the test? Was it 
adequate? 
 
About access to information and services 
 What do you think you and other young people should be told about Chlamydia? 
 Where would you like to access this information? 
 
About Chlamydia screening sites 
 What are the places you can get a screening kit in Havering? 
 Where would you be most comfortable acquiring one? (pharmacy, GP surgery, 
School/college nurse, youth club, sexual health clinic, local hospital) 
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Appendix 5.7: Participant Response Form 
                                                                                                      
 
Title of research study: Factors associated with Chlamydia screening and prevalence 
among young people in Havering. 
 
Thank you for your interest in taking part in this research study. In order for me to contact 
you and provide more details on interview/discussion venue, date and time, please 












Ever been screened for Chlamydia?  
(Please tick as applicable) 
 
Yes           No          Not sure  
If yes, where did you get the 
screening kit? 
(Please tick as applicable) 
 
GP Surgery                         Pharmacy     
School                                 College         
Youth Club             Ordered via website     
 







Telephone:                  Mobile: 
                                     






Preferred method of contact 
 
 
Mobile / Landline / Email  
             (Please delete what is not applicable) 
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Appendix 5.8: Study Advertisement 
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Appendix 5.9: Participant Support Services Information  
 
In case you feel distressed or anxious during an interview or focus group discussion please let the 
researcher know. You will be free to withdraw completely or take a short break and resume when 
able to. The following are important contacts in case you require further help afterwards. 
 
Your GP (Doctor)                                                                                                    
Contact your local GP. If the surgery is closed, please telephone your doctor's usual 
number.  An answer-phone message will give you information on how to access a doctor 
out of hours. 
 
Queen’s Hospital 
For pregnancy testing, Contraception, Sexually transmitted infections screening and treatment 
Romvalley Way, Romford, Essex, RM7 0AG, Tel. 02089246400 
                                                                                                                                                                                                                                                                                                 
NHS Direct 
NHS Direct provides confidential health advice 24 hours a day. Call NHS Direct on 0845 4647 or 
log on to NHS Direct Online www.nhsdirect.nhs.uk 
 
Chrysalis counselling project 
Free confidential counselling service to young people living, educated or working in Havering. For 
further information, call Lara on Tel: 07930 908 965 
 
Rape and Sexual Abuse Support  
Free and confidential support service for anyone affected by rape. 
Web: www.rasasc.org.uk 
Tel: 08451 221 331 (Mon-Fri, 12pm-2.30, 7pm-9:30pm. Sat-Sun, 2.30pm-5pm) 
Email: info@rasasc.org.uk 
 
Samaritans   
Confidential help for anyone who is experiencing feelings of distress or despair, including those 
which may lead to suicide. 
Web: www.samaritans.org.uk 
Tel: 08457 909090 
     
Sexual Health Help Line 
Information, advice and counselling on all aspects of HIV, AIDS and sexual health. 
Web: www.condomessentialwear.co.uk 
Tel: 0800 567123 
 
Sex-wise       
A helpline available to young people concerned about any sex-related issue. Trained helpers can 
also provide details of your nearest sexual health clinic.  
Web: www.ruthinking.co.uk 
Tel: 0800 28 29 30 
Brook Advisory Centres                                                                                                 Advice, 
counselling and medical help on contraception, pregnancy, abortion and sexual health. 
Web: www.brook.org.uk/ 
Tel: 0808 802 1234   Text: 81222 (text BROOK INFO for information or BROOK SERVICE + 
your postcode for local services 
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Appendix 5.10: Havering deprivation scores aggregated 
to ward level 
 
Ward Name IMD Quintile (a) Local Rank (b) IMD Score 
(c) 
Gooshays 1 (most deprived) 1 32.18 
Heaton 1 (most deprived) 2 28.89 
St Andrew's 1 (most deprived) 3 23.18 
Havering Park 1 (most deprived) 4 21.65 
Romford Town  2 5 18.68 
Brooklands 2 6 18.11 
Elm Park  2 7 16.66 
Rainham & Wennington 3 8 16.56 
Harold Wood 3 9 16.42 
Mawneys 3 10 16.2 
Squirrel's Heath 3 11 13.46 
South Hornchurch  4 12 11.15 
Hylands 4 13 11.1 
Hacton 4 14 10.03 
Pettits 5 (least deprived) 15 9.84 
Emerson Park  5 (least deprived) 16 8.78 
Cranham 5 (least deprived) 17 7.68 
Upminster 5 (least deprived) 18 6.7 
Havering      16.7 
 
Source: NHS Havering, Key Health Data 
 
 
 a. The 2007 IMD local quintiles are 
provided.  For example, if the 
value is 1, it means that the ward 
is in the 20% most deprived 
wards locally, and a value of 5 
means that the ward is in the 
20% least deprived wards locally. 
 
b. The local ranks are provided with 
a value of “1” denoting the most 
deprived areas locally and 18 
denoting the most affluent areas 
locally. 
 
c. The IMD scores for the wards of 
Havering the higher the IMD 
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Appendix 5.11:  A Map of Havering Local Deprivation 




Ordnance Survey Crown copyright 2008. All rights reserved. License number 100048745 
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Appendix 5.12: Chlamydia Fact Sheet 
What is Chlamydia? 
Genital Chlamydia infection is a sexually transmitted infection caused by the bacterium, 
Chlamydia trachomatis. It is the most commonly reported bacterial sexually transmitted 
infection at GUM clinics in the United Kingdom. 
  
Who gets Chlamydia? 
Anyone who has sex can get genital chlamydial infection. The people at risk are those 
having unprotected sexual intercourse (i.e. not using condoms), especially those with more 
than one sexual partner and those who change sexual partners. Eye infection can occur in 
adults and in infants who are born to infected women. Rates are highest in young people, 
especially men and women under 25 years of age. 
  
How do you catch Chlamydia? 
Genital Chlamydia is a sexually transmitted infection. It is caught through unprotected 
vaginal, oral or anal sex or genital contact with an infected partner. An infected person will 
frequently have no symptoms of Chlamydia, however he or she can still infect a partner 
without knowing. Genital Chlamydia cannot be caught by casual contact (toilet seats, 
swimming pools, saunas). Pregnant women can pass infection to infants during birth. 
  
How do you know that you have Chlamydia? 
At least 50% of infected men and 70% of women do not have any symptoms and 
consequently a large proportion of cases remain undiagnosed. A person may carry the 
infection, have no symptoms and be able to pass it on to any sexual partner during that 
time. Of those with symptoms of genital Chlamydia, women may experience some unusual 
vaginal discharge, bleeding between periods, pain when passing urine and lower 
abdominal pain. Men may experience discharge from the penis, burning and itching in the 
genital area, and pain when passing urine. Symptoms may persist but in some cases, they 
may only last for a few days then disappear. If symptoms do occur, they start 1-3 weeks 
after becoming infected. 
  
How serious is Chlamydia? 
If left untreated, chlamydial infections can progress to serious reproductive and other 
health problems. In women, untreated infection can cause chronic pelvic pain and lead to 
pelvic inflammatory disease (PID), ectopic pregnancy and infertility. An infected pregnant 
woman, who does not receive antibiotic treatment prior to delivery, can also pass the 
bacteria on to her baby causing it to be born with conjunctivitis (inflammation of the lining 
of the eye) or pneumonia. However, both are treatable 
In men, complications are rarer but can include epididymitis (pain and swelling around the 
testicles) and Reiter's Syndrome (arthritis). 
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What is Pelvic Inflammatory Disease (PID)? 
Pelvic inflammatory disease affects the uterus, ovaries and fallopian tubes and is caused by 
micro-organisms migrating from the lower to upper genital tract. 
Chlamydia is a common cause of PID and the risk of PID increases with the number of 
Chlamydia episodes. 
  
What are the complications of PID? 
Up to 1 in 5 women who develop PID will consequently become infertile and the risk of 
ectopic pregnancy greatly increases. Furthermore, the risk of infertility will increase if a 
woman has more than one episode of PID. The consequences of PID are not easily 
treatable and can have lifelong implications for the individuals concerned. 
  
How can you protect yourself against Chlamydia? 
Sexually active men and women can reduce their risk of Chlamydia by reducing their 
numbers of partners, reducing frequency of partner change, and by using condoms 
correctly and consistently during sexual intercourse. 
  
How is Chlamydia diagnosed? 
Recently, new laboratory tests have been introduced to diagnose genital chlamydial 
infections using non-invasive samples, such as urine or self-taken vulva-vaginal samples. 
Most testing for sexual infections is done in STI clinics (also called genitourinary medicine 
or GUM clinics) which have specialist facilities for testing and systems for contacting, 
testing and treating sexual partners. Details of these clinics can be found in the telephone 
book, from your local hospital or from the STI clinic directory on the web site of the 
British Association for Sexual Health and HIV (www.bashh.org). Clinics are confidential 
and will not inform GPs of any results, unless specifically requested to do so. You can 
attend one of these clinics at any age (even if you are under the age of consent to sex which 
is 16). The National Chlamydia Screening Programme works to ensure that all sexually 
active men and women under 25 years of age are aware of Chlamydia, its effects, and have 
access to services providing screening, prevention and treatment to reduce their risk of 
infection or onward transmission.   To find out more about the NCSP log on to: 
 http://www.chlamydiascreening.nhs.uk. 
 
Some people now choose to be tested for Chlamydia and some other infections when 
starting a new sexual relationship. 
A person with confirmed Chlamydia should also be offered screening for other sexually 
transmitted infections, which may be present without symptoms. 
  
How is Chlamydia treated? 
Once diagnosed, uncomplicated chlamydial infection is easy to treat and cure. 
There are a number of antibiotics which are used to treat chlamydial infection. 
Azithromycin (single dose) or Doxycycline (twice daily for 7 days) are currently the most 
commonly prescribed treatments. Recent sexual partners (within the last six months) of an 
infected person should be tested and treated to prevent re-infection and further spread of 
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disease. Partners need to be tested whether or not they show symptoms of infection and 
may be offered treatment whether or not a positive diagnosis is made. 
  
What is the National Chlamydia Screening Programme (NCSP)? 
The NCSP in England aims to: 
Prevent and control Chlamydia through early detection and treatment of asymptomatic 
infection, reduce onward transmission to sexual partners and prevent the consequences of 
untreated infection. The NCSP aims to ensure that all sexually active men and women 
under 25 years of age are aware of Chlamydia, its effects, and have access to services 
providing screening, prevention and treatment to reduce their risk of infection or onward 
transmission. 
 
Source: Health Protection Agency, England. Available at: 
http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/Chlamydia/GeneralInform
ation/ Accessed 15.07.2011 
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Appendix 5.13: Brunel University Research Ethics 
Committee Approval Letter 
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Appendix 5.14: NHS Research Ethics Committee 
Approval Letter 
 
